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Bronchiolitis is a viral lower respiratory tract infection of infancy and a major cause 
of infant morbidity. Respiratory syncytial virus is the most common cause of 
bronchiolitis. The majority of infants infected with bronchiolitis will have mild 
symptoms, lasting up to five days with the infant being successfully managed at 
home. However, up to 3% of all infants will be admitted to hospital for supportive 
therapy, such as oxygen and/ or fluids. A small proportion of these hospitalised infants 
(10%) will rapidly deteriorate further and require critical care admission for either 
invasive or non-invasive ventilation.  
Many clinical trials have been undertaken to evaluate a number of pharmaceutical 
interventions used to treat bronchiolitis. However, no treatment intervention has been 
proven to be effective. A large proportion of these clinical trials used clinical severity 
scores as an outcome measure. These clinical severity scores had not undergone any 
rigorous development and validation as recommended by the Food and Drug Agency 
(FDA) when developing an outcome measure for clinical trials. 
This thesis sets out the psychometric methods used to develop and validate the 
Liverpool Infant Bronchiolitis Severity Score – Proxy Reported Outcome Measure 
(LIBSS-PRO). The premise of the LIBSS-PRO is two-fold. Firstly, the LIBSS-PRO has 
been primarily developed for use in daily clinical management to identify infant 
improvement or deterioration. This will contribute to the standardisation of patient care 
and facilitate clinical decision making. Secondly, by fulfilling the FDA criteria as an 
outcome measure the LIBSS-PRO will improve the quality of future clinical trials of 
treatment interventions for bronchiolitis. The study was divided into three phases over 
three bronchiolitis seasons. 
The first phase was concerned with the development of the LIBSS-PRO. Items 
were identified from the literature and through stakeholder group workshops. A 
conceptual framework of bronchiolitis severity was developed. Consensus methods 
were used to identify which items were considered the most important and to develop 
criteria for mild, moderate and severe bronchiolitis.  
The second phase determined the content validity of the LIBSS-PRO. The LIBSS-
PRO was evaluated by a range of health care professionals working in a variety of 
clinical environments by applying the score to eligible infants. Cognitive interviewing of 
health care professionals was used to assess comprehension and interpretation of 
each section of the LIBSS-PRO.  
Finally, in phase three, clinical field testing was undertaken in a variety of clinical 
locations by health care professionals to establish construct and criterion validity and 
reliability of the LIBSS-PRO. Responsiveness to change and cross cultural validation 
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1  Introduction 
 Bronchiolitis 1.1
Bronchiolitis is a common lower respiratory tract infection and a significant 
cause of morbidity within the first 12 months of life (1). There is a spectrum of 
disease from mild lower respiratory tract symptoms to respiratory failure 
requiring mechanical ventilation (2). Most infants experience mild symptoms 
and can be successfully managed in a community setting (3). However, 
approximately 3% of all infants (defined as a child less than one year) are 
admitted to hospital with bronchiolitis, usually during the seasonal epidemic 
over the Christmas period in the Northern hemisphere (4, 5). Hospitalisation 
with bronchiolitis peaks between three and six months of life for most infants 
(6). Epidemiological studies show that it is a leading cause of morbidity 
amongst infants less than one year of age in the developed world (7-11).  
 Respiratory syncytial virus 1.2
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis 
in infants, and is the single most common cause of hospital admissions in 
infancy (6). In 2005, it was estimated that 33.8 (95% Confidence Intervals (CIs) 
19.3-46.2) million new episodes of RSV associated respiratory infection 
occurred worldwide in children younger than five years with associated 
mortality ranging between 66, 000 – 199, 000 deaths (12). Hospitalisation 
rates for RSV infection have steadily increased over the past few decades 
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(13). About 28 per 1000 children in the United Kingdom (UK) are admitted to 
hospital with RSV bronchiolitis and RSV accounts for up to 45% of all hospital 
admissions for lower respiratory tract infections in children younger than two 
years of age, with inpatients tending to be younger and experiencing greater 
disease severity (14, 15). RSV is contagious and is thought to be spread by 
large droplets of secretions from an infected person, either via contamination 
of surfaces or hand-to-hand transfer (16). Viral replication is greatest and most 
prolonged in infants with viral shedding being detected in infants for up to 21 
days (7). In the UK, surveillance data suggests that bronchiolitis and RSV have 
similar winter seasonal trends with infection rates peaking during the coldest 
months (November-March) (6, 17). These trends are consistent with the rest of 
Europe (18), although the exact timing and duration of RSV seasons vary by 
region and year (19). Adenovirus, bocavirus, rhinovirus (RV) and human 
metapneumovirus (hMPV) are all viral pathogens that also cause bronchiolitis 
(10, 20). A large prospective study found that infants and children can be 
infected with more than one virus with a co-infection rate of approximately 6% 
(21). Laboratory tests for viral diagnosis include viral cultures, rapid antigen 
detection tests, polymerase chain reaction (PCR) and measurements of acute 
and convalescent antibody titres (22). Establishing the causative viral 
pathogen can be useful with respect to the management of these infants. This 
information enables healthcare professionals to consider the need for isolation, 
cohorting and other infection control measures to limit nosocomial infection 
and may help to reduce the need for other costly diagnostic investigations and 




Bronchiolitis is characterised by acute inflammation, oedema and necrosis 
of epithelial cells lining small airways, increased mucous production, and 
bronchospasm (25). The degree of airway obstruction due to mucous varies as 
these areas are cleared, resulting in rapidly changing clinical signs that 
confound an accurate assessment of the severity of illness (26). Diagnosis of 
bronchiolitis is not straightforward as RSV also is an important cause of croup 
and is responsible for a significant proportion of exacerbations of asthma in 
young children (27). Diagnosis is usually based on recent medical history and 
clinical findings on examination (22). Typical clinical features include coryza, 
difficulties in breathing, tachypnoea, recession, low oxygen saturations, cough, 
poor feeding, apnoea, irritability, low grade temperature, and on auscultation, 
wheeze and widespread crepitation (17, 22, 28). Although a number of these 
features are common to other lower respiratory tract infections for instance, 
bacterial infections, acute viral infections, viral induced wheeze, bronchitis and 
asthma (22, 27), there is currently no test available to help discriminate 
between bronchiolitis and these other clinically similar pathologies (22, 27). 
Studies have emphasized variations in terms of diagnosis, hospital 
admission, hospital length of stay, treatment interventions and management 
worldwide for bronchiolitis (29-33). In the UK, a 15 fold variation was found for 
children under the age of two years for hospital admission rates and a six fold 
variation for mean length of hospital stay (34). It was suggested that these 
variations were partly due to epidemiological factors, such as, socio-economic 
deprivation, maternal tobacco smoking during pregnancy, household tobacco 
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smoking and partly due to patient management, assessment or clinical 
admission criteria in the emergency department (2, 30). 
There is poor agreement between physicians worldwide on how to 
differentiate bronchiolitis from other early childhood wheezing phenotypes (27). 
This lack of a standard definition can impact on bronchiolitis treatment 
interventions and research recommendations. Definitions for bronchiolitis 
varied in terms of age, clinical findings and viral aetiology (35). Furthermore, if 
children with wheeze are enrolled into studies, it is likely that they will 
represent a spectrum of wheezing phenotypes with treatment response 
dependent on the specific phenotype (36). In the UK, bronchiolitis diagnosis 
tends to be restricted to the first 12 months of life to avoid misdiagnosis with 
early presentations of asthma and viral wheeze (17, 37). 
 Treatment  1.4
Despite these variations in diagnosis and management the mainstay of 
treatment is supportive care through nasal suction, oxygen therapy, fluid 
management, and in severe cases, ventilation (invasive or non-invasive (NIV)) 
(17, 25, 38). Due to perceived clinical similarities between asthma and 
bronchiolitis, treatments typical for asthma such as, inhaled bronchodilators, 
epinephrine, glucocorticoids and inhaled corticosteroids are often used in 
clinical practice to treat bronchiolitis. The effectiveness of these interventions 
has been assessed in clinical trials and systematic reviews. A Cochrane 
overview of 11 systematic reviews examined the efficacy and safety of a 
different bronchiolitis treatment interventions including: antibiotics, 
bronchodilators, chest physiotherapy, epinephrine, extra-thoracic pressure, 
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glucocorticoids, heliox, hypertonic saline, immunoglobulin, inhaled 
corticosteroids and oxygen therapy (35). The findings of this overview 
concluded nebulised epinephrine may be useful in outpatients to avoid 
hospitalisation, and nebulised 3% hypertonic saline may help reduce length of 
hospitalisation. Since the publication of this overview three of the included 
systematic reviews have been updated (39-41). Despite identifying and 
incorporating more recently published trials into these reviews the conclusions 
remain largely unchanged. Hypertonic 3% saline was found to be the only 
intervention to show any benefit by significantly reducing length of hospital 
stay, clinical scores and having no significant adverse events (41). However, a 
recent large randomised controlled trial (RCT) undertaken in the UK, 
investigating the effectiveness of 3% hypertonic saline compared with standard 
care, found no difference between the two arms for the primary outcome: time 
for being declared fit for discharge (hazard ratio (HR): 0.95, 95% confidence 
intervals (CIs) [0.75−1.20]) (42).  
Several other Cochrane systematic reviews, not included in the 
aforementioned overview, found insufficient evidence for the routine use of 
recombinant deoxyribonuclease (rhDNase) (43), steam inhalation and humidity 
(44), exogenous surfactant (in mechanically ventilated infants) (45), 
immunoglobulins (46), nasal continuous positive airway pressure (nCPAP) (47) 
and high flow nasal cannula (HFNC) (48). All of these reviews concluded that 
further research in the form of large multi-centred RCTs is required. Finally, 
one systematic review and network meta-analysis demonstrated a benefit for 
adrenaline on clinically relevant outcomes amongst outpatients and there may 
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be a beneficial synergistic effect between adrenaline and dexamethasone 
although further research was required (49).  
 Outcome measures 1.5
A heterogeneous group of outcomes were used to evaluate the 
effectiveness of bronchiolitis treatment interventions within the aforementioned 
systematic reviews. These include: rate of hospital admission; length of stay 
(either hospital or paediatric intensive care unit (PICU)); change in clinical 
severity score; hospital re-admissions; need for ventilation (invasive or NIV); 
oxygen saturation; pulmonary markers; wheeze; adverse events (35). These 
outcomes were found to be inconsistently measured. For instance, admission 
and length of stay could be influenced by external factors, such as, individual 
decision making or daily volume of patient admissions as opposed to the 
treatment under investigation (35, 50). Clinical scores were found to be limited 
by their inconsistency and have unknown clinical relevance (50). The absence 
of standardised and validated patient important outcomes has been 
considered a serious threat to bronchiolitis trial validity (50). 
Given the reliance on clinical judgement for referral and admission to 
hospital, bronchiolitis should be an ideal condition for a clinical severity scoring 
instrument to aid clinical decision making. However, two literature reviews 
undertaken as part of the development of bronchiolitis guidelines (17, 25), 
found neither good quality evidence of validated clinical scoring instruments in 
infants with acute bronchiolitis, nor any good quality studies on the 
effectiveness of indicators for referral from primary to secondary care, or for 
admission to the PICU. This was further supported by a more recent overview 
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of systematic reviews which highlighted the need for a validated, reliable 
scoring instrument that is sensitive to important clinical changes in patients 
with bronchiolitis (35). Furthermore, it was found that clinical trials using 
unpublished outcome measures were more likely to report the treatment under 
investigation as being more effective than the comparison group suggesting 
detection bias (51). 
 Critical appraisal of bronchiolitis scoring instruments 1.6
Prior to developing a new outcome measure, a search of the literature and 
critical appraisal of existing outcome measures for their measurement 
properties (validity, reliability and responsiveness to change) is recommended 
(52, 53). This has become a prerequisite due to the burgeoning number of 
health outcome measures used in clinical practice and research (54). However 
critical appraisal of existing instruments is often poorly undertaken (53).  
An electronic search to identify validated, published severity scoring 
instruments for use in infants with bronchiolitis was undertaken in the following 
databases; Medline, EMBASE, CINAHL and Cochrane Library. Seven studies 
that developed and validated a bronchiolitis scoring instrument were identified 
(1, 33, 55-60). The COSMIN (Consensus Based Standards for the Selection of 
Health Measurement Instruments) checklist was modified and adapted for use 
together with the Food and Drugs Administration (FDA) criteria for the 
development to facilitate critical appraisal of these seven instruments (54, 61).  
Of these seven studies, four developed scoring instruments for use in 
generic childhood respiratory conditions (56, 58, 60, 62), and three were 
specific for bronchiolitis (1, 33, 59). The development and validation of these 
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instruments were undertaken in the following countries: Canada (58, 60); 
United States of America (USA) (33, 55, 56); UK (1); Republic of Ireland (59). 
The clinical settings in which these instruments were developed included: 
primary care (60); emergency department (ED) (1, 63); hospital (secondary or 
tertiary) (33, 55, 56, 58). As can be seen, the generalisability of these 
instruments may be limited to certain countries and clinical settings. 
Jacobs et al (2000) developed the Canadian Acute Respiratory Infection 
and Flu Scale (CARIFS) in Canada (60). This instrument was developed for 
use by parents at home, with children up to 12 years of age with an acute 
respiratory infection. This instrument consisted of 18 items, responses to which 
used a four point ordinal scale: 0=no problem; 1=minor problem; 2=moderate 
problem; 3=major problem. The score for each item is summed and interpreted 
as 0 (best possible health) to 54 (worst possible health). Psychometric testing 
was undertaken on 206 children with 65 children falling within the 0-2 year age 
group. RSV was isolated in 29 children. Independent assessments for mild, 
moderate and severe illness were undertaken by either a physician or a nurse. 
The CARIFS score was validated using construct validity and responsiveness 
to change. Construct validity was determined by comparing the CARIFS with 
an assessment by either a health care professional (HCP) or a parent. The 
CARIFS score was also compared with the Yale Observation score. The 
authors reported good correlation between the CARFIS and physician 
assessment (0.36), nurse assessment (0.44) and Yale Observation score 
(0.48). The CARIFS mean score changed from 28.0 (10.3) on day one to 2.5 
(5.7) on day 14. 
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Lui et al (2004) developed a four item instrument respiratory score for use 
by HCPs with children who are diagnosed with asthma, bronchiolitis or other 
wheezing phenotypes (55). Each item in the instrument was answered using a 
scale ranging between 0 and 3 points. These were then summed together to 
provide an overall score total. There was no instruction provided on how to 
interpret the score total. Fifty-five children participated with the inter-rater 
reliability testing. Of these 55 children, 28 children were aged below 24 months 
and 17 were diagnosed with bronchiolitis. The overall agreement for the rater 
pairs was 84% with a weighted kappa of 0.62 (95% CIs not provided). For the 
age group below 24 months the agreement was 80% with a weighted kappa of 
0.39 (95% CI, 0.12-0.72). 
Lowell et al (1987) developed the Respiratory Distress Assessment 
Instrument (RDAI) as an outcome measure for clinical trial of nebulised 
epinephrine (56). The instrument was developed for use by HCPs in children 
below 24 months of age with a diagnosis of asthma, bronchiolitis or other 
wheezing phenotypes. The instrument comprised three items that were 
answered using a scale from 0 to 4 points with the score for each item being 
summed. There was no instruction on how to interpret the summed score. The 
results for the overall inter-rater reliability were not presented. Results for inter-
rater reliability were only presented for wheezing (96% agreement; weighted 
kappa 0.9) and retractions (96% agreement; weighted kappa 0.64).  
Marlais et al (2011) developed an instrument to predict hospital admission 
(Bronchiolitis Risk of Admission Scoring System) (1). This instrument was 
developed for use by HCPs in infants with a clinical diagnosis of bronchiolitis in 
the ED. The authors identified 29 items for inclusion from a literature review. A 
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logistic regression analysis was used to determine which items were significant 
in predicting admission. Five items were included in the final instrument. Each 
item was answered with either a score of 0 or 1, with the score for each item 
being summed. A cut-off value of three or greater indicated that the infant 
being assessed required admission.  
Walsh et al (2006) developed an instrument to predict hospital admission 
(63). The instrument was developed for use by HCPs in children up to 18 
months of age with a clinical diagnosis of bronchiolitis in the Republic of 
Ireland. It contained four items. Two items were answered with a dichotomous 
answer response: present (1) or absent (0). One item was answered by using 
their age in months and the final item was answered by deciding whether the 
infant had mild, moderate or severe dehydration. The score for each item was 
then multiplied with a number unique to that item then summed together. The 
cut-off values suggested a score less than -0.645 indicated the child had ‘mild’ 
disease, whereas a score greater than 1.866 indicated ‘severe’ disease. Inter-
rater reliability was assessed in a cohort of children in the USA. There was 
good agreement for severity of illness (actual agreement, 91.3%; (kappa 
=0.676). (59) 
Wang et al (1992) modified an existing scoring instrument (58). The 
instrument was developed for use by HCPs in children up to the age of two 
years of age with a clinical diagnosis of bronchiolitis or pneumonia. The 
finalised instrument had four items with each item being scored on a scale 
from 0 to 3. The score of each item was summed together. For inter-rater 
reliability the Kappa was 0.48 for general assessment, 0.38 for respiratory rate, 
0.31 for wheeze and 0.25 for retractions.  
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Wilson et al (2000) evaluated the paediatric component of the 
Comprehensive Severity Index (CSI) in a group of children who had been 
coded with ICD-9 codes for bronchiolitis (33). This score had been modified 
from the adult CSI. This instrument comprised seven domains and 27 items. 
Each item is answered using a four point scale: level 1 through to level four. 
The score total was a composite of the scores for each item. There was no 
instruction on how to interpret the summed score. To validate the score the 
authors appear to have applied the instrument retrospectively to the charts of 
the children included in the cohort. The CSI scores were more strongly 
correlated than the Paediatric Risk of Mortality (PRISM) III scores (24 hours) 
for costs CSI (r2 =0.23) versus PRISM III (r2 =0.07); p<0 .0001 and length of 
stay CSI (r2 = 0.23) versus PRISM III (r2 = 0.07) p<0 .0001.  
Overall, there was minimal conceptual work undertaken within the studies to 
identify all important domains and items relevant to bronchiolitis. Furthermore, 
there was limited consultation with key stakeholder groups such as, nurses, 
physiotherapists and parents and/or carers. Four of these instruments require 
the user to be able to auscultate the chest for wheeze (33, 55, 56, 63). In the 
UK, this requirement immediately excludes a large number of HCPs as chest 
auscultation is not a skill routinely taught to nurses (though, it is debatable how 
much auscultation actually adds to clinical severity assessment as inter-rater 
reliability between physicians has been proven to be poor) (64). None of the 
studies evaluated instrument face validity or acceptability. There was limited 
evidence presented to indicate that rigorous psychometric testing had been 
fully undertaken to establish both validity (content, construct and criterion) and 
reliability (61). For instance, the RDAI was developed and “validated” in 
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tandem with its use as the primary outcome measure in a randomized 
controlled trial investigating the use of epinephrine in infants with bronchiolitis 
(56). Three studies provided fair evidence of content validity testing (1, 60, 63). 
Two studies provided fair evidence for construct validity (1, 60) and four 
studies provided fair evidence for reliability testing (33, 55, 56, 63). No study 
undertook cognitive interviews or cross-cultural validation. No study calculated 
sample size or any of the psychometric tests. Similarly, information on 
percentage of missing data was not provided or a description of how missing 
items were handled (Appendix 1).  
 Why is it important to develop and validate a bronchiolitis 1.7
severity score? 
There is a very real clinical need for the development of a robust clinical 
severity scoring instrument with broad application for infants with bronchiolitis. 
Assessment and early detection of changes in clinical condition would facilitate 
decisions such as; admission to hospital, escalation of treatment, weaning 
treatment and discharge. Furthermore the instrument may help to reduce the 
number of unplanned admissions to critical care and cardiopulmonary arrest. 
Integration of a clinical severity scoring instrument within current bronchiolitis 
care pathways would assist with the standardisation of patient care and reduce 
variation in clinical management. Moreover, a clear and effective gauge of 




 Aims and objectives 1.8
This thesis seeks to describe in detail the methods used to develop and 
rigorously validate the Liverpool Infant Severity Score-Proxy Reported 
Outcome (LIBSS-PRO) Measure. The principle function of the LIBSS-PRO 
measure is to assess severity of illness and evaluate treatment interventions in 
infants up to twelve months of age with a clinical diagnosis of bronchiolitis. The 
LIBSS-PRO is intended for use by nursing staff in the daily care and 
management of these infants. However, the LIBSS-PRO has been designed in 
such a way that it could be used by any HCP caring for these infants, in any 
clinical location within secondary/tertiary care settings in the UK.  
 Plan of investigation 1.9
To facilitate understanding, an overview of the plan of investigation will be 
presented. A more detailed description of each aspect of the LIBSS-PRO 
development will be reported and discussed within each discrete chapter. An 
overview of the study methods have been published in the Journal of 
Advanced Practice and on-line in the Core Outcome Measures in 
Effectiveness Trials (COMET) Initiative database (http://www.comet-
initiative.org/) (65). The methods will be covered briefly in this thesis. The 
development and validation of the LIBSS-PRO was undertaken in three linked 

















Figure 1: Study overview flow diagram 
The aim of phase one was to generate a pool of domains and items for 
potential inclusion into the LIBSS-PRO. These domains and items were 
identified using top-down (literature review) and bottom-up (stakeholder 
consultation) approaches (Chapters 2-5). The Delphi survey of HCPs provided 
expert consensus over which of the identified items should be included in the 
LIBSS-PRO and which items were redundant (Chapter 6). A conceptual 
framework of bronchiolitis severity was formed based on the agreed domains 
and items. This framework was used to develop the LIBSS-PRO.  
The purpose of phase two was to assess the content validity of the LIBSS-
PRO within the clinical environment. The LIBSS-PRO was applied to infants 
with bronchiolitis. Included domains and items were assessed for relevance. 
The domains and items were also assessed to ensure they covered the 
Phase I: Item generation and reduction 
 Literature Review 
 Stakeholder Consultation (Focus Group Workshops) 
 Stakeholder Consultation (Parent Interviews) 
 Stakeholder Consultation (Delphi Survey) 
 Development of Bronchiolitis Conceptual Framework 
Phase II: Content validity testing 
 Face Validity Testing 
 Content Validity Testing  
 Cognitive Interviews with HCPs 
Phase III: Validity and reliability testing 
 Construct Validity 
 Criterion Validity 
 Inter-rater Reliability 
 Test-retest Reliability 
 Final revision of the LIBSS-PRO 
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concept of bronchiolitis severity. In addition to this, response burden and 
acceptability was assessed and redundant items identified (Chapter 7). 
Cognitive interviews were used to assess comprehension and identify issues 
with answer responses (Chapter 8).  
Finally, phase three was concerned with developing cut-off values to 
determine ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis (construct validity), with 
examining the agreement between the LIBSS-PRO and a clinically agreed 
reference standard (criterion validity), and with assessing LIBSS-PRO score 
agreement between HCP dyads at two different time points (reliability) 
(Chapter 9). As with phase two, response burden and acceptability were also 
assessed. Items which performed poorly in field-testing were considered for 
removal. Following field-testing, the LIBSS-PRO was further revised ready for 
final validation (responsiveness to change and cross-cultural validity) in a 
future RCT. 
The study protocol was reviewed and approved by the National Health 
Service (NHS) National Research Ethics Service, January 2011 
(10/H1002/76). The study was funded through a National Institute of Health 






2  Literature review 
A preliminary step in devising items for a new scoring instrument is to 
examine those used in previously developed scoring instruments (52). In this 
chapter the literature review methods used to identify signs, symptoms and risk 
factors of bronchiolitis are described, and a narrative synthesis of the results, 
with a particular focus on risk factors, have been presented. 
 Aims 2.1
Phase one aimed to identify signs, symptoms and risk factors of 
bronchiolitis to be considered for inclusion into a bronchiolitis severity score. 
 Methods 2.2
  Criteria for considering studies for this review 2.2.1
2.2.1.1 Types of studies 
Guidelines, RCTs, systematic reviews of observational studies and 
observational studies (cohort or case control), specifically investigating 
bronchiolitis, were included. 
2.2.1.2 Types of participant 
Studies that included infants up to the age of 12 months with a clinical 
diagnosis of bronchiolitis were eligible for inclusion. Bronchiolitis was defined 
using the SIGN (2006) criteria, i.e. an infant with nasal discharge and a 
wheezy cough, in the presence of fine inspiratory crackles and/ or high pitched 
expiratory wheeze, with or without apnoea (17). 
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2.2.1.3 Exclusion criteria 
Studies were excluded if they: 
 Were not published in English  
 Included animal subjects 
 Did not present bronchiolitis data separately from other lower respiratory 
tract infections 
 Comprised reviews, letters, commentary or case reports 
  Search methods for identifying studies 2.2.2
Studies were identified through searching the following databases: 
Cochrane Central Register of Clinical Trials (CENTRAL) (The Cochrane 
Library 2015, Issue 9); OvidSP MEDLINE (2000 to January 2015); OvidSP 
EMBASE (2000 to January 2015) and NHS Evidence CINAHL (2000 to 
January 2015). The search was initially undertaken in January 2011 and was 
updated in January 2015. All index terms were exploded. Due to the volume of 
research published, the electronic search for observational studies examining 
risk factors for severe bronchiolitis and signs and symptoms was restricted by 
date: year 2000 to 2015. However, there was no date restriction imposed on 
published or unpublished clinical scores used to assess severity of illness in 
bronchiolitis. The search strategy used can be found in Appendix 2. 
  Selection of studies 2.2.3
All the titles and abstracts from the search results were scrutinized against 
the inclusion criteria described above to identify potentially eligible studies from 
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the search. Full publications were obtained for those studies that appeared to 
meet the inclusion criteria. 
  Data extraction and management 2.2.4
The following data were extracted from the included studies and tabulated: 
first author, reference, country, population, sample size, exposure, outcomes, 
signs, symptoms, risk factors and outcome measure effect estimates. Data 
were also extracted on how bronchiolitis severity was defined and measured. 
A quality assessment was not undertaken and was considered unnecessary 
due to individual study outcomes not being included in a statistical synthesis. A 
narrative synthesis was used to summarise the results of the included studies 
in this review. 
 Results 2.3
  Signs and symptoms for bronchiolitis 2.3.1
One hundred and ninety six bronchiolitis signs and symptoms were 
extracted from guidelines, observational studies and from existing scoring 
instruments (published and unpublished) (Appendix 3). The included scoring 
instruments comprised generic respiratory scores and asthma scores as well 
as bronchiolitis scores. All of these instruments had been used as outcome 
measures within bronchiolitis research. 
  Risk factors for bronchiolitis 2.3.2
The yield from the electronic database search was 2,887 studies. 2,779 
studies were excluded due to overlap between databases or did not fulfil the 
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review inclusion criteria. A full publication was obtained for 108 studies. 
Following further scrutiny, an additional 58 studies were excluded, as they did 
not meet the inclusion criteria. Fifty studies with a sum total of 166,4938 




























Figure 2: Search flow diagram 
Database search     2,887 
 
Medline:                                680 
Embase:                               881 
CINAHL:                                 93 
CENTRAL:                          1,233 
 
Excluded studies 2,779  
 
Due to either an overlap 
between databases or did not 
fulfil inclusion criteria 
   
 
 
Full paper review:  108
  
Excluded: 58 
Included studies:  50 
Al-Shehri (2005); Banerji (2009); Bloemers (2007); Bockova (2002); Boyce (2000); Bulkow, (2002); 
Calvo (2008); Carbonell-Estrany (2000); Carbonell-Estrany (2001); Carroll, (2007); Carroll, (2008); 
Chan (2002); Cilla (2006); Doering (2006); Dornelles (2007); Eriksson (2002); Figueras-Aloy (2004); 
Figueras-Aloy (2008); Garcia, (2010); Gavin (2007); Grimwood (2008); Hervas (2012); Kaneko (2001); 
Karr (2006); Karr (2007); Karr  (2009); Koehoorn, (2008); Kristensen (2009); Kristensen (2012); Law 
(2004); Liese (2003); von Linstow (2008); Mansbach (2005); Marguet (2009); Nielsen (2003); Norwood 
(2010); Nishimura (2009); Murray (2014); Papenburg (2012); Paranjothy,(2013); Pedersen (2003); 
Perzotti (2009); Ricart (2013); Rietveld, (2006); Rossi (2007); Semple (2005);  Semple (2011); Simon 




The included studies were undertaken in the following countries: Brazil (66); 
Canada (67-70); Denmark (71-75); France (76); Germany(77-79); Italy (80, 
81); Japan (82); Malaysia(83); Netherlands (84, 85); New Zealand (86); Saudi 
Arabia (87); Spain(88-93); Sweden (94); UK (2, 95-99); and USA (38, 100-
110). 
  Participants 2.3.3
Seven studies included otherwise healthy full term infants (38, 66, 73, 76, 
103, 104, 111). Eleven studies included only infants born pre-term (69, 75, 77-
80, 89, 90, 92, 93, 106). One study included infants born with Downs’ 
Syndrome (84). One study included infants born with congenital heart disease 
(71). Thirty studies included infants with or without any co-morbidity (2, 30, 68, 
70, 72, 74, 81, 82, 86, 94-99, 105, 107-110, 112-114). Three studies only 
included infants from particular ethnic communities: Inuit (67); Navajo and 
White Mountain Apache (100); and Alaskan Native (102).  
  Outcomes for severe bronchiolitis 2.3.4
The outcomes reported within these studies included: hospital admission 
(38, 67-73, 75, 77, 78, 80-82, 84-87, 89, 91-96, 100-104, 106-112, 115); 
duration of supplemental oxygen (66); supplemental oxygen requirement (91, 
105, 111); clinic visit (103); emergency department visit (103, 110); PICU 
requirement (99, 105, 112); mechanical ventilation (79, 97, 105); hospital 
length of stay (70, 76, 88, 105); clinical severity score (70, 113); apnoea (79); 
death (79, 98); fever (88); hypoxia (116); and respiratory failure (116). 
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  Risk factors for severe bronchiolitis 2.3.5
The following 23 risk factors for severe bronchiolitis were identified from fifty 
observational studies: atopy (69, 81, 87, 92, 104); chronic lung disease (CLD) 
(72, 75, 78, 80, 85, 87, 89, 94, 95, 101, 105, 113, 117); congenital heart 
disease (CHD) (71, 72, 79, 80, 82, 87, 91, 95, 99, 101, 105, 112, 113); day-
care attendance (69, 81, 92, 93); Downs’ Syndrome (71, 72, 84, 95, 105); 
environmental air pollution (107-109); ethnicity (38, 67, 86, 101, 104, 105, 
110); gender (38, 68, 69, 71, 75, 77, 78, 80, 85, 86, 91, 96, 99-101, 104, 106, 
110, 112); immunodeficiency (95); infection (viral or bacterial) (70, 76, 88, 97-
99, 105); low birth weight (2, 68, 74, 79-81, 85, 91, 104, 106); month of birth 
(38, 69, 73, 86, 91, 96, 106); neuromuscular disorders (72, 95, 105); non-
breast fed (66-68, 70, 73, 81, 87, 92, 93, 96, 102, 111); overcrowding (67, 69, 
92, 102); parental age (68, 80, 91, 96, 104); parental education (68, 80, 92, 
101, 104); prematurity (2, 70, 71, 73, 74, 79-81, 83, 85-87, 89-91, 95, 96, 99-
101, 105, 110, 112, 113); previous episode of bronchiolitis (81, 110); siblings 
(68-70, 78, 81, 86, 89, 92, 93, 104, 106); residence (68, 91, 101, 104); tobacco 
smoke exposure (2, 67-69, 73, 81, 86, 87, 90, 92, 93, 96, 101, 103, 104, 106); 
young age (70, 80, 81, 87, 89, 90, 92, 93, 99, 100, 110). Outcome data from all 
of these studies were extracted for each risk factor and tabulated. 
2.3.5.1  Atopy 
Five studies, (69, 81, 87, 92, 103) with a sum total of 106,665 participants 
examined atopy as a risk factor for bronchiolitis (Appendix 4). One study 
found maternal asthma increased the risk of hospital admission for an 
otherwise healthy infant with RSV positive bronchiolitis (Odds Ratio (OR): 1.45, 
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95% CIs [1.33–1.59]) (104). Conversely, another study did not find having an 
atopic parent significantly increased hospital admission (87). However, this 
study did find a significant increase in hospital admissions if there was an 
atopic child in the family (OR: 4.75, 95% CIs [3.98-5.16]) (87). There was also 
an increase in hospital admissions for pre-term infants with a family history of 
wheezing (OR: 1.83, 95% CIs [1.21–2.77]) or eczema (OR: 1.68, 95% CIs 
[1.08–2.63]) (92). Two studies found no significant difference in hospital 
admission for either eczema or a family history of allergy (69, 81). 
2.3.5.2  Chronic lung disease (CLD) 
Thirteen studies (72, 75, 78-80, 85, 87, 89, 94, 95, 101, 105, 113) with 
706,702 participants examined the effects of CLD as a risk factor for severe 
bronchiolitis (Appendix 5). Seven studies found an increased risk of hospital 
admission for those infants with CLD of prematurity (72, 78, 87, 89, 94, 95, 
101). It was also found that CLD of prematurity also significantly increased the 
risk of supplemental oxygen requirement (OR: 1.88, 95% CIs [1.32–2.67]); 
PICU admission (OR: 1.80, 95% CIs [1.12–2.89]); length of hospital stay (OR: 
1.47, 95% CIs [1.30–1.67]); apnoea (OR: 4.53, 95% CIs [2.19-8.92]); death 
(OR: 19.60, 95% CIs [2.96-104.3]) (79, 105); and clinical severity score (OR: 
7.2, 95% CIs [1.2–43.3]) (113). However, two studies failed to demonstrate 
that CLD of prematurity increased the risk of intubation or mechanical 
ventilation (79, 105).  
Two studies suggested that cystic fibrosis (CF) was a risk factor for hospital 
admission (72, 95). 
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2.3.5.3  Congenital heart disease (CHD) 
Thirteen studies with 704,994 participants examined the relationship 
between CHD and severe bronchiolitis (Appendix 6) (71 72, 79, 80, 82, 87, 
91, 95, 99, 101, 105, 112, 113). Five studies indicated that CHD was a 
significant risk factor for hospital admission, (71, 72, 80, 95, 101) but two 
studies did not (87, 112). CHD was also found to increase hospital length of 
stay; clinical severity scores (105, 113); supplemental oxygen (91, 105); PICU 
admission (79, 112); mechanical ventilation (OR: 2.77, 95% CIs [1.89-4.05]) 
(105) and mortality (RR: 2.98, 95% CIs [2.16-4.12]) (99). 
2.3.5.4  Day care attendance  
Four studies with a total of 8,270 participants investigated day care 
attendance as a risk factor for severe bronchiolitis (Appendix 7) (81, 92, 93, 
118). Two studies found that day care attendance increased hospital 
admission, (69, 81) whilst two studies did not detect a difference (92, 93). 
2.3.5.5  Down’s syndrome 
Five studies with a total of 694,235 participants investigated Down’s 
syndrome as a risk factor for severe bronchiolitis (Appendix 8) (71, 72, 84, 95, 
105). Four studies demonstrated an increased risk of hospital admission (71, 
72, 84, 95). Furthermore, one study found a significant increase in 
supplemental oxygen requirement (OR: 2.32, 95% CIs [1.27–4.21]) (105). 
2.3.5.6  Environmental air pollution 
Three studies examined the effect of air pollution on bronchiolitis (Appendix 
9) (107-109). It was unclear as to whether these three studies were presenting 
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data from the same study or for three individual studies. Therefore the number 
of participants for each study has not been summed. One study found an 
increased risk of hospital admission with an increase in fine particulate matter 
(Sub-chronic: OR: 1.09, 95% CIs [1.04-1.14]; Chronic: OR: 1.09, 95% CIs 
[1.04-1.14]) (107). One study found no significant increase in hospital 
admissions with increased ambient air pollution (108). One study found no 
significant association between bronchiolitis hospital admissions and distance 
between household residence and main transportation routes (109). 
2.3.5.7  Ethnicity 
Seven studies with over 112,582 participants investigated the role of 
ethnicity as a risk factor for severe bronchiolitis (Appendix 10) (38, 67, 86, 
101, 104, 105, 110). One study did not provide data on the number of included 
participants (38). Infants who were of full Inuit ethnicity had an increased risk of 
hospital admission (OR: 3.77, 95% CIs [1.12-12.75]) (67). Caucasian infants 
were found to have an increased risk of hospital admission (Incidence Rate 
Ratio (IRR): 1.3, 95% CIs [1.2-1.4]) (101). One study found no increased risk 
of hospital admission for black (OR: 0.66, 95% CIs [0.61–0.71]) or Latino (OR: 
0.87, 95% CIs [0.67–1.13]) infants (104). There was an increased risk of 
hospital admission for infants who were Maori (RR: 3.64, 95% CIs [2.27–
5.85]), Pacific island (RR: 3.60, 95% CIs [2.14–6.06]) or of ‘other’ ethnicity 
(RR: 1.09, 95% CIs [0.52–2.25]) (86). There was a reduced requirement for 
supplemental oxygen in black infants (OR: 0.49, 95% CIs [0.41–0.60]) (105). 
There was an increased intubation requirement for Hispanic infants (OR: 2.17, 
95% CIs [1.32–3.58]) (105). For those infants with an unspecified ethnicity 
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there was an increase in intubation requirement (OR: 2.37, 95% CIs [1.06–
5.29])) and PICU admission (OR: 1.59, 95% CIs [1.03–2.44]) (105).  
2.3.5.8  Gender 
Twenty studies with over 449,637 participants examined gender as a risk 
factor for severe bronchiolitis (Appendix 11) (38, 68, 69, 71, 75, 77, 78, 80, 
85, 86, 91, 96, 99-101, 104, 105, 110, 112). One study did not provide data on 
the number of included participants (38). Nine studies found male gender to be 
a significant risk factor for hospital admission (68, 69, 77, 78, 80, 85, 101, 104, 
110). One study found male gender reduced hospital admission (OR: 0.68, 
95% CIs [0.51-0.91]) (105), whilst another study found a reduction in hospital 
admissions for female infants (HR: 0.77, 95% CIs [0.75–0.80]) (96). There was 
a reduction in supplemental oxygen requirement in male infants (OR: 0.80, 
95% CIs [0.71–0.91]) (105). There was an increase in unscheduled ED visits 
for male infants (OR: 1.7 95% CIs [1.1-2.5]) (110). Although it was found that 
male infants did not have an increased risk of mortality (RR: 1.02, 95% CIs 
[0.75-1.4]) (99). 
2.3.5.9  Immunodeficiency 
One study with a total of 296,618 participants found no increased risk of 
hospital admission for bronchiolitis, in infants who had immunodeficiency (RR: 
1.69 95% CIs [0.80 to 3.58]) (Appendix 12) (95). 
2.3.5.10 Infection (viral and bacterial) 
Seven studies with 7,020 participants investigated the effect of viral and 
bacterial infections on bronchiolitis severity (Appendix 13) (70, 76, 88, 97-99, 
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105). The viruses isolated within these studies included: adenovirus (88); RV 
(76, 88); hMPV (76, 88); influenza A (88); influenza C (88); parainfluenza (88); 
enterovirus (88); coronavirus (88); cytomegalovirus (88); RSV (70, 76, 88, 97-
99, 105).  
Two studies compared infants with RSV to infants without RSV (70, 105). 
Both studies found that RSV infection significantly increased hospital length of 
stay (70, 105). Furthermore, it was found that RSV increased clinical severity 
score (RR: 4.04, 95% CIs [1.32–12.31]) (70); supplemental oxygen 
requirements (OR: 1.60, 95% CIs [1.40–1.82]) (105); and PICU admission 
(OR: 1.57, 95% CIs [1.25–1.98]) (105). One study compared infants infected 
with RSV to infants infected with either RV, hMPV or both (76). There was a 
reduction in length of hospital stay for those infants infected with RV (OR 0.13, 
95% CIs [0.03-0.57]) and hMPV (OR: 0.09, 95% CIs [0.01-0.69]) (76). Two 
studies compared infants with RSV to infants with RSV plus a viral co-infection 
(76, 88). One study found those infants with a co-infection had an increased 
hospital length of stay (OR: 1.12, 95% CIs [1.0-1.23]) (88). Conversely, one 
study found a reduction in length of stay in the co-infected group (OR: 0.26, 
95% CIs [0.09-0.76]) (76). Viral co-infections were also associated with 
increased fever (OR 2.36, 95% CIs [1.35–4.12]) and increased antibiotic 
therapy (OR: 2.3, 95% CIs [1.05–2.27]) (88). Finally, two studies did not detect 
a significant result for either PICU admission (99) or death (98) for those 
infants with RSV and a bacterial co-infection.  
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2.3.5.11 Low birth weight 
Ten studies with 122,604 participants investigated low birth weight as a risk 
factor for severe bronchiolitis (Appendix 14) (2, 68, 74, 79-81, 85, 91, 104, 
106). Six studies found that infants born with a birth weight below 3.0kg was a 
significant risk factor for hospital admission (68, 74, 80, 81, 85, 91). One study 
found that low birth weight did not increase the need for supplemental oxygen 
(OR: 0.94, 95% CIs [0.83-1.06]) or mechanical ventilation (OR: 0.48, 95% CIs 
[0.36-0.64]) (2). Another study found an increase in apnoea (OR: 3.73, 95% 
CIs [2.28 to 5.96]) and mortality (OR: 11.34, 95% CIs [2.09 to 61.65]) (79).  
2.3.5.12 Month/ season of birth 
Seven studies with over 323,258 participants investigated month or season 
of birth as a risk factor for severe bronchiolitis (Appendix 15) (38, 69, 73, 86, 
91, 96, 106). One study did not provide data on number of participants (38).Six 
studies were undertaken in the northern hemisphere (38, 69, 73, 91, 96, 106). 
One study found increased hospital admissions for those infants born in the 
months November, December and January (OR: 4.88, 95% CIs [2.57-9.29]) 
(69). Another study found hospital admissions were higher for those infants 
born in April and June (HR: 1.05, 95% CIs [1.03–1.08]), July and September 
(HR: 1.19, 95% CIs [1.17–1.22]) and October and December (HR: 1.22, 95% 
CIs [1.19–1.25]) compared with infants born between January and March.(96) 
One study found increased hospital admissions for those infants born between 
July to November (OR: 3.00 95% CIs [1.86-4.84]). None of the remaining three 
studies reached statistical significance. (38, 73, 91) One study was undertaken 
in the southern hemisphere (New Zealand) and found an increase in hospital 
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admissions for babies born between February and July (OR: 1.23 95% CIs 
[0.97-1.56]) (86).  
2.3.5.13 Neuromuscular disorders 
Three studies with 692,886 participants investigated neuromuscular 
disorders as a risk factor for severe bronchiolitis (Appendix 16) (72, 95, 105). 
Two found an increased risk of hospital admission for those infants with a 
neuromuscular disorder (72, 95). One study found an increased risk of PICU 
admission (OR: 2.79, 95% CIs [1.43–5.46]) and length of stay in (OR: 1.69, 
95% CIs [1.42–2.02]) (105). 
2.3.5.14 Breast feeding 
Twelve studies with more than 329,153 participants examined the 
relationship between breast feeding and severe bronchiolitis (Appendix 17) 
(66-68, 70, 73, 81, 87, 92, 93, 96, 102, 111). Two studies found non-breast fed 
infants had a significantly increased risk of hospital admission (67, 87). 
Furthermore, another study found an elevated risk of hospital admission for 
those infants whose mothers did not initiate breastfeeding in hospital (hazard 
rate ratio (HRR): 1.33, 95% CIs [1.14–1.54]) (68). Six studies found a reduced 
risk of hospital admission in infants and children who had been breast fed (70, 
73, 81, 92, 96, 102). Conversely, three studies found no difference in rates of 
hospital admission (87, 93, 111). Three studies examined the effect of breast 
feeding duration had on hospital admission (81, 92, 93). Only one study 
demonstrated a statistically significant difference which indicated infants who 
had breast fed for less than two months were more likely to have a hospital 
admission than those who breast fed for greater than two months (OR: 3.26, 
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95% CIs [1.96 to 5.42]) (92). One study found that for each month of exclusive 
breastfeeding, infants had an 11 hour reduction in oxygen use when admitted 
to hospital with bronchiolitis (p=0.011) (66). One study observed a significant 
reduction in oxygen requirement in fully (OR: 0.25, 95% CIs [0.07-0.89]) and 
partially (OR: 0.61, 95% CIs [0.20-1.87]) breast fed infants (111). 
2.3.5.15 Overcrowding 
Five studies with 8,586 participants investigated overcrowding as a risk 
factor for severe bronchiolitis (Appendix 18) (67, 69, 92, 93, 102). Three found 
overcrowding to be a significant risk factor for hospital admission (67, 92, 102). 
2.3.5.16 Parental age 
Five studies with 426,635 participants investigate parental age as a risk 
factor for severe bronchiolitis (Appendix 19) (68, 80, 91, 96, 104). Four 
studies found an increased risk of hospital admission for infants whose parents 
were aged below 25 years of age (68, 91, 96, 104). 
2.3.5.17 Parent education 
Five studies with 111,778 participants investigated parent education as a 
risk factor for severe bronchiolitis (Appendix 20) (68, 80, 92, 101, 104). Three 
studies found a significantly increased risk of hospital admission for those 
infants whose mothers had less than 12 years education (92, 101, 104). One 
study investigated the risk of hospital admission associated with maternal 
educational quartiles based on census data: high (greater than 44% of 
neighbourhood residents with postsecondary education); medium high (36% to 
44%); medium low (28% to 36%); and low (less than 28%) (68).There was an 
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increased hospital admission risk for three education quartiles: medium high 
(OR: 1.25, 95% CIs [1.08–1.46]); medium- low (OR: 1.41, 95% CIs [1.22–
1.64]); low (OR: 1.78, 95% CIs (1.55–2.06)) (68). One study observed 
significantly higher incidence rates of hospital admission for children born to 
mothers with less than eight years education when compared to those with 
greater than eight years education (p = 0.02) (80). 
2.3.5.18 Prematurity 
Twenty-four studies with in excess of 648,402 participants examined 
prematurity as a risk factor for severe bronchiolitis (Appendix 21) (2, 70, 71, 
73, 74, 79-81, 83, 85-87, 89-91, 95, 96, 99-101, 105, 110, 112, 113). Eleven 
studies found that those infants born before 37 weeks gestation were at 
increased risk of hospital admission (74, 80, 81, 85-87, 91, 95, 96, 100, 101). 
A further study also found an increased risk of hospital admission (OR: 3.44 
95% CIs [2.27-4.33]) but did not provide a definition of prematurity (87). 
Prematurity was also found to be a risk factor for supplemental oxygen 
requirement (OR: 1.36, 95% CIs [1.17–1.59]) (105); increased hospital length 
of stay (OR: 1.16, 95% CIs [1.11–1.22]) (105); PICU admission (79, 105, 112); 
mechanical ventilation (2, 105); and increased clinical severity scores (70, 
113). One study did not find prematurity was a risk factor for increased 
unscheduled ED visits (OR: 1.6, 95% CIs [0.8-3.2]) (110). 
2.3.5.19 Previous episode of bronchiolitis 
Two studies with 1,159 participants examined whether having a previous 
episode of bronchiolitis as a risk factor for severe bronchiolitis (Appendix 22) 
(81, 110). Having a previous episode of bronchiolitis was found to increase 
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hospital admission (OR: 1.85, 95% CIs [1.02-3.36]) (81) and unscheduled ED 
visits (OR: 1.7, 95% CIs [1.1-2.8]) (110). 
2.3.5.20 Siblings 
Eleven studies with 117,569 participants investigated siblings as risk factor 
for severe bronchiolitis (Appendix 23) (68-70, 78, 81, 86, 89, 92-94, 104). 
Nine studies found that having one or more siblings significantly increased 
hospital admission (68, 69, 78, 81, 89, 92-94, 104). Multiple births did not 
significantly increase hospital admissions (70, 86). 
2.3.5.21 Tobacco smoke exposure 
Sixteen studies with 541,384 participants examined the effect of exposure to 
household tobacco smoke as a risk factor for severe bronchiolitis (Appendix 
24) (2, 67-69, 73, 81, 86, 87, 90, 92, 93, 96, 101, 103, 104, 106). Eleven 
studies found that household tobacco smoke exposure significantly increased 
hospital admissions (67, 68, 73, 87, 90, 92, 93, 96, 101, 103, 104). One study 
found a significant increase in clinic visits (OR: 1.06, 95% CIs [1.01–1.12]) and 
ED visits (OR: 1.22, 95% CIs [1.13–1.31]) (103). Another study found an 
increase in supplemental oxygen requirement (OR: 2.23, 95% CIs [1.21-4.10]) 
and mechanical ventilation (OR: 2.23, 95% CIs [1.21- 4.10]) (2). 
2.3.5.22 Residence (suburban or rural) 
Four studies with 109,168 participants examined the impact place of 
residence had on severe bronchiolitis (Appendix 25) (68, 91, 101, 104). Three 
studies found living in a rural residence significantly increased hospital 
admission (91, 101, 104). Whereas one study found living in a rural residence 
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did not significantly impact on hospital admissions (68). In addition, two studies 
found living in a suburban residence also significantly increased hospital 
admissions (91, 104). 
2.3.5.23 Young age (less than 12 months) 
Eleven studies with 14,655 participants investigated whether young age 
(less than 12 months) was a risk factor for severe disease (Appendix 26) (70, 
80, 81, 87, 89, 90, 92, 93, 99, 100, 110). Seven studies found infants below 
the age of 12 months were at increased risk of hospital admission (70, 80, 81, 
87, 92, 93, 100). Whilst one study found hospital admissions reduced with 
increasing gestational age (OR: 0.85, 95% CIs [0.72-0.99]) (89). There was an 
increase in unscheduled ED visits for infants less than two months of age (OR: 
2.1, 95% CIs [1.1-4.3]) (110). Mortality increased for infants less than six 
weeks of age (RR: 2.98, 95% CIs [2.16-4.12]) (99). 
 Conclusion 2.4
In summary, 196 signs and symptoms and 23 risk factors were identified 
from the literature to be considered for inclusion as items into a bronchiolitis 
severity score. To date, there is no published comprehensive review that has 
summarised all the risk factors for severe bronchiolitis. Considerable 
heterogeneity was observed amongst the included studies in terms of 
geographical location, bronchiolitis definition, outcomes, and how outcomes 
were measured. Therefore it is questionable as to whether all the results of all 
these studies could be generalisable to a UK bronchiolitis population. The 
strengths of this review include pre-defining inclusion/exclusion criteria, and 
the rigorous methods used to search and identify studies for inclusion from 
34 
 
electronic databases. Despite this, there were a number of methodological 
limitations. The search was restricted by English language and date. 
Furthermore unpublished studies were not sought. These restrictions may 
have introduced publication bias and important studies may have been 
excluded. To reduce bias it is recommended to have two researchers 
independently assess studies for inclusion, extract data using a specifically 
developed data extraction sheet and appraise the quality of each included 
study (119). A meta-analysis to provide a pooled estimate for each of the risk 
factors was not undertaken either. This literature review was chosen to be 
pragmatic at the expense of using a more robust systematic review 
methodology. The reason for this was that undertaking a systematic review is 
time consuming and would have been difficult to complete within the allocated 
time. Critical time points for completion of the review were imposed to prevent 
the next stage of the study being delayed. Any delays with completion would 
have had a knock on effect with the rest of the study. It was crucial that delays 
in the development of the LIBSS-PRO were not incurred due to the number of 
discrete research projects planned within the overall study and more 




3  Family stakeholder group workshop 
Parents (including carers or legal guardians) of infants with bronchiolitis can 
offer a unique insight into the condition and therefore their perspectives should 
not be overlooked as a source of items for a potential severity score. Parents 
can facilitate with item wording, suggest general themes, evaluate 
completeness of item coverage and perform initial assessment of clarity and 
readability (52, 61). This chapter outlines a stakeholder group workshop with 
parents using nominal group technique (NGT) to elicit signs, symptoms, 
important outcomes and potential items. Focus groups enable data to be 
collected on ideas, attitudes, understandings and perceptions from a target 
population (120). Unique data are generated from dynamic group interactions 
which may not be achieved through other data collection methods, such as 
one-to-one interviewing (120, 121). The purpose of using NGT was to achieve 
a degree of consensus as to which domains or items should be included in the 
LIBSS-PRO. NGT uses democratic methods allowing all ideas to be presented 
and discussed before facilitating consensus prioritisation (122).  
 Aims 3.1
The aims of the family stakeholder group workshop were to: 
i) To identify signs and symptoms of bronchiolitis for potential inclusion as 
items in a bronchiolitis severity score. 
ii) To identify outcomes important to parents 
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 Sample and setting 3.2
Recruitment for the family stakeholder group workshop took place during 
February 2011. Participants were identified from four hospitals sites (one 
paediatric tertiary centre and three district general hospitals (DGH)) through 
the Cheshire and Merseyside Comprehensive Local Research Network 
(CLRN). Workshop participants were parents (including carers or legal 
guardians) of an eligible infant who had been recently discharged from hospital 
(within two weeks) with a clinical diagnosis of bronchiolitis. A purposive sample 
frame was devised (Appendix 27) to ensure representation of individuals with 
a wide range of personal experience. Families of eligible infants were stratified 
by their infant’s age, gender and severity of illness. CLRN research nurses 
initially approached parents with information on the workshop event during the 
infant’s hospital stay. Parents who expressed an interest in participating were 
contacted via telephone by Clare van Miert (CvM) and provided with further 
verbal and written information about the workshop event. The workshop was 
planned for approximately two weeks following hospital discharge to reduce 
the possibility of recall bias. It was held at a local family friendly attraction (Blue 
Planet Aquarium) in the North West of England. Crèche and play facilities were 
provided for infants and siblings. To facilitate family participation, travel 
expenses were reimbursed and each family was provided with an entry ticket 




 Informed consent 3.3
Written and verbal information was provided to parents prior to attending the 
workshop and again on the day of the workshop. Written informed consent 
was obtained from all participating parents on the day of the workshop.  
 Methods 3.4
Two researchers (CvM & Bernie Carter (BC)), trained in qualitative research 
methods, facilitated the workshop. Two research nurses (Janet Clark (JSC) & 
Julie Cummings (JC)) and a research administrator (Sarah Olsen (SO)) 
provided additional support. Informed written consent was obtained from all 
participants prior to the start of the workshop. CvM provided a brief introduction 
to the workshop and to outline the research aims and workshop schedule. The 
workshop lasted approximately three hours and was digitally audio recorded 
(Tascam DR-100). The recordings were transcribed verbatim and anonymised 
for analysis (CvM). JSC, JC & SO acted as observers throughout the workshop 
and recorded handwritten notes. These notes were used to document salient 
points made during the workshop, non-verbal communication/behaviour, 
issues which created tensions and the group dynamics. Spatial maps of the 
room layout and where participants and researchers were located were also 
included within the notes. 
At the beginning of the workshop the first NGT question (Table 1) was 
posed to the parents. Each parent was asked to silently reflect on the signs 
and symptoms their infant had displayed and which ones had given them 
cause for concern. This period of individual reflection was shortly followed by a 
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round-robin exercise whereby each parent was asked to share a sign or 
symptom to the group. This exercise continued around the group until no 
further new signs or symptoms were identified. All identified signs and 
symptoms were recorded on flip-charts. The group then discussed each of 
these signs and symptoms to clarify meaning, and to rationalise and condense 
similar signs and symptoms. Parents were then asked to group related signs 
and symptoms together, categorise them under an overarching heading 
(domain) and develop a statement(s) for each domain. Finally, parents were 
asked to rank each of the statements in order of importance. This process was 
repeated for the second NGT question which aimed to identify improving signs 
and symptoms. The rationale for identifying signs and symptoms of 
deterioration (question 1) and improvement (question 2) in infants with 
bronchiolitis was to ensure that the finished scoring instrument was responsive 
to change in clinical condition. 
The final NGT question was used to explore parental experiences of their 
infant having bronchiolitis. The structured NGT process that was used to elicit 
answers for the first two questions (individual silent reflection and sharing) was 
not used for final NGT question. Instead parents were asked to freely describe 
their experiences: the researcher’s followed their responses up by using 





Table 1: NGT Questions (family stakeholder group workshop) 
NGT Question 1: What prompted you to seek medical help when your baby became 
unwell? 
NGT Question 2: How did you know when your baby was improving? 
NGT Question 3: What could have improved your experience of having a baby with 
bronchiolitis? 
 Analysis 3.5
All audio-recorded discussions were transcribed by CvM. The NGT ranking 
process by the participants within the group provided an initial form of data 
analysis. CvM analysed the other data sources derived from the workshop. 
These data sources included the audio-recorded discussions that had taken 
place. The lists of words and phrases written down by the parents, words and 
phrases recorded on flip charts, and field-notes made by the observers during 
the workshop, and those made by CvM and BC, were also analysed. The 
workshop transcript and these extra data sources were examined iteratively 
several times during the course of the analysis. Initial examination of the 
collected data was used to obtain an overview of the data and to record any 
general impressions, key ideas, themes and concepts arising from the content. 
Following on from this a descriptive thematic analysis was undertaken (124). 
This process involved manually coding the raw data then collapsing the coded 
data under broader themes. Codes and themes were inductively derived from 
the data. As new codes emerged, these were applied iteratively to the whole 
data set in subsequent examinations of the data sources until no new codes or 
themes were identified. Finally, a descriptive account was produced for each 
theme. QRS NVIVO (Version10) software was used to support the coding and 
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synthesis of the collected data. Field notes were used to support the analysis 
through describing the environmental geography, participant interaction, group 
dynamics, behaviour and non-verbal communication. Field notes also enabled 
the lead researcher to reflect on the workshop and record any meaningful 
thoughts and insights. 
 Results 3.6
The aim was to recruit ten families to participate with the workshop. 
However due to the short two-week timeframe between hospital discharge and 
the workshop event, fewer families (n=7) than anticipated agreed to 
participate. Ultimately, only five families (nine parents) attended the workshop 
event on the day. Family names were anonymised with the following labels F 
01, F 02, F 03, F 04 and F 05. For the purpose of anonymity, all infant names 
used within the narrative have been changed. Family characteristics are 
described in Table 2. 
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Table 2: Family stakeholder group workshop - characteristics 




No previous experience (n=2) 
Infant with more than one episode of bronchiolitis 
(n=2) 




Male     (n=4) 




Gender (infant) Female (n=3) 
Male     (n=2) 
Ethnicity (infant) White British (n=4) 
Mixed race (n=1) 
Prematurity (infant) <37 weeks (n=2) 
>37 weeks (n=3) 
Co-morbidity (infant) Yes (n=0) 
No   (n=5) 
Severity of illness 
(infant) 
Severity of Illness (infant)  
Mild (n=1) (no hospital admission) 
Moderate (n=1) (hospital admission for oxygen/ 
feeding support) 
Severe (n=3) (required non/invasive ventilation) 
Number of children 
in household  
Family F 01   (n=1) 
Family F 02   (n=2) 
Family F 03   (n=3) 
Family F 04   (n=1) 
Family F 05   (n=3) 
  NGT questions one and two: round robin exercise 3.6.1
A sum total of 91 ‘worsening’ and 27 ‘improving’ signs and symptoms were 
identified from the round robin exercise, and a further 17 ‘worsening’ and 12 
‘improving’ signs and symptoms identified from transcribed workshop 
discussions (Table 3). These signs and symptoms were broadly related to 
changes in vital signs, appearance/behaviour, and feeding. Particular signs 
and symptoms were highlighted on more than one occasion during the 
process, with parents using different adjectives (e.g., “floppy” and “lifeless”) 
and synonyms (e.g., “lethargic” and “sleeping a lot”) to describe them. During 
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the round-robin exercise a parent from each family took turns to suggest a sign 
or symptom of bronchiolitis. As the exercise advanced it became apparent that 
individual parents were disclosing explicit and related details of their own 
individual family experience. Their accounts were corroborated and sometimes 
elaborated upon by their partner. If other parent’s had similar experiences then 
they sometimes verbalised agreement and wanted to discuss their 
experiences. Although this part of the NGT process does not require parents to 
engage in discussion, CvM allowed these conversations to take place and 
reach their natural conclusion. Throughout the NGT process it was noted that 
three family dyads (F 01, F 02 & F 03) were more confident in sharing their 
experiences than F 04 and F 05 and they were apt to dominate group 
discussions at times. This was particularly so for fathers from F 01 and F 03. 
Family dyad (F 04) and F 05 (a single parent family) required CvM and BC 
(facilitator) to provide opportunities for them to contribute towards the general 
discussions. Sensitive probing questions specifically directed toward these two 




Table 3: Signs and symptoms identified from round–robin exercise 
(presented in chronological order)  
‘Worsening’ signs and symptoms listed on flip charts (n=74) 
Irregular breathing; not taking feeds; cough & cold; slept a lot, colour changed; 
constant crying; not taking fluids – no wet nappies; feed – cough so hard made 
him vomit; stopped feeding; lethargic and dead weak; crackly; bit clammy 
looking especially in the face; restless and crying when she was awake; he lost 
his voice; grey green colour; wasn’t himself; sucking in his stomach; breathing 
got worse crackling; turned blue; very lethargic; been sleeping a lot – not 
taking feeds this didn’t bother me too much and then his colour changed and 
that triggered things; floppy; lifeless; no interaction; hear him breathing; 
sounded like an old man; like breathing through bubbles; popping sound; 
couldn’t make her laugh or smile; you just know when they are not themselves; 
kept having to check she was still breathing; nostrils were flaring; sniffles and 
snuffles to begin with; vomiting; about two days from knowing they were ill; 
weight loss; diarrhoea – browny yellowy water; didn’t poo; constipated; crying 
was hoarse; lower pitch; whiney cry – like was in pain; mouth got sore and 
sore throat; dry lips; trying to breathe through his neck muscles; sucking in his 
stomach to breathe; breathing set my alarms off; went downhill quite fast; 
really bad cough; bringing up phlegm and swallowing it; she was choking; 
nappies were dry; mum in law could see he wasn’t himself; snuffly; personality 
change; like a really bad hangover; can’t be bothered; temperature – felt hot 
but did not have a temperature when we took it; mottled - all over her 
especially her chest deep purple; first few days okish but just not right then 
things got worse; breathing was rapid and quite deep; working hard with 
breathing; using whole body to breathe; head bobbing breathing; stomach 
expanding – like a pot belly; sometimes very rapid – then sometimes a pause 








‘Worsening’ signs and symptoms discussed but not listed on flip charts 
(n=17) 
Recession; limp; very pale and grey; look really unwell and sick; temperature 
was really high; using muscles all over her body especially her chest; felt hot; 
breathing difficulties lasted for ages; apnoea; loud breathing; low oxygen 
levels; laboured breathing; deep breathing; struggling to breathe; press the 
skin – it takes longer for the colour to come back; colour drained; sleeping 
pattern; mucous 
‘Improving’ signs and symptoms listed on flip charts (n=15) 
Colour returned; stopped vomiting; kept feeds down; perk up/ interact more; 
more alert; breathing got better; normal looking nappies (soiled); lest 
restless/more settled; no longer mottled; complexion better; oxygen levels 
rising on machine; needs less oxygen; weaning off CPAP; visitors saying he 
looks better; taken off antibiotics and iv fluids 
‘Improving’ signs and symptoms discussed but not listed on flip charts 
(n=12) 
Appearance returns to normal (4/5 days); behaviour and interaction (2 days); 
more interactive – smiling/eye contact; eating properly; breathing improved 
with oxygen and/or CPAP; gradual improvement; less pain killers; less medical 
treatment; handling it herself better; cough doesn’t clear up straight away; 





Following the round-robin exercise parents were asked to group together 
signs and symptoms that they thought were related to each other. One father 
(F 01) suggested starting with “the breathing thing”. Collectively the parents 
went through words and terms on the flip charts to identify signs and 
symptoms related to ‘worsening breathing’. Parents were then asked to clarify 
some of the terminology they used to describe particular signs and symptoms. 
For example, with regards to the “popping sound”, CvM asked parents to 
elaborate on what they perceived caused the “popping sound”. “Was it bubbles 
going pop or was the infant making this noise with their little mouth?” This 
process was repeated for ‘improving breathing’ and the other three concepts 
identified by the parents; colour change, cough and body language. These 




























Domains Sub-domains: associated signs and symptoms 
‘Worsening’  ‘Improving’ 
Breathing Irregular breathing (fast, slow, pauses)  
Hearing them breathe (crackly, quite 
loud, popping) 
Using stomach more than chest 
Their stomach was going in and out a 
lot and this made their head seem to 
bob 
Head bobbing 
Nostrils were flaring,  
Breathing through neck muscles 
Using muscles (all over body especially 
chest) 
Working hard it was a struggle and it 
was laboured 






My baby’s colour was ok to begin with 
and then as they got worse around the 
second day they looked pale and 
drained  
When their colour changed and they 
became very pale, mottled, grey or 
blue, they were at their worst. 
Crying 
Choking 
Colour returns quickly 
(with oxygen) 
 
Cough Cough (chesty, bad) 
Cough up phlegm/mucous and 
swallowing 










Routine was off 
Floppy, lifeless, no interaction 
Couldn’t make them laugh or smile 
Personality change (bad hangover) 
Can’t be bothered 
Cry/pitch 
Family noticed not themselves 




No longer vomited 
Appearance returns to 
normal gradually (4/5 
days) 




*These signs and symptoms were included under the domain of “body language” 
during the NGT ranking exercise.  
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  Domain one: breathing 3.6.2
This domain describes parents’ observations of their infants’ breathing 
‘worsening’ and ‘improving’ during the course of the illness. 
3.6.2.1 ‘Worsening’ breathing 
Parents noted that it was approximately two days between their infants 
developing cold-like symptoms to their breathing becoming laboured, with one 
mother describing: 
“…by Sunday that was when the irregular breathing and when she 
started to go down-hill…the second day I would say…” (Mother, F 02). 
Parents identified several changes to their infants’ breathing pattern, rate 
and noise, which they associated with ‘worsening breathing’. These changes 
included rate irregularity which varied between being “very rapid and deep” to 
“slow” [with occasional] “pauses”. Parents perceived the slowing of breathing 
or “pauses” to be connected with their infant becoming fatigued:  
“…but when he got really tired it would slow down” (Father, F 01);  
and/ or sleeping: 
“…especially if she went to sleep… she was like…she’d be stopping 
breathing wouldn’t it? [checks with partner]…” (Mother, F 02).  
Furthermore, “slow” breathing rate or “pauses” were such a concern for 
parents that it prompted increased watchfulness of their infant:  
“…yeah it’s like we had to keep checking to make sure they were still 
breathing … it was fast and slow…” (Father, F 04).  
Parents commented on the additional effort their infant had to make in order 
to take a breath. They referred to this “effort” or “work” of breathing using the 
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following terms; “sucking in” the stomach and/or neck, “using muscles all over 
the body but especially the chest”, “nostrils flaring” and “head bobbing”. In 
addition, parents remarked that the breathing had become more audible. One 
father stated: 
“You don’t even have to get that close and you can hear from just being 
in the room” (Father, F 03). 
Adjectives the parents used to describe breath sounds included; “crackly”, 
“popping”, “breathing through bubbles”, “like they have been smoking” and 
“sounding like an old man”. One parent considered “worsening breathing” to be 
associated with a sudden deterioration in their infant’s general condition: 
“…that’s when you start looking at their breathing and all that sort of 
stuff…they go downhill quite fast” (Father, F 03). 
3.6.2.2  ‘Improved’ breathing  
Parents noticed that “breathing got better” as their infant improved. In spite 
of this, they did not really specify in what way or how the breathing improved 
other than being “less noisy”. One mother (F 03) commented on how “she [her 
infant] just stopped being dead wheezy”. Although the wheeze was mentioned 
within ‘improving breathing’, it was not suggested as a worsening symptom. 
For those parents whose infant had been admitted to hospital, they took their 
cues for improvement from clinical monitoring, for example: 
“…his oxygen erm well when they had him on the machine his oxygen 
levels were rising on their own…” (Father, F 01); 
and also through the weaning of the respiratory support their infant required, 
as one mother explained: 
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“…the CPAP is it...getting weaned off it...coming off for a couple of 
hours each day” (Mother, F 02).  
However, although ‘worsening breathing’ was talked of as being of sudden 
onset, the parents described ‘improving breathing’ as being a gradual process. 
Breathing improved over a few days or over a more extended period with 
“difficulties last[ing] for ages”. One father talked about his son’s experience, 
saying:  
“...like for Thomas he has only started to get better now [time of workshop] 
and you think how long is it…two weeks...three weeks...” (Father, F 01). 
  Domain two: colour change 3.6.3
This domain describes parents’ observations of changes to their infants’ 
colour ‘worsening’ and ‘improving’ during the course of the illness. 
3.6.3.1  ‘Worsening’ colour change 
Colour change was another sign which triggered concerns of deterioration, 
as the mother in the following quote explains: 
“…just the colour...that triggers a lot of stuff, you know, a baby isn’t 
supposed to look like that...” (Mother, F 03). 
Parents reported how the colour would “drain” from the infant and described 
a range of colours associated with the ‘worsening’ infant: “pale and grey”, “grey 
green”, “blue” and “mottled and deep purple”. Parents’ understanding of colour 
change was quite nuanced and they presented different explanations to 
account for particular colour changes. Crying was implicated as one father (F 
02) noted “constant crying changed their colour”. Another father reflected on 
other reasons for colour change: 
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 “Depends on the colour…if they are pale, obviously it could be that they 
are a bit queasy or ill…phlegm on the stomach...blue they obviously… 
they are not getting enough oxygen are they…” (Father, F 03). 
Deterioration in their infants’ colour was often the key prompt for parents to 
seek medical help. One father described their response to his infant’s 
‘worsening’ colour: 
 “He went that grey colour and we took him to the hospital…” (Father, F 
03). 
3.6.3.2  ‘Improving’ colour change 
When asked “How did they know their baby was getting better?” parents 
recalled how “their [infant’s] colour returned” or their “complexion was better”: 
these were reported as being amongst the first signs and symptoms which 
suggested improvement. One father noticed a rapid colour change following 
the administration of oxygen therapy: 
“The colour comes back quite quickly once they start getting oxygen 
so…you know how they get over that hump erm they get the colour 
back quite soon…” (Father, F 03). 
The ‘improving’ appearance of the infant was also observed by visitors and 
other family members, “…coming to see him as well saying doesn’t he look 
better today…” (Mother, F 01).  
  Domain three: cough 3.6.4
This domain describes parents’ observations of their infants’ ‘worsening’ 
and ‘improving’ cough during the course of the illness. 
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3.6.4.1  ‘Worsening’ cough 
In the early stages of bronchiolitis, parents described how the infant 
exhibited coryzal symptoms, such as “sniffles” together with a cough. At this 
point in their infants’ illness the parents did not appear to be overly concerned, 
as one father explained: 
 “The first few days they are not too bad they just seem as though they 
are not quite right” (Father, F 03). 
However, some parents did seek a medical opinion:   
“On the Friday…I noticed she was not well…she had like the 
sniff…snuffles and a crackly cough so I took her to the Walk-in and I 
took her to the Doctors and they both said that she was fine” (Mother, F 
05). 
Parents described a ‘worsening’ cough as being “bad”, “crackly”, “choking” 
and “chesty”. Parents remembered how the cough induced mucous 
expectoration: 
“She would cough that hard that she would be bringing phlegm up, and 
she would be trying to swallow it and choke” (Father, F 02); 
and/ or vomiting: 
“It got worse and made them vomit and bring up their bottles…” 
(Mother, F 04).  
3.6.4.2  ‘Improving’ cough 
Although cough was a prominent feature of ‘worsening’ bronchiolitis no 
signs or symptoms were included under the domain of ‘improving cough’. 
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Parents noted that as their infant improved, the cough was one of the final 
symptoms to resolve and could potentially last for up to several weeks: 
 “The cough was still there like but when Thomas was coughing…after he 
coughed he would go Ahhh! As if it was hurting him…and that seemed to 
lessen…but he still had a cough for a week or two afterwards…” (Father, F 
01). 
  Domain four: body language 3.6.5
This domain describes parents’ observations of their infants’ ‘worsening’ 
and ‘improving’ body language during the course of the illness. 
3.6.5.1  ‘Worsening’ body language 
Within this domain parents reported observed changes with their infants’ 
behaviour and routine. Parents found these changes difficult to describe at 
times, often summing up their concern by saying their infant “wasn’t 
themselves”, as one father explained: 
“It is hard to describe you just know they are not them self...” (Dad, F 
03). 
Parents discussed altered feeding and sleeping patterns and changes to 
their infants’ general disposition. Infants’ reduced or inability to feed was of 
considerable concern to their parents. Parents commented on how their infants 
either did not wake for feeds: 
“…he had been sleeping a lot, not waking up and not taking feeds…” 
(Mother, F 03), 
or would vomit after feeding provoking parents to seek medical advice: 
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“The first time I took him because he wasn’t keeping his feeds down...he 
hadn’t kept a full bottle down within 24 hours, so that’s why we took 
him…” (Mother, F 01). 
Parents considered the impact poor feeding had on their infants’ overall 
hydration status and were aware of the link between poor feeding and signs of 
dehydration: 
“…if they are not feeding they are not going to create wet nappies are 
they…” (Father, F 03). 
Dry nappies over a period of time were clearly a concern to the parents as 
this mother described: 
“She was not taking her feeds and no wet nappies, her nappies were 
still dry” (Mother, F 04). 
Parents described strategies to try and manage their infants’ hydration. For 
instance, small volumes of milk feed were offered more frequently or additional 
fluids such as water or juice were offered to either supplement or as a 
substitute for milk feeds. Although juice was not necessarily seen as a good 
milk substitute it was used, as one father described when his daughter: 
“She wasn’t even taking a bottle so even if she has juice to keep her 
hydrated” (Father, F 04). 
These strategies were developed through intuition, previous experience or 
on the advice of a HCP. Drawing on his previous experience with his infant’s 
elder sibling, one father explained: 
 “What I’d try to do last time is like, with the previous one [elder sibling], 
when he started to show the same symptoms […] between every say 
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two or three bottles...a tiny bit of water in a erm bottle just to try and re-
hydrate him and that helped a lot…” (Father, F 03). 
Advice from HCPs guided some parents’ actions, for example: 
“…we were told essentially with feeds...two ounces at a time […] she 
would get nauseous with a full stomach and have difficulty in breathing” 
(Father, F 02). 
One mother recalled the medical intervention required when her daughter 
stopped feeding: 
“…Molly stopped feeding so they had to give her a drip [...] an IV thing 
erm I would say that she stopped feeding totally...she couldn’t take 
nothing at all...” (Mother, F 05). 
Other feeding related issues the parents briefly discussed included 
diarrhoea, constipation, sore throat and weight loss. During the ‘worsening’ 
phase of bronchiolitis parent’s observed a number of key differences to their 
infants’ personality, behaviour and routine. Parents reported an increase in 
lethargy describing how their infant would sleep for extended periods:  
“…will wake two hours, they will be awake for a little and then go back 
to sleep...it is offset a little...” (Father, F 03).  
Words such as, “floppy”, ”limp” and “lifeless” became part of the lexicon 
parents used to describe their infants’ ‘worsening’ body language. Parents 
detected subtle changes to their infants’ personality. Infants ceased to interact 
with their parents and appeared unhappy as one father summed up: 
“With her she is normally dead happy, always smiling, but she was not 
like that at all, ...couldn’t make her laugh couldn’t make her smile” 
(Father, F 02). 
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Poor interaction was suggested by parents who used phrases, such as, 
“they can’t be bothered” or were “quiet” or likened the change in their infants’ 
behaviour to having a “bad hangover”. Whilst some parent’s reported their 
infant as being “quiet”, other parent’s reported “constant crying” and described 
the quality of their infants’ cry as either “whining”, “hoarse” or “low pitched”. 
This change in quality of cry also triggered concern as one father explained:  
“Yeah whining more than a cry… like he was in pain” (Father, F 01). 
3.6.5.2  ‘Improving’ body language 
As the infant recovered, parents reported that their infants’ feeding 
“improved”, they became more “alert”, “less restless”, “smiling” and returned to 
their usual routines. This return to usual feeding regimes was perceived as a 
good sign: 
“…as soon as they […] start eating properly again they start getting 
more alert, that’s when you know they are getting better and you can 
see it in them...” (Father, F 03). 
One of the mothers explained how her daughter became more interactive as 
her condition ‘improved’ and interventions were reduced: 
“…when she was off the oxygen… the CPAP… and feeding more...she 
started to be more interactive...I noticed she was smiling again...it was the 
best thing ever...she just smiled at you...you know when they normally look 
at you and smile at you...she was more interactive [...] she was actually 
making eye contact with you…” (Mother, F 02). 
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  NGT ranking exercise 3.6.6
Collectively, the parents were invited to produce one or two statements for 
each of the previously identified four domains written in “layman’s terms”. The 
purpose of this exercise was to prioritise statements related to ‘worsening’ and 
‘improving’ bronchiolitis in order of importance. To assist the parents with 
creating these statements CvM suggested the parents consider how they 
would describe each domain to a doctor or nurse or alternatively, to imagine 
they were writing an information sheet for other parents to read. It was also 
suggested that each statement started with the opening phrase ‘My baby…’.’ 
The parents made the following refinements when developing the statements; 
the term “crackly” was preferred over “popping” as was “more of a 
generalisation” of the breath sound heard. One father (F 03) suggested 
including “short” into the description of ‘pauses in breathing’ as opposed to just 
pauses, “…’cause it [pauses] was about ten or 15 seconds” in length. As with 
the changes reported with breathing the parents stated that their infants’ colour 
changed “around the second day”. Although parents did not object to saying 
the word “phlegm”, it was felt that mucous was preferable “…’cause it [phlegm] 
is spelt quite weird […] people may not know what it is…” if written down in a 
leaflet. The parents decided to include “temperature” and “dry lips” under the 
domain of body language. Only one family (F 01) reported their infant had a 
high temperature their infants’ temperature was initially “normal” although “felt 
hot to the touch”. Following hospital admission the father (F 01) reported that 
his infants’ “temperature did elevate to about 39 degrees”. Although, “dry lips” 
was included with the statement on feeds, the parents had primarily associated 
“dry lips” as being a side effect of “oxygen”. Parents initially included “lifeless” 
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in the statement about their infant being “floppy”. However, the parents 
decided to exclude the word “lifeless” as it made the statement “a bit scary”. 
The finalised statements are listed in Tables 5 & 6. Each statement was 
assigned a letter. Using the ‘letter’ the parents in each family worked together 




Table 5: NGT ranking exercise (worsening bronchiolitis statements and 
results) 
 ‘Worsening’ bronchiolitis statements 
A My baby was working harder than usual to breathe. Their 
breathing was a struggle and they used their stomach to help 
them. Their stomach went in and out a lot and this made their 
head bob. Their breathing was irregular and mostly faster than 
usual but sometimes it slowed down and there were some short 
pauses. Their breathing sounded crackly. 
B My baby started with a chesty cough and cold which got worse. 
Sometimes their cough made them vomit after feeding. They may 
cough up mucous.   
C My baby’s colour was ok to begin with and then as it got worse – 
around the second day – they looked pale and drained. As they 
became worse they became very pale or mottled or grey or blue 
D My baby was sleeping a lot and did not seem like themselves. 
Their routine was ‘off’.   
E My baby seemed very floppy and didn’t interact with me. 
F My baby stopped taking their usual feeds. They did not have as 
many wet nappies. 
They got dry lips. Some babies got diarrhoea.   
G My baby felt hot and had a temperature 
H You know your own baby – look out for differences in their 
personality, cry and sleeping patterns.  
I We could not make them smile or laugh. 
Ranking 
Order 
Family 01 Family 02 Family 03 Family 04 Family 05 
1 A A D B A 
2 B F E A F 
3 F B C C G 
4 G C F F D 
5 E E A D B 
6 D G H E E 
7 C I B G I 
8 I D G Missing 
data 
I 




For the top three ranking categories for ‘worsening bronchiolitis’, four out of 
five families considered statement ‘A’ (breathing) as being most important. 
Statements ‘B’ (cough) and ‘F’ (feeding) were also considered important with 
three out of five families including them in their top three rankings. Family F 03 
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stood out as an outlier for this part of the ranking exercise as their top three 
rankings statements were ‘C’ (colour change), ‘D’ (lethargic) and ‘E’ 
(floppy/poor interaction). This family described how they called for an 
ambulance after their infant “suddenly changed very rapidly” at home; their 
infant required a period of time on nCPAP. When an infant is in extremis, these 
three symptoms (C, D, and E) may be of more concern for parents than 
breathing, cough and feeding, as described by families whose infants had 
been less acutely ill. Statements, ‘H’ (different to usual) and ‘I’ (not smiling or 
laughing) were included in the three lowermost rankings (least important) of 
four out of five families. Data were missing from family F 04 for statements ‘H’ 
and ‘I’. Even if these data were available they could only have been included in 





Table 6: NGT ranking exercise (‘improving’ bronchiolitis statements and 
results) 
 ‘Improving’ bronchiolitis statements 
A My baby returned to a normal routine. 
B My baby wanted to feed and no longer vomited. 
C My baby’s appearance returned to normal. 
D My baby became more interactive and less restless and more 
settled. My baby smiled. Other relatives noticed my baby looked 
better.  
E My baby’s breathing improved gradually over a few days. 
F My baby’s cough started to get better but it took longer to get better 
than the breathing. 
G My baby’s breathing got less noisy and more regular. 
H My baby needed less medical care. 
Ranking 
Order 
Family 01 Family 02 Family 03 Family 04 Family 05 
1 D E B B D 
2 C B C C E 
3 G C A E B 
4 E D E G A 
5 H H H A C 
6 B G D D C 
7 A F G F H 
8 F A F H F 
 
The top three ranking categories for improving bronchiolitis - statements ‘B’ 
(feeding) and ‘C’ (appearance normal) -.were both jointly ranked as being most 
important by four out of five families (Table 6). Statement ‘F’ (cough) was 
ranked as being the least important by all five families. 
3.6.6.1 NGT question three: what could have improved your experience 
of having a baby with bronchiolitis? 
Throughout the various workshop discussions the parents identified a 
number of key issues that could have improved their experience of having an 
infant with bronchiolitis. For this exercise the parents were asked to consider 
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“What could have improved your experience?” and “How could HCPs have 
helped you?” Their responses are listed in Table 7. 
Table 7: What could have improved your experience of having a baby 
with bronchiolitis? 
What could have improved your 
experience? 
How could HCPs have helped you? 
Comfier mattress 
Once in [admitted to hospital] 
everyone good 
Took two hours to get seen, palmed off 
with Calpol – which didn’t do nothing 
What is bronchiolitis?  
Just say its bronchiolitis 
This is what is going to happen 
Will she get worse or better 
Nurses/doctors should tell us 
Should talk to you 
Health visitors and midwives should 
know 
Leaflets, bullet points (e.g. meningitis) 
Hadn’t heard of it before but kept 
hearing it was very common 
We know some wards/beds were 
empty – should open these up instead 
of sending home 
Leaflets on early signs and symptoms 
Lots of kids get it but parents don’t 
know much about it 
Had to stay on a ward – not go to 
intensive care 
Nurses expect it at particular times of 
the year 
Sending him home to come back 
then he’d got worse – up to mum to 
make judgement – felt a bit not 
enough room at hospital to take 
babies in  
Shouldn’t say is this your first baby  
and then give you a ‘look’ 
Asking if you smoke (even if you 
don’t) makes me feel guilty 
Hospital should get geared up for the 
expected influx – needs to plan 
 
Parents reported finding that their infant having bronchiolitis to be 
frightening and confusing; they felt unprepared to deal with the situation. The 
reasons they gave for their fear included the sudden deterioration and young 
age of the infant: 
“It was a shock that a six week old baby got bronchiolitis.” (Mother, F 
02); 
 and a lack of knowledge of bronchiolitis and associated signs and symptoms:  
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“It was quite frightening for us first time […] we did not know what was 
going on at all…we didn’t even know what bronchiolitis was until he got 
it…” (Father, F 03). 
Confusion occurred when they were seeking help due to unsatisfactory 
information and advice from HCPs. Additionally there was a perceived lack of 
forward planning from secondary/tertiary health services. When the infant 
displayed signs and symptoms that were a cause for concern, parents initially 
sought medical help from either a primary care setting (General Practitioner 
(GP) or Walk-in Centre) or ED. Parents reported that some of their initial 
interactions with HCPs were at times, inadequate and unhelpful. Bronchiolitis 
was not always mentioned as the diagnosis. Instead parents were often 
provided with what they perceived to be a nebulous diagnosis such as “viral 
infection”. Information about managing the condition was sometimes vague 
with suggestions, such as, “come back if they get worse”. This advice was not 
usually qualified with what the HCP meant by ‘getting worse’. Parents reported 
seeking medical help on more than one occasion with similar information and 
advice being provided. This process left some parents questioning their own 
judgement on being able to assess how sick their infant was. Moreover, 
parents were made to feel like they were being overly anxious; they felt their 
parenting ability and knowledge was being brought into question. As one 
mother explained: 
“We got sent home saying it was a viral infection... and then they say ‘Is 
that your first baby?’ and I say ‘yeah’ and then they look at you and go 




The lack of guidance coupled with the expectation that their infant might get 
worse, often left parents feeling helpless and abandoned, as one mother 
explained: 
“…especially when I got sent home the second time, and the doctor said 
he was just going to get worse […] I felt that I was just left on my own” 
(Mother, F 03).  
Another mother experienced similar feelings of being out of her depth and felt 
rejected: 
“...the doctor said we expect him to come back but until he is worse you 
will have to go home…so we did and it was basically it was up to me to 
judge when he was bad enough... so I felt a bit kicked out really…” 
(Mother, F 01)  
The parents of those infants eventually admitted to hospital appeared 
surprised by the number of infants hospitalised with bronchiolitis during the 
seasonal epidemic. Furthermore, as parents became aware of the prevalence 
of bronchiolitis, they remarked upon the lack of knowledge of bronchiolitis 
amongst other parents, as one mother noted: 
 “There does seem to be lots of kids that get it and yet there are a lot of 
people that still don’t know what it is...” (Mother, F 03). 
One mother commenting on the lack of preparation by the health services to 
cope with the increased seasonal demand made a comparison to the lack of 
preparedness for snow, saying: 
“It’s like every year when the snow comes and it’s such a surprise and 
there is no grit...” (Mother, F 03). 
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Whilst understanding the pressures on the health service, the perceived 
lack of preparation surprised parents as, one father noted:  
“You can understand that they are short staffed and that they have a lot 
of work on, there’s not a lot of money to go around, not enough room 
and all the rest of it, that’s fair enough, I guess maybe a better priority 
system. It’s this time of year… it’s going to happen let’s think ahead 
maybe if they opened up another ward...” (Father, F 03). 
Another father described how the lack of resources impacted on his son’s 
care:   
“...they [HCPs] said that Thomas was meant to be in intensive care…but 
because there was no room they just kept him on this ward…it was only 
supposed to be a 24 hour ward…they had to keep him there as there 
was no room” (Father, F 01) 
One key feature all the parents felt would have enhanced their experience 
was more verbal or written information. The parents contrasted the lack of 
information for bronchiolitis with other illnesses, for example, “meningitis” 
where more information was available. The parents gave consideration to the 
timing of the information and felt it should be given prior to the infant becoming 
ill with health visitors as possible informants:  
“Maybe when the health visitor came around maybe have leaflets on it 
to look out for the early signs and symptoms so you can get them in 




A group of nine parents identified 91 ‘worsening’ and 27 ‘improving’ signs 
and symptoms of bronchiolitis to be considered for potential inclusion into the 
LIBSS-PRO. Furthermore the parents developed a bronchiolitis conceptual 
framework incorporating four domains characterising ‘worsening’ or ‘improving’ 
bronchiolitis. ‘Difficulties with breathing’, ‘cough’ and ‘poor feeding’ were 
ranked as the most concerning characteristics of ‘worsening’ bronchiolitis. The 
parents reached consensus on improvement and this was judged through the 
infants’ ‘routine returning to normal’ and ‘improved feeding’.  
Parents, irrespective of their infants’ age or number of children in the family, 
appeared to develop instinctive knowledge of what is considered ‘normal’ in 
terms of their infants’ appearance and behaviour when well. This knowledge 
seemed to enable the parent to observe both subtle and more obvious 
changes which occurred in their infant during an episode of acute illness such 
as bronchiolitis. The parents were able to identify most of the signs and 
symptoms that typically characterise bronchiolitis. However, at times parents 
would find it quite difficult to articulate these differences and would refer back 
to their instinctive knowledge of their infant.  
 “…you know your baby isn’t supposed to look like that…” (Mum FW3)   
Parents rapidly learned and adopted medical vocabulary to describe their 
infants’ symptoms through their encounters with HCPs.  
“I referred to his breathing like, it is called recession but I said he was 
breathing with his stomach” (Mum FW3).  
Having a young infant with bronchiolitis was perceived to be a frightening 
experience by all the parents. All the parents’ reported that their experience 
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could have been greatly improved with accessible, good quality information 
(written and/or verbal) on bronchiolitis including guidance on severe symptom 
recognition. 
The strength of this group workshop was the use of a democratic method 
(NGT) to identify and achieve consensus on signs and symptoms perceived as 
important to parents. NGT enabled all parents to present their opinions 
throughout the group. Holding the group in a family friendly venue with 
childcare provision facilitated parental engagement with the research. 
However, there were a number of limitations. The small number of family 
participants may impact on the findings being generalisable to the wider 
community of parents with infants clinically diagnosed with bronchiolitis. In 
particular, ethnic minority families were under-represented within the sample. 
To address these issues, an ethics amendment for the study was successfully 
submitted to undertake parent interviews by telephone. The data collected 
during the group workshop were analysed by one researcher (CvM) and 
therefore bias could possibly be introduced. However, the data were partially 
analysed by the parents themselves within the group workshop and a second 




4  Health Care Professional (HCP) stakeholder 
group workshop using NGT 
 Introduction 4.1
Through their clinical experience and observations, HCPs provide in depth 
knowledge of bronchiolitis. This chapter describes the HCP stakeholder group 
workshop, which used NGT to identify signs, symptoms and risk factors of 
bronchiolitis. In addition, HCPs were also asked to critically appraise existing 
scoring instruments and develop criteria statements for classifying infants as 
either ‘mild’, ‘moderate’ or ‘severe’ bronchiolitis. This critical appraisal was 
used to inform the development and layout of the LIBSS-PRO. Furthermore, 
criteria statements for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis and severity 
criteria extracted from the literature were collated to form the Delphi consensus 
survey. These criteria were also used in subsequent construct and criterion 
validity testing.  
 Aims 4.2
i) To identify signs and symptoms of bronchiolitis for potential inclusion as 
items in a bronchiolitis severity score. 
ii) To critically appraise scoring instruments that have currently been used 
in bronchiolitis research 
iii) To develop criteria for mild, moderate and severe bronchiolitis 




 Sample and setting 4.3
Recruitment for the HCP workshop was undertaken during March 2011. All 
participants were identified through the CLRN. Workshop participants were 
doctors, nurses or physiotherapists with recent experience of managing infants 
with bronchiolitis. HCPs came from one paediatric tertiary and three DGHs and 
represented a range of specialities including ED, critical care, and general 
medical wards. A purposive sample frame was devised (Appendix 28) to 
ensure adequate representation of individuals with a wide range of 
professional clinical experience. Eligible HCPs were stratified by profession 
type, employment grade and clinical speciality. CLRN research nurses 
approached eligible HCPs with information on the workshop event. The 
workshop was held at Alder Hey Children’s Hospital in Liverpool. HCPs were 
reimbursed with travel expenses and given a certificate of participation.  
 Informed consent 4.4
Written and verbal information was provided to HCPs prior to attending the 
workshop and again on the day of the workshop. Written informed consent 
was obtained from all participating HCPs on the day of the workshop. 
 Methods 4.5
Two researchers (CvM & BC) trained in qualitative research methods, 
facilitated the workshop. One research nurse (JSC) and a research 
administrator (SO) provided additional support. Informed written consent was 
obtained from all participants at the beginning of the workshop. CvM provided 
a brief introduction to the workshop to outline the research aims and workshop 
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schedule. The workshop lasted approximately three hours and was digitally 
audio recorded (Tascam DR-100). The recordings were transcribed verbatim 
and anonymised for analysis (CvM). JSC & SO acted as observers throughout 
the workshop and composed handwritten notes. These notes were used to 
document salient points made during the workshop, non-verbal 
communication/behaviour, issues which created tensions and the group 
dynamics. Spatial maps of the room layout and where participants and 
researchers were located were also included with the notes.  
During the workshop the HCP participants were given a series of group 
exercises (Figure 3) to facilitate with the development and design of the 
bronchiolitis scoring instrument.  
 
 Figure 3: Flow chart illustrating HCP workshop group exercises 
  Round-robin exercise to identify ‘worsening’ signs and symptoms 4.5.1
of bronchiolitis  
The purpose of this exercise was to identify ‘worsening’ signs and 
symptoms for potential inclusion into the scoring instrument. At the beginning 
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of the workshop, NGT question one (Table 8) was posed to the HCPs. Each 
HCP was asked to silently reflect on ‘worsening’ signs and symptoms. This 
period of individual reflection was shortly followed by a round-robin exercise.  
Each HCP was asked to share a ‘worsening’ sign or symptom to the group. 
This exercise continued around the group until no further new signs or 
symptoms were identified. All identified signs and symptoms were recorded on 
to flip-charts. The HCPs discussed each of the recorded signs and symptoms 
to clarify meaning.  
  Development of criteria for ‘mild’, ‘moderate’ and ‘severe’ 4.5.2
bronchiolitis 
The purpose of this exercise was to develop criteria for ‘mild’, ‘moderate’ 
and ‘severe’ bronchiolitis: 
 To enable the development of thresholds for ‘mild’, ‘moderate’ and 
‘severe’ bronchiolitis within the scoring instrument and, 
 To assist with the standardisation of the reference standard (clinical 
assessment by senior HCP) when used to evaluate criterion validity. 
The HCPs were split into three smaller groups approximately containing six 
participants. Each group was allocated one of the three bronchiolitis severity 
categories: ‘mild’, ‘moderate’ or ‘severe’. Using the identified signs and 
symptoms from task one; the HCPs were asked to produce criteria for their 
particular category. Each group presented their statements to the whole group 
for further discussion and clarification.  
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  Critical appraisal of existing scoring instruments 4.5.3
The purpose of this exercise was to critically appraise the content and 
design of existing bronchiolitis scoring instruments. The results of this exercise 
helped to inform the design of a new scoring instrument. Six scoring 
instruments used as outcome measures in bronchiolitis research were 
identified for use in this exercise (33, 55, 56, 58, 63, 125). Each of the three 
small groups was provided with two of the six scoring instruments. The HCP 
participants in each group were asked to critically appraise the two scoring 
instruments for content and layout. Each of the three small groups fed back 
their scoring instrument appraisals to the whole group. A power point slide of 
each instrument was shown to the whole group during the feedback. The 
group as a whole also discussed each scoring instrument. 
  Ranking activity: prioritisation of ‘worsening’ signs and symptoms 4.5.4
The purpose of this exercise was to prioritise which ‘worsening’ signs and 
symptoms to include in the scoring instrument. Using the information and 
discussions from the previous group exercises, the HCPs were asked to 
design their ‘perfect’ bronchiolitis severity score/instrument. HCPs were 
required to individually choose up to ten signs and symptoms and rank them in 
order of importance (one being most important and ten being least). The HCPs 
were asked to discuss signs and symptoms and rankings with the other small 
group members. A final group decision was made for the top ten signs and 
symptoms for their particular bronchiolitis severity category. The group ranked 
these signs and symptoms in order of importance. The three individual groups 
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fed back their prioritised ‘worsening’ signs, symptoms and group rankings to 
the entire group for further discussion. 
  Round-robin exercise to identify ‘improving’ signs and symptoms 4.5.5
of bronchiolitis  
The purpose of this exercise was to identify ‘improving’ signs and symptoms 
to ensure that the developed score is responsive to clinical change. NGT 
question two (Table 8) was posed to the HCPs. Each HCP was asked to 
silently reflect on ‘improving’ signs and symptoms for their pre-allocated 
‘severity’ category. This period of individual reflection was shortly followed by a 
round-robin exercise. Each HCP was asked to share an ‘improving’ sign or 
symptom with the group. This exercise continued around the group until no 
further new signs or symptoms were identified. All identified signs and 
symptoms were recorded on flip-charts. The HCPs discussed each of the 
recorded signs and symptoms to clarify meaning. 
Table 8: NGT questions (HCP workshop) 
NGT question 1: What signs and symptoms characterise an infant with 
worsening bronchiolitis? 
 
NGT question 2: What signs and symptoms characterise and infant with 
improving bronchiolitis? 
 Analysis 4.6
Initial data analysis was undertaken by the participants themselves during 
the workshop though the NGT ranking process. CvM analysed other data 
sources derived from the workshop (124). These included audio-recorded 
discussions that had taken place, all transcribed by CvM. The lists of words 
and phrases written down by HCPs, the words and phrases recorded on flip 
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charts, and field notes made by the observers during the workshop, and those 
made by CvM and BC, were also analysed. The workshop transcript and these 
extra data sources were examined several times during the course of the 
analysis. Initial examination of the collected data was used to obtain an 
overview of the data and to record general impressions, key ideas, themes and 
concepts arising from the content. Following on from this a descriptive thematic 
analysis was undertaken. This process involved manually coding the raw data 
then collapsing the coded data under broader themes. Codes and themes 
were inductively derived from the data. As new codes emerged these were 
applied iteratively to the whole data set in subsequent examinations of the data 
sources until no new codes or themes were identified. Finally, a descriptive 
account was produced for each theme. QRS NVIVO (Version 10) software was 
used to code and synthesise the data. Field notes also enabled the 
researchers to reflect on the workshop and record any meaningful thoughts 
and insights. 
 Results 4.7
The aim was to recruit 15 HCPs to participate in the workshop. In total, 18 
HCPs attended the workshop. The HCPs characteristics are described in 





Table 9: HCP Workshop participant characteristics 
HCP 
Groups/grades 
Doctors                 (n=8) 
Consultant            (n=5) 
ST3 and above     (n=3) 
Nurses                  (n=9) 
Band 7                  (n=1) 
Band 6                  (n=1) 
Band 5                  (n=6) 
Student                 (n=1) 
Physiotherapist     (n=1) 




General medical   (n=13) 
A&E                      (n=3) 
PICU                     (n=2) 
  Round-robin exercise to identify ‘worsening’ signs and symptoms 4.7.1
of bronchiolitis 
To maintain anonymity the HCPs were allocated an identification number 
from one to eighteen. When transcribing the workshop it was difficult at times 
to identify the speaker. In these instances, the HCP was referred to as 
unidentified male or female (UIM/F). During the round-robin exercise each 
HCP took it in turns to suggest a sign or symptom of bronchiolitis. As the 
exercise progressed, individual HCPs started to provide additional information 
and context, and highlight key issues with particular signs and symptoms to 
support their inclusion/exclusion into the scoring instrument. This prompted 
other HCPs to contribute to the discussion. Although this part of the NGT 
process does not require the HCPs to engage with discussion, CvM allowed 
these conversations to take place and reach their natural conclusion. 
Throughout the workshop the senior doctors had a tendency to dominate some 
of the group discussions, most notably HCPs 05, 14 and 15. The HCPs 
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identified 66 ‘worsening’ signs and symptoms from the round-robin exercise. A 
further seven ‘worsening’ signs and symptoms, not listed on flip charts, were 
identified from the transcribed workshop discussions (Table 10).  
A number of these signs and were repeated during the exercise or 
discussed in different contexts. During the thematic analysis related signs and 
symptoms were collapsed together and broadly grouped under the following 
five major themes: respiratory, feeding/hydration, appearance/ behaviour, risk 
factors and miscellaneous symptoms (Table 11).  
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Table 10: Group Task 1-Signs and symptoms identified from round-robin 
exercise  
‘Worsening’ signs and symptoms as listed on flip charts (n=66)  
Respiratory rate (slight, moderate, desperate, about to stop); apnoeas; 
cyanosed; low sats; lethargic; irritable; low GCS; worsening ability to feed; 
nasal flare; increased work of breathing with NG feeds; tracheal tug; 
tachycardia; poor perfusion (cap refill); getting tired; poor laboured breathing; 
increased oxygen need; increased recession at rest; getting tired and reduced 
air entry; complete inability to feed; any of these getting worse – TREND; 
instability on handling; desaturation on handling; wet nappy; increased PcO2; 
head bobbing; grunting; pyrexia; increased subcostal recession; vomiting; 
decreased urine output; respiratory arrest; no improvement with suction; 
generally looking unwell; late fever; gut feeling; parental concern; dependent 
on child & threshold (prem, cardiac, chronic respiratory, Downs, underlying 
muscle disorder); day of illness; social background; secondary infections; 
increased work of breathing- breakdown into components and weighted (e.g. 
recession, tracheal tug); and change from increased work to more shallow 
breathing/effort →exhaustion; what baby is doing (sleep, feed etc context) – 
when would you do an assessment (e.g. x minutes post feed/handling); link 
breathing and other components (e.g. cyanosis & increased/decreased  effort); 
?what is baseline – then weight score re: 20%, 30% etc over baseline; many 
items but need to include these; transient nature of S&S – re: feeds etc then 
score to see if increased/decreased has been maintained; like PEWS – if 2+ 
borderline – review, if massively high then needs immediate review; increased 
oxygen demands & big jumps; ?quantify or look for trends in increased oxygen 
demands; will tool work on admission & in-patient tool – can it cover both; 
admission linked to softer factors (not bronch related) e.g. presenting at 2am – 
then increased likelihood of admission; SpO2 may be ok when awake but dips 
when asleep; is baby feeding 100mLs/kg -  as this may be appropriate if baby 
overfed; is nappy wet; generally look unwell (pale, mottled, floppy, posture, 
glassy eyed, lethargy, difficult to handle, clammy, sweaty, don’t care – being 
handled (stopped screaming/crying/coughing)); don’t mind being handled; 
unstable (??septic); resisting & screaming) – if all of these then maybe not 
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bronchiolitis but septic; pink & apnoeic; ‘septic’; apnoea – little pauses, self-
correcting (not quite sure if they are apnoeas), increased frequency, increased 
concern, “real” apnoea, apnoea definition – bradycardia + apnoea; pre-apnoea 
breathing; context – need to see trends – graphs, trend over time, (e.g. resp 
(tug & recession), oxygen requirement, effort, heart rate, GCS (irritable/floppy), 
central cyanosis); well - obvious, very severe – obvious, middle group – 
harder; would want to predict differently for admission/transfer (PICU/HDU) as 
consequences would be different; GCS – maybe hard to get a full assessment 
– (reduced handling); PEW triggers for most bronchs; pathway should have 
guidance for ‘juniors’- prompt – should explain these are the signs…beware of 
‘red flag’ boxes; score could be included into a pathway – score x then do A, 
score y then do B; aiming not to reinvent the PEW – so tool could be linked to 
this (overlap) – what would be different as most is relevant to sick child 
      
‘Worsening’ symptoms discussed but not listed on flip charts (n=7) 
Iv fluids; intercostal recession; hospital re-attendance; length of cough; oral/NG 





Table 11: Bronchiolitis conceptual framework (HCP workshop) 
Major themes ‘Worsening’ signs and symptoms 
Respiratory Respiratory rate (slight, moderate, desperate, about 
to stop) 
Breathing (laboured/shallow/exhausted) 
Apnoea (little pauses self-correcting, increasing 
frequency, apnoea + bradycardia) 
Cyanosis 
Increased work of breathing (nasal flare, tracheal 
tug, head bobbing, grunting) 
Recession (intercostal/subcostal) 
Respiratory arrest 
Increased oxygen requirements  




Feeding/hydration Worsening ability to feed  
Vomiting 
Feeding support (NG feeds/IV fluids) 
Poor perfusion (cap refill) 
Decreased urine output 
Appearance/behaviour Lethargic 
GCS (irritable/floppy) 
Instability on handling 
Generally looking unwell (pale, mottled, posture, 
glassy eyed, clammy, sweaty, fluey)  
don’t care-being handled (stopped screaming, 
crying, coughing) 
Resisting and screaming 




Underlying muscular disorder 
Social background 
Secondary infection 
Hospital re-attendance  
Miscellaneous Pyrexia 









The HCPs initially considered diagnosis and identification of the worsening 
infant through observing trends with certain signs and symptoms, with one 
HCP describing: 
“The question is asking how can you tell that they are worsening [...] you 
are absolutely right it is the trend […] none of them tell you that the child 
has got bronchiolitis ...some don’t really tell you that it is getting worse 
whilst some clearly tell you that it is getting worse…” (HCP 14). 
In addition to trends, the HCPs commented on the inclusion of thresholds to 
indicate normal and/or abnormal ranges, as one HCP explained: 
“I suppose you would need kind of parameters as well so respiratory 
rate within normal range...respiratory rate slightly 
tachypnoeic...respiratory rate absolutely desperate...about to 
collapse....” (HCP 15); 
One HCP suggested thresholds could be standardised through calculating a 
percentage above the infant’s baseline:  
“The only other way you could try and standardise is perhaps to 
percentage over their baseline...everybody had a different baseline resp 
rate aren’t they so if their resp rate is 20% higher than normal...would 
that score you anything ...than 40% higher than normal” (HCP 06); 
The practicalities of undertaking this calculation were questioned by another 
HCP: 




The HCPs discussed the possibility of lowering thresholds for hospital 
admission for infants with risk factors, such as prematurity, with one HCP 
stating: 
“I suppose if you were looking for admission criteria [...] you have a 
lower threshold for admitting things like prems [premature infants]…kids 
with lung disease...kids with cardiac complaints...you will always have a 
lower threshold to admit...” (HCP UIF). 
The HCPs also thought social circumstances and/or the parental educational 
level should be taken in to account when considering admission: 
“The other thing I suppose you kind of judge when admitting a child is 
the social background and the understanding of parents […] you don’t 
really want to send a child […] who ordinarily with sensible parents you 
might send home but parents who may have learning difficulties or it’s a 
child in need or a child in an unstable family...” (HCP 15). 
Feed intake thresholds were also discussed in the context of admission. 
One HCP described how it can be difficult to gauge an accurate volume intake 
from the parents as some infants were perceived to be “overfed”. Another HCP 
suggested that fluid intakes 50% of normal volume were their local threshold 
for admission. In order to achieve a more truthful reflection of hydration status, 
in addition to feeding, HCPs advised evaluating urine output, one HCP noted: 
“…you have got a wet nappy and you just think that’s a miracle […] you 
start losing your bit of faith in the amount of feeding […] you watch them 
guzzle and you think things are looking up…” (HCP 01). 
When asked to clarify the concept of “increased work of breathing” HCPs 
felt it encompassed a number of individual signs and symptoms listed on the 
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flip charts, for example, “recession”, “increased respiratory rate”, “grunting”, 
“head bobbing” and “nasal flare”. Furthermore, HCPs felt “increased work of 
breathing” within the score would be more objective if broken down into 
individual components with different weightings. It was suggested that 
increasing oxygen requirements were also related to “increased work of 
breathing” as one HCP recounted: 
“…when there is increased work of breathing…your oxygen requirement 
would be increasing and there would be desats [oxygen desaturations] 
that are fleeting” (HCP 07); 
Another HCP suggested quantify these changes by documenting trends of 
oxygen percentage increase: 
“…you are looking for predominantly is your change in oxygen so if you 
have like a 5 % increase or something then that can also score… so 
you can sort of see the trend of oxygen getting worse...if you have got a 
baby ticking along quite well in 35% ...40% head box that’s fine but if it 
is suddenly going ...you know ...up sort of hour by hour” (HCP 15). 
Some HCPs felt certain actions, such as “feeding” and/or “crying” or 
becoming “pyrexial” could trigger the infant to have a temporary episode of 
“increased work of breathing”. The group reflected on their experience of 
obtaining abnormal paediatric early warning scores (PEWS) following an 
episode of “crying” or “feeding” and how this would trigger a medical review: 
“…you do this with PEWS […] if there is a massively high score then 
they need immediate review […] even if it is just after them feeding but 
the baby looks knackered” (HCP 15).  
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The group felt these anomalies should be documented at the time of scoring 
the infant and reassessed within a short timeframe. “Increased work of 
breathing” following a feed was reported to potentially indicate the need to 
pass a nasogastric tube. The HCPs discussed how inserting a nasogastric 
tube could also “tip them [the infant] over the edge” if they put up a “fight”. 
Conversely, one HCP suggested that “increased work of breathing” may be 
misleading in certain circumstances:  
“…increased work of breathing can be a bit of a false sign you can 
actually get very shallow breathing ...exhausted looking baby who has 
been working very hard [...] so actually not very much increased work of 
breathing…” (HCP 15); 
especially if there was a reduction in the “work of breathing”: 
“…if you see reduced effort but increased cyanosis clearly you would be 
very worried...” (HCP 05); 
with potentially important nuanced clinical changes not being captured by a 
score: 
“…tying that up with a score that gives you a total may mean you miss 
some of those subtleties...” (HCP 14). 
When asked to explain the notion of the infant “generally looking unwell”, 
adjectives used included; “mottled”, “floppy”, “pale”, “fluey looking” and “glassy 
eyed”. The HCPs perceived the infant being “irritable” and “don’t like being 
handled”. However, the HCPs agreed that it was more concerning if an infant 
became “quiet” and/or “unresponsive”. One HCP described: 
“It’s when they don’t mind...when they have got to the stage actually 
they don’t care what you do to them...you drip them and you get nothing 
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at all […] they are completely passed the stage of caring...they have 
stopped screaming and they have stopped crying […] it’s a progression 
downhill” (HCP 01). 
In this situation the HCPs recalled how they would initiate a septic screen to 
exclude “a secondary bacterial infection”. The HCPs also discussed how the 
appearance of the infant would differ between seasons. Some seasons they 
would appear “septic” whilst at other times they would be “pink and apnoeic” or 
“milder”:  
“That’s where you get the variation with the winters like this year we 
have a lot of those [septic and floppy] where as last year they tend to be 
much milder…” (HCP 01). 
The group participants were asked to further describe and clarify what was 
meant by the term “apnoea”. The HCPs reported how respiratory rate may 
noticeably decrease. Although, it was questionable as to whether the infant 
was having a “self-correcting apnoea” or a “normal pause”.  
“...they might be self-correcting apnoeas...you know the ones where you 
are not quite sure and you just look and you watch and you wonder if 
they are going to and then they don’t and they carry on…” (HCP 02) 
The HCPs proposed these pauses would gradually become longer and 
more frequent until they require an intervention:  
“You wonder to begin with then gradually they get longer […] and then it 
gets to the stage that you feel you need to encourage them a bit and 
then they get more frequent and then you get to the stage where they 
need bagging...” (HCP 01). 
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A conversation ensued over using the traditional medical definition to 
classify apnoea as described by one HCP:  
“…they [apnoeas] should be associated with bradycardias and only 
when the heart rate is going down for 30 seconds…20 seconds then 
they are called apnoeas” (HCP 07). 
Some of the HCPs disagreed with the use of the aforementioned definition 
in the context of bronchiolitis:  
“…they have got increased recession and then all of a sudden they start 
having briefer pauses and their respiratory rate is slowing down ...in the 
context of their oxygen requirements staying high...you probably don’t 
need to wait […] until they meet the official definition of apnoeas before 
you increase their score...so it is context that is really important…” (HCP 
14). 
Neurological assessment in the worsening infant was perceived to be an 
important factor when assessing a deteriorating infant. Signs of neurological 
deterioration identified by the group included: “irritability”, “more floppy”, and 
“less responsive”. Commonly used neurological scoring instruments, such as, 
the Glasgow Coma Scale (GCS) and Alert, Verbal, Pain, Unresponsive 
(AVPU) were discussed. One HCP reported difficulties in obtaining a GCS 
score on an infant: 
“I don’t know whether you will be able to get a definitive GCS on a 
bronchiolitis because you don’t tend to do sort of neuro obs on them 
...you don’t tend to touch them […] I don’t know if you would be able to 
get proper 15, 14 ....” (HCP 10). 
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Finally, the HCPs debated the need for a bronchiolitis score when PEWS 
are currently being used in clinical practice. They drew attention to the fact a 
number of aforementioned signs and symptoms are generic to “all sick 
children” and included in the PEWS, for instance, “work of breathing” and 
“trends in observations”. To prevent reinvention of the PEWS it was suggested 
having bronchiolitis specific criteria especially for admission and guidance on 
“red flag symptoms” for more junior HCPs. The sensitivity of the PEWS was 
brought into question as it was emphasised that most infants with bronchiolitis 
will unnecessarily “trigger the PEW”: 
“Most bronchs [bronchiolitis] that will sit above that trigger [...] you will 
be constantly triggering a PEW [...] they have always been at that 
level...it’s not like they are getting worse but they are just sitting at that 
level anyhow...” (HCP UIF). 
  Development of criteria for ‘mild’, ‘moderate’ and ‘severe’ 4.7.2
bronchiolitis  
Using the pre-identified ‘worsening’ signs and symptoms of bronchiolitis, 
HCPs created statements they felt characterised ‘mild’, ‘moderate’ and ‘severe’ 




Table 12: Characteristics of ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis 
‘Mild’ bronchiolitis  ‘Moderate’ 
bronchiolitis 
‘Severe’ bronchiolitis  
Generally doesn’t 
require admission 
Increased work of 
breathing – recession, 







Sats >92% in air and 
heart rate <150 bmp 
when settled 
Feeding – 2/3 of 
appropriate intake for 
weight 
Well hydrated – wet 
nappies mucous 
membranes 
Alert and active 
“grumpy” no irritability 
Improvement with 
simple measures 
Duration and underlying 
chronic conditions/social 
circumstances  
Child has at least one of 
the following:- 
Low saturations <92% in 
room air/maybe fleeting 
Feeding less than 50% 
of required amount 
150mL/kg 
Signs of moderate 
respiratory distress; 
subcostal/intercostal 
recession; tracheal tug; 
mild/audible at close 
distance grunt 
Normal neurological 
status; alert (maybe 
tired); normal 
responsiveness; normal 
tone; consolable by 
parents 
< one year old 
HR < 160 bpm  
A child with severe 
bronchiolitis is likely to 
have significant hypoxia, 
with increasing oxygen 
requirements, have 
apnoeas that require 
stimulation (with or 
without bradycardia) and 
have not responded to 















Hydration – IV 
Positioning 
Difficult to include signs 
of respiratory distress as 




Continuing or prolonged 
apnoeas despite NIV 
Cardiorespiratory arrest 
  
4.7.2.1  ‘Mild’ bronchiolitis group 
When considering infants with ‘mild’ bronchiolitis, the HCPs commented on 
what point should the scoring instrument “come in to play”. Would the infant 
require a positive diagnosis of RSV? Furthermore, they queried if based on 
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clinical symptoms alone, how would you make a robust clinical diagnosis? One 
HCP remarked: 
“I bet you a load of those kids are called bronchiolitis but they have a 
variety of other respiratory tract infections…” (HCP 14). 
4.7.2.2  ‘Moderate’ bronchiolitis group 
The HCPs acknowledged that ‘moderate’ bronchiolitis covered a wide 
spectrum of disease severity and found it difficult to encapsulate:  
“I suppose moderate covers a wide range doesn’t it...you get your mild 
to moderate ones that just about fit the criteria on the board and then 
you get the moderate to severe ones that you kind of keeping a closer 
eye on but we could sort of define it as anything that could be kept 
comfortable on the ward without danger of needing further intervention 
or didn’t need admission at all [...] they all overlap slightly, the mild, 
moderate & severe…” (HCP 15). 
It was felt that ‘moderate’ was a combination of at least three of the 
statements listed, particularly; “low sats below 92 in air”, “feeding less than 
50% of required amount” or “moderate respiratory distress”. Defining 
“moderate respiratory distress” was found to be difficult but the group settled 
on: “subcostal/intercostal recession”, “tracheal tug” and “mild grunt”.   
4.7.2.3  ‘Severe’ bronchiolitis group 
Similarly to the ‘moderate’ group the ‘severe’ group decided to divide this 
category into moderate/severe (PHDU patients) and severe/life threatening 
(PICU patients). They deliberately did not include a statements relating to 
“respiratory distress” as they thought this to be “variable” between patients and 
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“difficult to measure”. Level of consciousness was also omitted as it was 
considered subjective: 
“…we’ve seen very severe bronchiolitis could actually be quite alert and 
a lot of not that unwell ones could be quite sleepy and we didn’t feel that 
it was…a good objective criteria” (HCP 14).  
More emphasis was placed on apnoea requiring intervention. It was noted 
that some ‘worsening’ infants are managed on the wards due to the lack of 
available critical care beds. It was postulated whether earlier intervention 
would reduce length of stay in critical care areas such as PHDU. It was also 
highlighted that perceptions of ‘severity’ can differ between HCP experience 
and clinical environment. For instance a paediatric intensivist may consider an 
infant on nCPAP to be “not that severe” whereas a paediatrician from a district 
general hospital may think “if they are on nCPAP they are still pretty severe”. 
  Critical appraisal of existing scoring instruments  4.7.3
A summary of each group’s critical appraisal of scoring instruments can be 
found in Table 13.  
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Table 13: Critical appraisal of existing scoring instruments 
No. Author Comments 
1. Walsh et 
al 2006 
Likes Struggled  
Not to many things to calculate/ simple 
Dislikes: Thee decimal places (bad) 
Not user friendly 
Too simple 
Fair amount of subjectivity 
It is retrospective – not helpful/don’t know who 
came back 
Use of centile chart 
Doesn’t take into account other resp  
Not very intuitive how you work it out 
Could have a programme that enters 
absent/present 
2. Wang et 
al 1992 
Likes: Easy 
Nicely laid out 
Could use to calculate trends 
Dislikes: Not sure how to calculate score? 
RR – age dependent 
Not convinced that wheezing is a good indicator 
Didn’t talk of sub costal  
Is this a viral wheeze score (USA) or appropriate 
for European bronchiolitis? 
Nurses now getting trained for auscultation (not 
routine) – ok for nurses in MAU – not all 
Scoring has to be universal – e.g. for non-trained, 
paed nurses, Walk-in Centres 
Oximetry in title but no oximetry in table   
Layout good 
3. Wilson et 
al 2000 
Likes: Lots of criteria – some useful 
Dislikes: Some un-useful criteria 
Lab values not useful – anyone should be able to 




Fever not so useful 
Had to look for trends 
Doesn’t tell you how to score 
Busy 
Ranges are strange 
Overwhelming – can’t be bothered 
4. Liu et al 
2004 
Likes: Age related criteria -  could be more specific 
Easier on the eyes 
Easier than ‘3’ to use 
Dislikes: Some elements -  wheeze – not relevant 
Too simplistic – doesn’t included HR etc 
90 
 
5. Lowell et 
al 1987 
Likes: Simple to look at 
Clear scoring 
Could score change 
Retraction scoring good 
Layout simple 
Dislikes: Very specific – e.g. expiration ¼, ½ - need 
consistent person to score  
Not particularly useful  
Zones would be more useful than segments – no 
good for nursing 
Supraclavicular retractions – hard to see on 
babies (short necks) 
Wheezing not a useful thing to be scoring and 
very subjective 
6. Kerem et 
al 1991 
Likes: Simple – not overpowering  
Not operator dependent – could be used by 
relatively inexperienced staff 
Didn’t need auscultation 
Easy to interpret  
Dislikes: Is age taken into account 
‘for asthma’  
Should identify what’s happening – e.g. feeds, 
handling 
 
Walsh et al (2004) developed a score which included four items (retractions, 
HR>97 centile, age and hydration) (63). When assessing an infant, a 
numerical value would be determined for each item. Each individual item value 
would then be multiplied by an additional numerical value (three decimal 
places). The values for the four items would then be summed together. Cut-
offs values were developed for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis. 
This instrument was found to be “complicated” and “off putting” by the HCPs.  
An instrument which enabled you to calculate to three decimal places was 
considered a “bad thing”. Calculating the score was difficult and not “intuitive” 
to use. It was felt there was a “fair amount of subjectivity” when assessing 
hydration with hydration scores being more “heavily weighted” than heart rate, 
retractions and age. There were concerns with the instrument being developed 
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using a retrospective group of patients. Having to obtain information from 
percentile charts in order to “score” was considered an additional burden. 
Finally, the instrument did not take into account other clinical symptoms such 
as “retractions”, “saturations” and “respiratory distress”.  
Wang et al (1992) developed an instrument which enabled the user to score 
an infant on four items (respiratory rate, retractions, wheeze, and general 
appearance) using a scale from ‘0’ to ‘3’ (58). The HCPs liked the lay out of 
this instrument and found it “easy to use”. However they did question its 
relevance to the UK definition of bronchiolitis. They considered the score was 
more suited to the North American definition of bronchiolitis, which include viral 
wheeze. They were not convinced that “wheezing” was particularly useful in 
assessing severity of illness. For respiratory rate < 30 the infant would get a 
score of ‘0’. This scoring was perceived inappropriate for this age group with a 
score of ‘3’ deemed more appropriate in certain situations. It was also noted 
there was a lack of guidance on how to calculate and interpret the score. 
Ultimately, the HCPs believed that a score should have “universal” use. For 
this score the user would have to be competent in auscultation therefore 
certain HCPs may be excluded from its use. 
Wilson et al (2000) developed an instrument with seven items (digestive, 
lab-arterial blood gases, lab-haematology, neurology, radiology, respiratory 
and vital signs) (33). The respiratory item was further sub-divided into 
cyanosis, sputum/secretions, apnoea, dyspnoea, rales, breath sounds, nasal 
flare, retractions, expiratory grunt, wheeze and oxygen saturation. Each item 
would be assessed using a scale from ‘level one’ to ‘level four’. It was felt that 
this instrument was “too busy” with superfluous criteria and was found to be 
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“too difficult and too hard to follow”. Some criteria were perceived to be useful 
but required “further clarification”. The instrument includes criteria that prevent 
universal use. There was no guidance on how to calculate and interpret this 
score.  
Liu et al (2004) (55) developed an instrument with four items (respiratory 
rate, retractions, dyspnoea and wheeze) (55). The instrument is divided into 
age groups from new-born to five years of age. Each item is scored on a scale 
from ‘0’ to ‘3’. In general this score was “liked better” by the HCPs. It was felt 
that it was “easier to use”. They liked how the instrument was divided into age 
categories. Criticisms of this instrument were that it was generic and could be 
used for a number of respiratory conditions. Its “criteria could be more 
specific”, “wheeze not helpful”, “a little bit too simplistic” and it omitted the 
following; heart rate, colour, neurological status and feeding.  
Lowell et al (1987) (56) developed the RDAI which includes two items 
(wheeze (expiration/inspiration/location) and retractions 
(supraclavicular/intercostal/subcostal)) (56). Each item scored on a scale from 
‘0’ to ‘4’. The HCPs found this “simple to look at” and would be able to “score a 
change” in condition. However, it was perceived that the wheeze item was “too 
specific” and could lead to “subjective scoring”. The user had to assess 
whether wheeze occurred in either a half or three quarters of the expiration. In 
addition the location of the wheeze was required to be identified (< two or > 
three of four lung fields). It was felt that these assessments were operator 
dependent and could lack consistency. Assessing location of wheeze was also 
considered difficult to undertake and would prevent universal uptake.  
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Kerem et al (1991) developed an instrument for use in acute childhood 
asthma. This instrument contained five items (heart rate, respiratory rate, 
wheezing, skin colour/feeding, oxygen saturations) (125). The items would be 
scored on a scale from ‘1’ to ‘3’. The HCPs found this instrument to be “nice 
and simple”, not “operator dependent”, provided objective values and was 
“easy to interpret”. Age was raised as a concern and whether this was taken 
into account with criteria such as heart/respiratory rate. Documenting activity, 
for example asleep or crying, at the time of using the instrument was also 
discussed and considered important to include. 
  Ranking activity: prioritisation of ‘worsening’ signs and symptoms  4.7.4
4.7.4.1  ‘Mild’ bronchiolitis group 
The ‘mild’ HCP group considered signs and symptoms for those infants who 
could be managed at home or improving hospitalised infants who were being 
considered for discharge (Table 14). They decided that they could not rank 
these items in order of importance as they all had “equal significance”. The 
‘mild’ HCP group suggested that if the infant was being considered for hospital 
discharge: information on oxygen requirements would be required. History of 
apnoea was believed to be definite admission criteria. “Work of breathing” was 
considered “relative to what they were doing at the time”. They felt that oxygen 
saturation thresholds should be greater than 92% in air. An exception to this 
would be if the infant looked unwell then this might trigger them to consider 
admission. The example they gave would be an infant who looked “mottled”, 
with “heart rate up” but with “good saturations”. The HCPs felt they “would 
want to know the day of illness” to help decide if the infant was going to 
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improve or worsen. Although, they felt this information “might not stop us 
[HCPs] from necessarily sending them [infant] home”. One HCP from one of 
the other two groups disagreed with the ‘mild’ group’s inability to rank the signs 
and symptoms. This HCP felt saturations and feeding should be prioritised: 
“I would put saturations and feeding as the top two regardless of all the 
others if I was thinking of sending them home...they didn’t need oxygen and 
they were feeding ok then there would be absolutely nothing that I would be 
doing in hospital that I wouldn’t be doing at home” (HCP 14). 
A discussion arose amongst the whole group over the benefits and 
consequences to prioritising saturations and feeding over other signs and 
symptoms. Increased heart rate was argued for as being “a good red flag” 
indicator. Although, one of the ‘mild’ group HCPs suggested when assessing 
an infant you “look at the all over picture” which makes it difficult to prioritise 
particular signs and symptoms.  
4.7.4.2  ‘Moderate’ bronchiolitis group  
The ‘moderate’ bronchiolitis group considered signs and symptoms for 
those infants who required hospital admission. The reported that the 
‘moderate’ group “covered” everything that was discussed with the ‘mild’ 
[group] but being more “specific” for example, HCP 15 described: 
“…oxygen […] saturations less than 92% in air …’cause you are going 
to admit them …but probably requiring less [than] 50 [percent oxygen] 
to maintain saturations greater than 92%...” (HCP 15). 
Important negatives, which could mark “severe” work of breathing included: no 
head bobbing, nasal flare, sternal recession or audible grunt heard. Apnoeas 
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were thought to indicate that the infant is “getting knackered” and may need 
intervention. Feeding was thought to be “difficult” and should be considered in 
conjunction with age. The ‘moderate’ group suggested that an infant less than 
six months they would be taking 75mL/kg/day whilst infants aged over six 
months would take 500mL/day. It was thought that nasogastric (NG) feeds and 
intravenous (IV) fluids may be used to “differentiate the severity” within the 
moderate category but does not necessarily “differentiate between ‘moderate’ 
and ‘severe’”. An upper threshold limit of 60 was used for respiratory rate 
based on Advanced Paediatric Life Support (APLS) criteria. Whilst the upper 
threshold limit decided for heart rate was 160 beats per minute (bpm). It was 
noted by one HCP (HCP 05) from the main group that respiratory rate may 
increase if the infants’ nose is obstructed with either “vomit” or “snot” and the 
respiratory rate will “drop back down” following removal of the obstruction. 
Consciousness level was included and considered important, particularly for 
less experienced HCPs. However, the HCPs found it difficult to “differentiate” 
which items were “more important” when assessing level of consciousness. 
During the whole group discussion HCP 15 suggested including a comments 
box to document whether the infant has had an intervention. Overall 
assessment was still felt to be “quite subjective” by one HCP (UIF). Whereas 
HCP 15 suggested: 
 “…if you scored for all of these …in theory it’s supposed to make it less 
subjective and more objective…” (HCP 15). 
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4.7.4.3  ‘Severe’ bronchiolitis group 
The ‘severe’ group found it difficult to decide which sign or symptom should 
be ranked first so presented the signs and symptoms which they had ranked 
second, third, and fourth initially. Hypoxia despite supplemental oxygen was 
ranked second, reduced respiratory rate ranked third and abnormal blood gas 
results ranked fourth. The general consensus was “general appearance” 
should be ranked first although it was thought not “particularly helpful” for an 
“objective” instrument. Although HCP 14 explained:  
“…you look at them […] and think I am worried about this one …” (HCP 
14). 
The ‘severe’ group proceeded to try and objectify ‘general appearance’ by 
including “colour”, “activity”, “tone” and “consciousness level”, but thought the 
instrument could become “busy”. During the general discussion HCP 02 
commented on how PEW scores only pick up “50% of cardiac arrest calls” 
whilst 50 percent of the time HCPs will rely on their “gut instinct” […] no matter 
how good it [LIBSS-PRO] is…”. Furthermore, it was suggested that ‘gut 
instinct’ should be included at the beginning of the scoring instrument. 
“Parental concern” and using “mum as the expert” was also suggested for 
inclusion, although HCP 15 felt this needed to be qualified by “sensible 
parents”. The researchers observed that wheeze had not been included by the 
HCPs as a symptom for consideration into the scoring instrument in spite of 
being included as an item within the six scoring instruments in the previous 
exercise. When asked to confirm whether wheeze should be excluded from the 
scoring instrument the whole HCP group were unanimous. Wheeze was 
considered helpful for diagnosis but not for assessing severity of bronchiolitis.  
97 
 







“Fit to go home” 
Overall picture 
Saturations >92% in air 
and not requiring 
oxygen (review of recent 
oxygen requirement) 
Apnoeas 




Day of illness (consider 
for discharge and 
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HCP 14 (from the ‘severe’ group) suggested it was the “opposite of 
everything else” that was discussed for ‘severe’ in the previous exercise, 
although additional items were suggested such as: “not requiring 
interventions”; “feeding commenced” and “happier parents”. One HCP (UIF), 
from the ‘mild’ group, described how there would be “less nursing interaction” 
and the “parents getting confident” in taking over the care of the infant. A 
discussion ensued over discharge criteria, particularly with regards to oxygen 
saturation thresholds and at what point oxygen saturations should stop being 
measured as HCP 14 explained: 
“…you have these babies that are feeding fine…they are not working 
particularly hard with their breathing…but their [oxygen] saturations are 
kind of 90…91% when they are asleep…eventually the go home a 




Other HCPs reported how the parents become reliant on the oxygen 
saturation monitor, would be “looking at the numbers” and become “freaky” if 
the monitors were switched off. The oxygen saturation thresholds were 
contrasted to the lower thresholds accepted for infants with CHD as HCP 15 
described: 
“…we let cardiac babies run at eighty five…acceptably for months and 
months if not years on end” (HCP 15).  
Having different thresholds for supplemental oxygen requirement and 
discharge criteria may lead to confusion with the parents as one HCP (UIF) 
noted: 
“…the trouble is that we have spent how many days telling parents we 
want their sats to be above 92 and then we are then saying no…now 
you can go home at 91…” (HCP UIF). 
Another HCP reflected on how historically clinicians would gauge the infant 
being fit for discharge based on the infant’s appearance: 
“I mean what did we do years ago before we got obsessed with looking 
at sats? […] you would look at their colour” (HCP 03).  
 Conclusion 4.8
A group of HCPs (n=18) identified a total of 73 ‘worsening’ and 20 
‘improving’ signs and symptoms for potential inclusion into the LIBSS-PRO. 
When appraising scoring instruments the HCPs wanted an instrument that was 
simple, easy to calculate, could score a change, age specific and easy to 
interpret the score. The HCPs also obtained consensus over criteria for an 
infant with ‘mild’, ‘moderate’ or ‘severe’ bronchiolitis.  
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The strength of this group workshop was the diverse group of HCPs of 
different grades and from different clinical settings, which should make the 
findings generalisable to the wider HCP population. As with the family group, 
using NGT to identify and achieve HCP consensus on signs, symptoms and 
severity criteria, increases the validity of the data collected. Furthermore the 
data obtained from the HCPs compliments the data from the family stakeholder 
group workshop. The bronchiolitis signs and symptoms identified from both 
workshops were broadly similar with significant overlap.  
However, the large sample size of the group was also found to be a 
limitation. Transcribing the audio recordings proved difficult as distinguishing 
voices especially when more than one person was speaking at the same time 
was troublesome. In respect to this problem, the field notes made by the 




5  Parent interviews 
 Introduction  5.1
This chapter describes the methods used and the results obtained from 
undertaking semi-structured interviews (telephone or face-to-face) with parents 
(including carers or legal guardians) of infants with bronchiolitis. In-depth key 
informant interviews are recommended to exploit the unique knowledge and 
experience of important stakeholders (52). These semi-structured interviews 
aimed to add a greater depth to and corroborate the findings from the family 
workshop, particularly as the sample size of the family workshop was smaller 
than anticipated.  
 Aims 5.2
The main aims of these interviews were: 
 To identify signs and symptoms of bronchiolitis for potential inclusion as 
items in a bronchiolitis severity score; 
 To contribute towards the development of a bronchiolitis conceptual 
framework. 
 Sample and setting 5.3
Recruitment for the interviews was undertaken over two bronchiolitis 
seasons: 2011/12 and 2012/13. Participants were identified from five hospital 
sites (one paediatric tertiary centre and four DGHs) through the Cheshire and 
Merseyside CLRN. Participants were parents (including carers or legal 
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guardians) of an eligible infant who had been recently discharged from hospital 
(within two weeks) with a clinical diagnosis of bronchiolitis. A purposive sample 
frame was devised (Appendix 29) to ensure adequate representation of 
individuals with a wide range of experience. Eligible infants were stratified by 
age, gender and severity of illness. CLRN research nurses initially approached 
parents during their infants’ hospital stay with information about the research. 
Parents or carers who expressed an interest in participating were contacted via 
telephone by CvM and provided with further verbal information about the 
interviews. Interviews were arranged to take place within two weeks of hospital 
discharge. The short two week time period between hospital discharge and 
interviews was chosen to reduce the possibility of recall bias.  
 Informed consent 5.4
Information (written and verbal) was provided to parents prior to the infant 
being discharged from hospital. Parents were given time to consider this 
information before written informed consent was obtained by either CvM or 
from a CLRN research nurse. At the beginning of each interview CvM went 
through the consent process again and obtained an audio-recorded verbal 
consent off the parent.  
 Methods  5.5
One researcher (CvM) conducted all of the interviews. Parents were offered 
the option of either a telephone or face-to-face interview arranged at their 
convenience. Either a CLRN research nurse or CvM obtained informed written 
consent from all participants prior to the interview. At the beginning of each 
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interview CvM provided brief information on the research aims and checked 
that the parent still gave consent for the interview to proceed. The interviews 
lasted between 20-60 minutes. All interviews were digitally audio recorded 
(Tascam DR-100). The recordings were transcribed verbatim and anonymised 
prior to analysis (CvM). The interview schedule was based on the findings from 
the family workshop (Table 17). Probe questions were used in addition to the 
questions contained in the interview schedule. CvM took handwritten notes 
during the interview.  
Table 16: Parent interview schedule  
Question 1 Who is in your family? 
Question 2 What prompted you to seek medical help when your baby 
became unwell? 
Question 3 How could you tell your baby was improving? 
Question 4 What is your previous experience/knowledge of 
bronchiolitis? 
What information would you have liked? 
What format/provision? 
Question 5 What could have improved your experience of having a 
baby with bronchiolitis? 
 Analysis 5.6
The process of analysis was iterative and the interview transcripts were 
examined and re-examined several times during the course of the analysis. An 
initial examination of the transcripts provided an overview of what the parents 
talked about and any general impressions, key ideas or potential concepts. 
Following this a descriptive thematic analysis was undertaken (124). This 
process involved manually coding the raw data then collapsing the codes into 
broader themes. Codes and themes were inductively derived from the data. As 
new codes emerged, these were applied iteratively, as appropriate, to the 
whole data set in subsequent examinations of the data sources until no new 
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codes or themes were identified. As data analysis progressed some codes 
were merged or discarded and themes were further developed, refined and 
some discarded. This resulted in a final set of codes and themes. A descriptive 
memo was produced for each of the final themes that summarised what the 
theme represented. QRS NVIVO (Version10) software was used to support the 
coding and synthesis of the data. Field notes were used to support the 
analysis and enabled the researcher to reflect on the interviews and record 
any thoughts and insights. 
 Results 5.7
The aim was to recruit approximately 15 parent participants. Informed 
consent was obtained from 22 parent participants. However, CvM was unable 
to make contact with six parents by telephone to arrange the interviews within 
the time period of two weeks, therefore it was assumed that these parents 
were either unavailable or no longer wished to participate with the study and 
they were classed as withdrawals. Interviews were obtained from the 
remaining 16 participants (one face-to-face interview and 15 telephone 
interviews). Technical problems with the audio recorder occurred with two 
interviews (P 05 and P 06). One interview (P 05) was partially recorded and 
one interview recording (P 06) failed completely. Parent names were 
anonymised with the following labels P 01, P 02, P 03…etc. For the purpose of 
anonymity all given names of family members have been changed within the 
narrative. The data generated from these interviews were used to support the 
development of the scoring instrument. The presentations of themes have 
been structured under the following headings: ‘worsening signs and 
105 
 
symptoms’, ‘improving signs and symptoms’, ‘parental knowledge of 
bronchiolitis’ and ‘parent experience’. 
 Family demographics  5.8
Parent and family characteristics are presented in Table 18. The sample 
comprised one father and 15 mothers. The predominant ethnicity amongst the 
families was White British (n=9) with the remaining families being of mixed 
race (n=2). There were no data available on ethnicity for five families. Most of 
the families consisted of parents who were either married or cohabiting (n=15). 
Two of these families were blended and included children from a previous 
relationship. There was one single parent family. The number of children within 
each family varied. Four families had either one (n=4) or two (n=8) children. 
There were four larger with either three (n=1), four (n=2) or six (n=1) children. 
The majority of the infants admitted to hospital were aged below three months 
(n=10). There were five infants aged three months and older; data were 
missing for the age of one infant. Gender was evenly split between male (n=8) 
and female (n=8) infants. There were three sets of twins with bronchiolitis. 
Most infants had been categorised as having ‘moderate’ (n=9) bronchiolitis. 
Five infants were categorised as ‘severe’ and only two infants were 
categorised as ‘mild’. Four infants had one or more risk factor for ‘severe’ 
bronchiolitis (prematurity (n=3), chronic lung disease (n=1), congenital heart 
defect (n=2)). Two infants had had more than one bronchiolitis episode. 
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Table 17: Parent or carer characteristics 
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*m/d: missing data; *CLD: chronic lung disease; *CHD: congenital heart disease; *PBE: previous bronchiolitis 
episode 
  ‘Worsening’ bronchiolitis signs and symptoms 5.8.1
This theme describes ‘worsening’ bronchiolitis signs and symptoms as 
identified by the parents. This theme has been divided into two sub-themes: 
‘seeking help’ when the parent first suspects the infant is unwell and ‘hospital 
admission’ where parents observe signs of further deterioration during hospital 
admission. The ‘worsening’ bronchiolitis signs and symptoms were broadly 
related to changes in physiology, appearance and behaviour.  
107 
 
5.8.1.1  ‘Seeking help’ 
Several parents often reported a family member (parent/sibling), having a 
“cough” or “cold” that preceded the infant becoming unwell. In the early stages 
of bronchiolitis, parents noticed signs and symptoms attributable to a common 
cold: “cough”; “runny”/”blocked nose” and “snuffly”. The “cough” appeared to 
be of particular concern for parents. This symptom alone was significant 
enough for thirteen parents to decide to ‘seek help’.  The “cough” was 
characterised as being “noisy”, “bad”, “nasty”, “chesty”, “wet”, “irritating” and 
“wheezy”. Parents likened the sound of the “cough” to “an orchestra” or to 
“smoking 60 fags a day”. Furthermore, parents reported how the infant would 
have “coughing fits” with “a lot more effort going into the cough” than usual 
causing the infant to go “bright red and purple”. In addition to these cold-like 
symptoms parents witnessed the infant not seeming themselves explaining 
that the infants were: “unsettled” and “irritable”, “not feeding well” and had 
altered sleeping patterns. Five parents reported measuring their infant’s 
temperature in the early stages of bronchiolitis although all reported that the 
infant’s temperature initially fell within the normal range. One parent, who had 
previously heard of bronchiolitis, incorrectly assumed her infant did not have 
bronchiolitis “because she didn’t have a temperature”. A small proportion of 
these infants went on to develop a high temperature as the illness progressed, 
usually after the infant had been admitted to hospital. Other early signs and 
symptoms observed were related to changes in the infants’ breathing. Parents 
recalled how their infant was “wheezing” (n=6), “finding it difficult to breathe” 
(n=8) and had “mucous coming out of their mouth and their nose” (n=4). These 
signs and symptoms prompted parents to ‘seek help’ and advice from a HCP 
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usually based in a primary care setting (GP surgery, GP out of hours, Walk-in 
Centre). The timing of ‘seeking help’ varied between parents. Some parents 
would ‘seek help’ soon after the infant became unwell: 
“…at first it was just a little cough […] now and again […] it was getting 
a little bit worse so I took her to the out of hours…” (Mother, P 08) 
However, others were not overly concerned initially, choosing to delay 
‘seeking help’ until the signs and symptoms were perceived to have ‘worsened’ 
over a period of time: 
“…the baby started having a cough and a runny nose and it didn’t worry 
me too much…it was just like an occasional cough […] then […] after 
three days she got like really ill like from the morning when we woke up 
she couldn’t breathe very well and she had stopped feeding…” (Mother, 
P 07).  
When ‘seeking help’, a diagnosis or a differential diagnosis of bronchiolitis in 
a primary health care setting was not often provided by HCPs. Parents 
reported receiving nebulous diagnoses such as “it’s a cough”, “just a cold”, 
“catarrh”, “chest infection” or “virus”. Furthermore, parents reported receiving a 
limited explanation as one mother recalled: 
“He [the GP] didn’t explain what sort of virus he just said it was a 
virus…” (Mother, P 13). 
Treatment, management advice and guidance were also found to be 
inconsistent. Some parents received prescriptions for antibiotics or salbutamol 
inhalers, some were provided with limited advice on ‘worsening’ signs and 
symptoms, whilst others were just told to “come back if they [their infant] gets 
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worse” without explaining what was meant by getting “worse”. However, one 
parent did ask for clarification from her GP: 
“I sort of said ‘What am I looking out for?’ …thinking that this was a 
straight cold at this stage […] he said ‘If she doesn’t feed….you know 
the key things are if she stops feeding well and if she becomes less 
alert’ …so those were the things I was looking out for from the point of 
view of expecting a cold” (Mother, P 11). 
As the illness progressed, parents noted continued deterioration in 
breathing difficulties, feeding, appearance and behaviour. Parents reported 
their infants’ breathing was “really fast” or “laboured”. Some parents spotted a 
change in the breathing pattern with it becoming more “irregular” or “pausing” 
for a few seconds. This increased effort of breathing was characterised by the 
parents explaining how the infant’s “chest would “suck in” as would the area 
“between his collar bones”, the “stomach seemed to be going in and out a lot”, 
the “head was sort of going up and down”, and the “nostrils were going”. One 
parent witnessed her daughters’ lips turn “blue”. Feeding continued to be 
problematic with feeding patterns changing in terms of volume and frequency; 
milk was taken “little and often”. Feed intake was significantly “reduced” or the 
infant “stopped” feeding completely. Feeding difficulties were perceived to be 
related to either a “stuffy nose” or the infant not being able to “suck well 
enough to feed”. Parents suggested increased vomiting was a particular issue 
as infants’ were not “keeping bottles down”. A general perception amongst 
parents was that feeding appeared to make the infant “struggle to breathe”. 
Parents whose ethnicity were white/British described how the infant would 
appear “pale” and/or “grey” as they worsened. In general infants who were 
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worsening were described as “limp”, “lethargic”, “unresponsive” and having 
“reduced activity”. “Dull” appearance, “sunken eyes” and “eye rolling” were also 
seen. One mother described how her twin boys “wanted to be held a lot” and 
“kept upright”. These ‘worsening’ signs and symptoms caused concern and 
prompted parents to ‘seek help’ either from their GP surgery, Walk-in Centre, 
ED, or consult an NHS website or NHS Direct. At this stage in the illness, 
parents who ‘sought help’ from a primary care setting or NHS Direct were 
referred to ED. Two parents ‘sought help’ directly from ED. One parent 
described her daughter’s deterioration and her journey to ED:  
“…she just become […] not hungry and sleeping a lot […] then she 
missed her 11 o’clock feed at night […] I kept an eye on her and within 
two hours she had gone completely grey and her lips were going blue 
[…] I noticed her breathing… she was breathing from her stomach and 
her head was bobbing so I got straight up to hospital by taxi…not 
realising how ill she was….and within an hour she deteriorated […] she 
was […] on cpap in erm ICU…” (Mother, P 16). 
This parent did not appear to appreciate that the ‘worsening’ signs and 
symptoms she observed indicated severe respiratory distress and were 
potentially life threatening. This mother reflected back on her own lack of 
knowledge and the inappropriate use of a taxi to get to the ED. For those 
parents who attended ED, the infants were triaged and either admitted to 
hospital for treatment or monitored in an observation area prior to being either 
admitted or discharged. Three infants were discharged home. In all three 
cases the infants deteriorated further, re-attended ED and were admitted to 
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hospital within a 24-hour period. One mother describes her apprehension at 
returning home with her sick infant: 
“…I was very anxious about that actually because of how long they had 
monitored him for …it was six or seven hours […] the triage nurse […] 
said he’d almost definitely be admitted with the way he was breathing 
and obviously when the Walk-in centre had called an ambulance that 
was quite a dramatic thing to do really […] to hang around for six or 
seven hours just to be sent home …and the doctor…her words were ‘he 
is on the cusp of being admitted’…and I felt that with such a small baby 
he shouldn’t have been on the cusp of being admitted […] I felt that he 
should have stayed in” (Mother, P 13).  
Another mother, with previous bronchiolitis experience, felt more confident 
in returning home with her sick infant but reflected on how she may have felt if 
she had not had prior experience: 
“I felt alright because I’d had a child who’d had bronchiolitis before and 
he was premature and in and out of SCBU [special care baby unit] […] 
so felt quite confident about the things that I needed to look out for […] I 
think maybe if I hadn’t of had that experience […] I probably would have 
done one of two things…I’d either of felt very uncomfortable taking him 
home or the next morning maybe not reacted when I should have 
done…” (Mother, P 15).  
Some parents recounted how certain risk factors such as young age, were 
also taken into consideration when HCPs were deciding to admit to hospital as 
illustrated by one mother: 
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“…and then they decided to admit him because he was so small…” 
(Mother, P 04).  
5.8.1.2  ‘Hospital admission’ 
For most parents, bronchiolitis was diagnosed at hospital using clinical signs 
and symptoms. HCPs obtained nasal pharyngeal aspirates from infants to look 
for the virus that was causing the signs and symptoms. Some were told their 
infant was:  
“…positive for the RSV virus…” (Mother, P 13).  
Once admitted, parents became aware of other ‘worsening’ signs and 
symptoms from conversations with HCPs including reduced oxygen saturation 
levels, increased heart rate, increasing oxygen requirements, capillary blood 
gas results and exhaustion: 
“…Monday night they were just monitoring him […] they were just 
checking his sats every hour […] Tuesday morning they put him on 
oxygen […] the oxygen levels were supposed to be above 92 and they 
kept dropping…” (Mother, P 04).  
Some infants were admitted for observation whilst others required 
respiratory and/or feeding support. The type of respiratory support received 
would depend on the severity of symptoms but included oxygen therapy via 
nasal cannula, face mask or head box or NIV/invasive ventilation. Irrespective 
of the type of supportive therapy, parents found these therapies to be “horrible” 
as they acted as a barrier between them and their infant. Parents felt they 
were unable to “touch” (n=2) their infant and felt “completely helpless” (n=1);  
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“…it doesn’t mean that it is any less terrifying to see your tiny baby with 
a tube down and when she is in a head box you can’t touch them…” 
(Mother, P 11); 
and reported experiencing a loss of control; 
“…when they did the blood oxygen levels again […] they found that the 
levels had dropped […] they made the decision […] to put her on the CPAP 
ventilator […] I was absolutely heartbroken because I thought that was it 
and they did try and explain it the best they could but obviously it was still 
very hard because you just feel like you are losing complete control of 
everything…” (Mother, P 03). 
  ‘Improving’ signs and symptoms 5.9
Similarly to ‘worsening’ bronchiolitis ‘improving’ signs and symptoms were 
related to changes in vital signs, appearance and behaviour. Parents primarily 
took their cues for improvement from either HCPs or from the technology used 
to monitor their child:  
 “…you are clearly very led by the doctors […] I mean you can tell from the 
monitor […] but there were lots of updates I felt like the nurses and the 
doctors were quite good at keeping me informed about progress” (Mother, P 
11). 
One parent commented on how they became “too reliant” on the monitors 
for information and how they then had to revert to using physical signs when 
the monitoring was discontinued:  
“…you do almost become a bit too reliant on...staring at what their sats 
are or what the pulse rate is...I mean eventually when we obviously 
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didn’t have their sats monitors I would look at the effort they were 
making in terms of their breathing, looking at whether they were tired or 
whether they were coping with their feeds the same sort of physical 
signs…” (Mother, P 03). 
Other observations reported by parents included improved breathing, the 
infants required “less effort” to take a breath and had improved blood gas 
results, and a return to the infants’ “normal routine” particularly with regards to 
sleep patterns and feeding. The infant appeared more “alert” and “active”, 
“smiling”, “less irritable” and their colour had improved. Parents noticed that as 
the aforementioned signs and symptoms ‘improved’ their infant required less 
supportive therapy: non-invasive/invasive ventilation and oxygen would be 
weaned. Parents reported their infant would start to become more 
“demanding”, “difficult to look after” and less tolerant of supportive therapies. 
Cough was reported to be one of the last symptoms to improve, and although 
it became less “distressing”, “frequent” and “noisy”, it could still disrupt sleep.  
 Bronchiolitis conceptual framework 5.10
Using the conceptual framework created in the family workshop: the 
‘worsening’ and ‘improving’ bronchiolitis signs and symptoms identified from 
the interviews with the parents and carers were condensed and included under 
the relevant domains (Table 19).  
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Domains Sub-domains: associated signs and symptoms 
‘Worsening’ n=41 ‘Improving’ n=18 
Breathing n=15 n=4 




Oxygen levels dropping  
Increased respiratory rate 
Blood oxygen levels dropping 





High carbon dioxide 
Head nodding 
Protruding stomach 
Pauses in breathing 
Sats [oxygen saturations] 
had improved 
No chest in-drawing 
Not as wheezy 
Breathing: not struggling; 
improved; not heavy; 






Coughing  (bright red & purple) 
Blue lips 
Colour as well picked up 
(pink) 
Cough n=6 n=1 












Not them self 
Poor feeding 





Not as active 
Worse at night 
Not responding to pain 
Exhausted 







Gradually weaned treatment 
Improved feeding 
Information from monitoring 
Alert 
Sleeping less/more awake 
Less irritable/more content 
More demanding 





The data from the parent interviews was compared and contrasted with the 
data from the family workshop to assess for concordance. Overall the parent 
descriptions of ‘worsening’ and ‘improving’ bronchiolitis signs and symptoms 
were broadly similar and could be categorised under the four domains 
identified in the family workshop: breathing; colour change; cough; body 
language. This similarity between the family stakeholder workshop and the 
parents interviews provides confirmatory evidence to suggest the experience 
of the family workshop parents However, a small number of additional signs 
and symptoms were identified from the parent interviews and have been 
included into the conceptual framework these being: breathing (wheeze, 
grunting, altered oxygen saturations, carbon dioxide levels); and body 
language (clingy, worse at night, weight loss, sunken fontanelle, eyes 
(rolling/red/sunken)). With the exception of weight loss and worse at night 
these additional signs and symptoms were previously identified from the either 
the literature or the HCP stakeholder workshop.  
 Conclusion 5.11
The parent interviews identified a total of 41 ‘worsening’ and 19 ‘improving’ 
signs and symptoms. These signs and symptoms have been included as items 
under the domains of the conceptual framework developed from the data 
generated by the parents who attended the family workshop. There was 
significant overlap between the signs and symptoms identified from the family 
workshop and parent interviews although a small number of additional signs 
and symptoms were identified. The parent interviews were a later addition to 
the study following the small number of parents who attended the family 
117 
 
stakeholder group workshop. Due to having to submit an ethics amendment 
the parent interviews were not completed and analysed prior to Phase II of the 
study. Therefore it was not possible to incorporate the two additional 
symptoms identified (weight loss and worse at night) for consideration as items 
into the LIBSS-PRO. This could be considered a study limitation.  
The strength of this study was with the sampling strategy. The strategy 
ensured there was a cross-section of parents’ with infants of varying age, 
gender and severity. Furthermore, some infants had risk factors for severe 
disease. Recruiting parents from five study sites across the Northwest of 
England ensured parent perspectives were obtained from different localities 
and social groups. However, similar to the family workshop, an identified 
limitation of the sampling strategy was the under-representation of ethnic 
minority groups. Therefore these findings may not be generalisable to other 
population groups. Furthermore, mothers were the dominant parent and/or 
carer participating with the interviews. The inclusion of more fathers may have 
provided a different perspective on having an infant with bronchiolitis. In 
addition, the majority of included parents had infants classified as having 
‘moderate’ bronchiolitis. Consequently, there may be important missing signs 
and symptoms, pertinent to ‘mild’ and ‘severe’ bronchiolitis groups. Parent 
experience of infants with bronchiolitis in these two groups may also differ 





6  Delphi consensus survey 
 Introduction 6.1
The signs, symptoms and risk factors identified from the literature review, 
stakeholder workshops and parent interviews were reviewed. Similar signs and 
symptoms were collapsed and merged together and listed under the domains 
contained in the bronchiolitis conceptual framework previously devised by the 
HCP stakeholder workshop. A final list was created consisting of 101 signs, 
symptoms and risk factors identified as potential items for inclusion into the 
LIBSS-PRO. Incorporating all 101 signs, symptoms and risk factors into the 
LIBSS-PRO would lack clinical utility: the instrument would be too long to 
complete in a timely manner by HCPs in a clinical environment so a process 
was identified to reduce the number. This chapter describes the methods used 
to obtain consensus over which of the 101 pre-identified signs, symptoms and 
risk factors to include in the LIBSS-PRO to assess severity of bronchiolitis.  
The Delphi technique is an iterative process, which aims to seek consensus 
from a group of ‘experts’ through a series of structured questionnaires (rounds) 
(122, 126, 127). For each Delphi round the questionnaires are completed 
anonymously, the responses collated and fed back to the Delphi panel 
members until consensus is achieved (126). The Delphi survey has been 
found to be particularly useful when the included panel members are located 





i) To obtain consensus over which of the pre-identified signs/symptoms 
should be usefully included as items in the scoring instrument. 
ii) To obtain consensus definitions for ‘mild’, ‘moderate’ and ‘severe’ 
bronchiolitis.  
iii) To obtain consensus criteria for hospital referral, admission and 
discharge.  
 Sample and setting  6.3
HCPs located across the UK and Ireland was invited to participate in a four 
round Delphi survey. Eligible participants were identified through five hospital 
study sites (one paediatric tertiary centre and four DGHs) via the Cheshire and 
Merseyside CLRN. In addition, emails were sent to the corresponding author 
for bronchiolitis Cochrane reviews and SIGN guidelines. Members of the 
following professional organisations were emailed: Medicine for Children’s 
Research Network (MCRN) General Paediatrics Clinical Studies Group; 
Paediatric Intensive Care Nursing Group; Acute Paediatric Emergency 
Medicine; Royal College of Nursing Children and Young Peoples Forum. The 
Delphi survey was also advertised through newsletters to HCPs working for 
Wirral and Liverpool Primary Care Trusts. There is no statistical method to 
determine the size of the Delphi panel. A pragmatic decision to recruit between 




 Informed consent  6.4
Written information about the study was included as a separate attachment 
in the email with the hyperlink for the Delphi survey. The written information 
was also embedded into the first page of the electronic survey. The electronic 
survey was designed so that participants had to initially go through a formal 
procedure to indicate consent with participation otherwise they could not 
proceed to the next section of the survey. 
 Methods 6.5
The 101 signs and symptoms, criteria for hospital referral, admission and 
discharge and criteria for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis, identified 
from the literature and stakeholder consultation, were included into an 
electronic survey. The electronic survey was developed using SurveyMonkey® 
software and distributed to potential participants between May and October 
2011. A hyperlink to the survey was embedded into an email and forwarded to 
the potential participants with an information sheet. The information sheet 
provided details of the study, notified potential participants that participation 
was voluntary and that they could withdraw at any point during the Delphi 
process. All HCPs who accessed the survey were asked to electronically sign 
an informed consent form prior to completing the survey. Participants were 
asked to complete all four rounds. As an incentive to reduce attrition bias, 
participants were advised following completion of all four rounds they would be 
entered into a prize draw to win one of three prizes: shopping vouchers to the 
value of either £100 (x 1) or £50 (x 2). All participants, irrespective of their 
participation in the previous round, were sent emails inviting them to 
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participate with each of the four rounds. Follow-up emails were sent out to 
participants on days seven and fourteen reminding them to complete the 
survey. Participants were given three weeks to complete each survey round. 
Withdrawals were classed as those participants who either contacted CvM 
directly or wrote a comment in the comment box to indicate they did not want 
to participate with any further Delphi survey rounds.  
 Delphi rounds one and two  6.6
The aim of round one was to gain consensus over which of the pre-
determined signs and symptoms should be included in the scoring instrument. 
These signs and symptoms were grouped as items under the following domain 
headings: respiratory; feeding and hydration; level of consciousness; 
miscellaneous symptoms and risk factors. For each section the following 
question was posed: 
“In an otherwise healthy infant with a clinical diagnosis of bronchiolitis, how 
important are the following items when assessing severity of illness?” 
The participants were asked to rank each item using a Likert scale which 
ranged between 1 (extremely important) and 5 (completely unimportant). A 
‘don’t know’ answer option was also provided. Participants were asked to 
supply details of other signs and symptoms not currently listed in the survey 
that should be considered for inclusion into a scoring instrument. At the end of 
each section a free text box was offered for any additional comments. Prior to 
distribution, the survey was peer reviewed and amended by the study steering 
group members. The survey was pilot tested with ten participants to determine 
any technical issues with the software, clarity of wording, time taken to 
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complete the survey and ease of use. The survey was further refined in light of 
the pilot test. The Delphi survey was not anonymous: a name and email 
address was required so surveys for subsequent Delphi rounds could be 
forwarded to participants. This information was kept on a secure password 
protected NHS computer. However, the data from the returned surveys were 
anonymised by CvM with the use of identification codes.  
The questionnaire data were analysed using SPSS software (Version 22). 
Demographic data were collected and analysed using descriptive statistics for 
each participant on profession type, grade, NHS institution and area of clinical 
practice. An aggregate of the group Likert scores were collated and a 
percentage, mean (SD) and median (range) was determined for each item 
score. Consensus was determined a priori and considered achieved when 
greater than 80 percent of participant ratings fell into either the 1-2 (important) 
or 4-5 (unimportant) categories. Free text comments were saved verbatim into 
a word document and analysed using a descriptive thematic analysis.  
The purpose of round two was to complete the consensus process by 
providing the participants with the opportunity to re-rank those items which had 
not achieved consensus in round one. These items were revised in light of the 
survey comments and included into a second survey for distribution to the 
Delphi panel members in round two. The question posed to the HCPs for each 
section was changed to: 
‘Which of the following respiratory items should be usefully included in a 
clinical severity scoring instrument for infants with bronchiolitis?’ 
As for round one Delphi panel members were asked to rank each item on a 
Likert scale. The Likert scale responses were changed and ranged between 
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1(strongly agree) to 5 (completely disagree). In addition to the revised survey 
the Delphi participants were also provided with a summary report of the 
anonymised collated results (frequencies and percentages) for each included 
item and free text comments from round one. The Delphi participants were 
asked to re-rank the items in light of this information.  
 Delphi rounds three and four  6.7
In round three, Delphi panel members were asked to rate agreement using 
the same methods as described for rounds one and two, for the following: 
hospital referral/admission and discharge criteria and ‘mild’, ‘moderate’ and 
‘severe’ bronchiolitis. The response categories ranged between 1 (strongly 
agree) to 5 (completely disagree) and 6 (don’t know). In round four, those 
items which did not achieve consensus criteria in round three, were revised in 
light of the survey comments and re-distributed to the Delphi participants with 
the anonymised summary report. The Delphi participants were asked to re-
appraise these items in view of this information. 
 Results 6.8
The questionnaire was emailed to over three hundred HCPs across the UK 
and Ireland. The aim was to recruit between 50-70 HCPs to act as Delphi 
participants. One hundred and ninety five HCPs responded to participate with 
round one. Over the four rounds there was noticeable attrition with each 
subsequent round (Table 20). Response rates comprise: round two 136 out of 
195 (70%); round three 103 out of 195 (53%) and round four 96 out of 195 
(49%). The paediatrician HCP group had the least amount of attrition with only 
a 34% decrease in respondents between rounds one and four. Attrition rates 
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for the remaining HCP groups rose by 50% or greater by round four. Despite 
the attrition rate, recruitment for round four still exceeded the original 
recruitment target.  
Table 19: Characteristics of Delphi participants by round 








Profession/Role n (%) n (%) n (%) n (%) 
Paediatrician 53 (27.2) 48 (34) 39 (37.9) 35 (36.5) 
Children’s nurse 101 (51.8) 65 (46.1) 45 (43) 41 (42.7) 
Children’s nurse 
specialist/advanced 
nurse practitioner  
16 (8.2) 14 (9.9) 7 (6.8) 7 (7.3) 
Physiotherapist 9 (4.6) 4 (2.8) 4 (3.9) 3 (3.1) 
Assistant 
practitioner 
1 (0.5) 0 (0) 0 (0) 0 (0) 
General practitioner 6 (3.1) 2 (1.4) 2 (1.9) 2 (2.2) 
Student 
(nurse/medical) 
2 (1.0) 0 (0) 0 (0) 1 (1.0) 
Other  6 (3.1) 3 (2.1)  3 (2.9) 3 (3.3) 
Missing data 1 5 3 4 
 
The largest group of HCP participants recruited were children’s nurses 
(51.8%) with 46% of these nurses falling into Agenda for Change pay bands 5 
and 6. The next largest group of HCPs were paediatricians (27.2%) who were 
mostly either consultants (16.9%) or specialty training registrars (8.2%) 
(Figures 4 & 5). The category ‘other’ was made up of, nurse consultant, 
associate professor, senior lecturer, staff grade, locum, GP partner, research 
fellow and specialty doctor. Most HCPs (47.2%) were employed in a paediatric 
tertiary centre. The remaining HCPs were employed by district general 
hospitals (32.3%), primary care trusts (13.3%) or other healthcare settings 
(1%) (Figure 6). For the most part, HCP participants principally worked on 
paediatric medical wards (43.1%) Other clinical environments included: PICU 
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(19.7%); PHDU (12%); ED (8.2); acute admissions (6.6%) and GP surgery 
(2.7%) (Figure 7). In addition, 4.9% of HCPs reported working in ‘other’ clinical 
environments such as, community children’s nursing, hospital at home, adult 
ICU (receiving children), clinical lead for deteriorating patients, critical care 





Figure 4: Distribution of HCPs by Profession Type 
 





Figure 6: Distribution of HCPs by NHS Organisation Type 
 
Figure 7: Distribution of HCPs by Clinical Setting 
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 Delphi rounds one and two 6.9
Of the 101 items in round one the item with lowest mean item score was 
‘unresponsive’ (mean 1.12 [SD 0.36]) whereas the item with highest mean 
score was for ‘suburban residence’ (mean 3.61 [SD 0.98]). Forty four of 101 
items achieved consensus criteria of 80 percent or greater for importance 
(categories 1 & 2), whilst no items achieved consensus for unimportance 
(categories 4 & 5) in round one following preliminary analysis (Appendix 30). 
A further three items (clammy skin, convulsion, and altered behaviour), initially 
met the 80 percent criteria for consensus in the preliminary data analysis, but 
fell short of meeting the criteria for importance after the data was cleaned and 
further analysed. Nevertheless, as these three items originally met the criteria 
and were not included in the round two Delphi survey for re-ranking, they were 
still classified as meeting the consensus criteria for important. The outstanding 
54 items that did not achieve consensus were revised and included into round 
two (Appendix 31). 
A descriptive thematic analysis of round one participant comments 
highlighted a number of issues with trying to rank individual items for 
‘importance’. It was felt that it was “difficult to quantify” the importance of some 
individual items in isolation. It was perceived more important to regard 
combinations of symptoms and how they interact, for example, the effect of 
feeding on the effort of breathing. Subsequently for the round two Delphi the 
question was changed from assessing items for ‘importance’ or ‘unimportance’ 
to ‘agreement’ or ‘disagreement’ for inclusion into a bronchiolitis severity score. 
It was noted that context, history, duration, stage and direction of illness, HCP 
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experience, HCP type, and clinical setting were additional factors that should 
be taken into consideration when assessing severity of bronchiolitis. A number 
of items were challenged as to whether they actually assessed bronchiolitis 
severity. Some items were thought to contribute more to diagnosis, such as, 
secretion colour, cough or chest radiograph findings, whilst other items were 
perceived as being more of a “complication” of bronchiolitis, for instance, signs 
of dehydration. It was suggested that if one item ‘stridor’ was present then the 
diagnosis of bronchiolitis “must be questioned”. A number of HCPs recounted 
poor comprehension of particular terminology, for example, “air hunger” and 
“rhonchi”. These items were consequently left unanswered by some HCPs.  
Participants were asked to identify additional items not listed in the Delphi 
survey. Suggestions included PEW scores, trends, type of oxygen support 
required (for example, HFNC, nCPAP), age, pain score, response to treatment 
and previous admission to PICU/PHDU. After some consideration by CvM, 
none of these identified items were included in the round two Delphi survey. 
This was because: 
 Items ‘pain’ and ‘increasing oxygen requirements’ had been included 
in the round one Delphi survey.  
 Only a very small proportion of infants will have had a previous 
bronchiolitis episode with a critical care admission and the item 
‘previous admission/ episode of bronchiolitis’ had been included in 
round one  
 ‘Age’ and ‘response to treatment’ were both included as criteria 
statements in round three.  
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 For PEW score and trends, it was deemed unnecessary to include 
these as items for consideration in the round two Delphi because the 
premise of a PEW score is to identify a deteriorating child with any 
medical or surgical condition. The LIBSS-PRO has a similar premise 
to the PEW score in identifying deterioration but is bespoke to infants 
with a clinical diagnosis of bronchiolitis. Including a PEW score within 
a bronchiolitis score would create some degree of overlap and 
repetition. Regular use and documentation of the bronchiolitis score 
would provide information on ‘trends’.  
The results for the 54 items included into the round two Delphi found the 
lowest mean score was for wheezy/noisy breathing (mean 2.11 [SD 0.96]) and 
the highest mean score was for cervical adenopathy (mean 3.86 [SD 1.08]). 
Following re-ranking, none of the 54 items achieved the consensus criteria for 
agreement (categories 1&2) or disagreement (categories 4&5). Therefore none 
of these items were subsequently considered for inclusion into the LIBSS-
PRO. In general the descriptive analysis of the round two comments was 
similar to and confirmatory of the comments in round one. For example, a lot of 
the items again were considered as “diagnostic criteria not indicators of 
severity”, and highlighted issues of comprehension with certain terms. The 
AVPU score was generally perceived to be “the appropriate tool” for assessing 
“level of consciousness” by HCPs for use in this patient group as opposed to 
the Glasgow Coma Scale. In addition there were a number of other 
suggestions such as, changing “pitch of cry” to “strength of cry”, and 
separating “risk factors” from “clinical features” within the score. It was thought 
that “risk factors” could be “legitimately used to identify which infants to monitor 
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more closely […] but they do not measure disease severity”. Finally, it was 
noted that the item “born second half of the year” would “depend upon which 
hemisphere you were born in”. 
 Delphi rounds three and four 6.10
The results of rounds three and four will be presented together under the 
following headings: Criteria for Referral and/or Admission to Hospital; Criteria 
for ‘mild’ bronchiolitis; Criteria for ‘moderate’ bronchiolitis, Criteria for ‘severe’ 
bronchiolitis and Criteria for hospital discharge. The criteria included under 
these headings were identified from bronchiolitis publications including 
guidelines and from the criteria developed within the HCP stakeholder 
workshop.  
  Criteria for referral and/ or admission to hospital 6.10.1
The following question was posed:  
‘Which of the following criteria should be used when considering referral 
or admission to hospital for an otherwise healthy infant, up to 12 months of 
age, with bronchiolitis...?’  
Eighteen different criteria statements were presented under this section. 
These statements covered thresholds for oxygen saturations in air, respiratory 
rate and heart rate, presence of specific signs which indicate respiratory 
distress, fluid intake and output, consideration of risk factors/social issues, 
duration of symptoms and age at presentation of the infant. The statement with 
the lowest mean score was ‘frequent apnoea’ (mean 1.03 [SD 0.23]) whereas 
the statement with the highest mean score was ‘oxygen saturations less than 
97% in air’ (mean 3.98 [SD 0.83]). Six statements achieved consensus for 
132 
 
agreement (categories 1&2) in round three. These included: ‘oxygen 
saturations less than either 92% (93.2%) or 90% (95.0%) in air’; ‘respiratory 
rate greater than 70 bpm’ (96.1%); ‘presence of nasal flare or grunting’ (98%); 
‘frequent apnoea’ (99%) and ‘less than 50% feeds in preceding 24 hours’ 
(91.2%) (Appendix 32). A further statement ‘moderate to severe intercostal or 
sub-sternal recession’ initially achieved consensus following the preliminary 
analysis but fell short of the consensus criteria following data cleaning. As this 
statement was not included into the round four Delphi survey for re-ranking it 
has been classified as meeting the consensus criteria for agreement. This left 
11 statements that did not achieve the consensus criteria for either agreement 
(categories 1&2) or disagreement (categories 4&5).  
Comments from round three proposed the consideration of “the whole 
clinical picture” when contemplating referral or admission to hospital. It was 
noted that the respiratory rate threshold (greater than 70 bpm) would set “the 
bar too high” for older infants and that respiratory rate “varied with age”. 
“Duration of illness” was considered to provide important context when 
assessing the infant. One participant suggested that they would be less 
worried if oxygen saturations were “89% on day 10 of illness” than if they were 
“89% on day 1”.  
In round three, consensus for agreement (categories 1&2) was obtained for 
oxygen saturation thresholds (90% and 92%) and respiratory rate (>70 bpm) to 
be considered for inclusion into the bronchiolitis score. It was therefore judged 
unnecessary to re-rank oxygen saturation and respiratory rate threshold 
statements, which did not achieve the consensus criteria for agreement 
(categories 1&2) or disagreement (categories 4&5) in round four. Based on the 
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round three comments all the other remaining statements that did not achieve 
consensus were either changed or merged together. Four criteria statements 
were included in round four:  
‘Raised heart rate at rest greater than 150bpm’; ‘parents report a 
noticeable reduction in number of wet nappies and/or urine output in preceding 
12 hours’; ‘consideration of other risk factors, such as, young age, chronic lung 
disease and congenital heart disease’; ‘duration of symptoms less than three 
days in combination with other symptoms’.  
After re-ranking in round four a further two statements achieved 
consensus for agreement (Appendix 33):  
‘Parents report a noticeable reduction in number of wet nappies and/or 
urine output in preceding 12 hours’ (80%; mean 2.06 [0.64]); ‘consideration of 
other risk factors, such as, young age, CLD and CHD’ (96.8%; mean 1.52 [SD 
0.59]).  
  Criteria for ‘mild’ bronchiolitis  6.10.2
The following question was posed to the Delphi panel members:  
‘Do you agree or disagree with the following statements that describe an 
otherwise healthy infant, up to 12 months of age, with 'mild' bronchiolitis...?’  
Twenty different ‘mild’ criteria statements were developed. These 
statements covered a range of symptoms related to oxygen requirements, 
work of breathing, cardiovascular function, hydration and perfusion and 
neurology. The statement with the lowest mean score was ‘will not have 
cyanosis’ (mean 1.43 [SD 0.74]) and whilst the statement with the highest 
mean score was ‘duration of illness’ (mean 2.70 [SD 1.07]). Of these 
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statements, 17/20 met the consensus criteria for agreement (categories 1&2) 
following the round three rankings (Appendix 32). One statement initially 
achieved consensus in the preliminary analysis but fell short of the criteria 
following data cleaning: ‘may show some signs of improvement following 
administration of paracetamol or nasal pharyngeal suctioning’. As this 
statement was not included into the round four Delphi survey for re-ranking, it 
has been classified as meeting the consensus criteria for agreement 
(categories 1&2). This leaves two statements which did not achieve the 
consensus criteria and were included into round four (Appendix 33). The 
comments were mostly similar to what had been voiced previously in terms of 
assessing symptoms in combination. However it, was suggested the infant 
maybe “alert but not necessarily active” and for those infant’s being looked 
after at home, parents would need to be “alerted to deteriorating symptoms”. 
After consideration, one statement, ‘will have near normal wet nappies/urine 
output over preceding 12 hours’, was included into the round four Delphi 
survey but failed to meet the consensus criteria for either agreement 
(categories 1&2) or disagreement (categories 4&5).  
  Criteria for ‘moderate’ bronchiolitis 6.10.3
The following question was posed to the Delphi panel members:  
‘Do you agree or disagree with the following statements that describe an 
otherwise healthy infant, up to 12 months of age, with 'moderate' 
bronchiolitis...?’  
Fourteen ‘moderate’ criteria statements were developed and included into 
the round three Delphi survey (Appendix 32). As with ‘mild’ bronchiolitis, these 
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statements covered a range of signs and symptoms related to oxygen 
requirements, work of breathing, cardiovascular functions, hydration and 
perfusion and neurology. The statement with the lowest mean score was ‘may 
have moderate subcostal and or/intercostal recession’ (mean 1.77 [SD 0.57]) 
and the statement with the highest mean score was ‘may have increasing 
oxygen requirements (oxygen up to 50-60%) to maintain oxygen saturations 
>92%’ (mean 2.72 [SD1.22]). One statement initially achieved consensus in 
the preliminary analysis but fell short of the criteria following data cleaning: 
‘may have < four wet nappies in preceding 24 hours or urine output 
<2mLs/kg/hr’. As this statement was not included into the round four Delphi 
survey for re-ranking it has been classified as meeting the consensus criteria 
for agreement (categories 1&2). Eight out of the 14 ‘moderate’ statements 
achieved the consensus criteria. Within the comments it was felt that an 
oxygen requirement greater than 50% would constitute “severe” bronchiolitis. 
Whilst ‘grunting’ and ‘tracheal tug’ was perceived to be either absent or 
present rather than being on a continuum between ‘mild’ and ‘severe’. 
Measuring urine output was thought to be more accurate than counting 
number of wet nappies. ‘Unwell appearance’ was considered “too subjective”. 
As with previous Delphi rounds, context and constellation of symptoms were 
emphasized as important when assessing for ‘moderate’ bronchiolitis.  
Eight criteria statements for ‘moderate’ bronchiolitis were developed for the 
round four Delphi survey (Appendix 33). These statements were based on the 
statements which did not achieve the consensus criteria for agree or 
disagreement (categories 1&2; 4&5) and the participant comments from round 
three. The statement with the lowest mean score was ‘may be irritable/restless’ 
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(mean 2.05 [SD 0.73]) and the highest mean score ‘may have self-correcting 
apnoea’ (mean 2.78 [SD 1.18]). Four of these eight statements achieved the 
consensus criteria for agreement (categories 1&2) in round four, whilst the 
remaining four statements did not achieve the consensus criteria for either 
agreement or disagreement (categories 1&2; 4&5).  
  Criteria for ‘severe’ bronchiolitis 6.10.4
The following question was posed to the Delphi panel members:  
‘Do you agree or disagree with the following statements that describe an 
otherwise healthy infant, up to 12 months of age, with 'severe' bronchiolitis...?’  
Twenty-seven ‘severe’ criteria statements were developed for round three 
(Appendix 32). As with previous rounds, they were broadly related to: oxygen 
requirements, work of breathing, cardiovascular functions, hydration and 
perfusion and neurology. The statement with the lowest mean score was 
‘apnoea (+/- bradycardia) increasing in frequency & duration, requiring bag and 
mask intervention’ (mean 1.20 [SD 0.40]), whilst the statement with the highest 
mean score was ‘alert but inactive and or/ passive’ (mean 1.97 [SD 1.01]). All 
the statements with one exception (‘alert but inactive and or/ passive’) met the 
consensus criteria for agreement (categories 1&2). There were a minimal 
number of comments for the ‘severe’ criteria in comparison to the other criteria. 
It was felt that “signs of exhaustion need to be objective”, the term ‘toxic’ 
brought to mind the “toxic shock look” and finally there was poor 
comprehension of the following statement: ‘alert but inactive and or/ passive’. 
In round four, the Delphi participants were asked to vote on which adjective 
they preferred to describe the appearance of an infant with ‘severe’ 
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bronchiolitis (Appendix 33). The adjectives provided were either ‘toxic’, 
extracted from the literature, or ‘lifeless’ which was a term used by parents 
participating with the family workshop. A total of 79.7% of respondents 
preferred the adjective ‘lifeless’ (mean 1.79 [SD 0.40]) to describe the 
appearance of ‘severe’ bronchiolitis. 
  Criteria for hospital discharge 6.10.5
The following question was posed:  
‘Which of the following hospital discharge criteria, should be used for an 
otherwise healthy infant, up to 12 months of age, with bronchiolitis...?’  
Twelve ‘hospital discharge’ criteria statements were developed for the round 
three Delphi survey (Appendix 32). The hospital discharge criteria covered 
monitoring frequency, last documented apnoea, oxygen saturation thresholds 
in air, work of breathing, hydration and neurology. The lowest mean score was 
for the statement ‘infant is alert and active’ (mean 1.53 [SD 0.53]) and the 
highest mean score was for the statement ‘greater than 12 hours since last 
documented apnoea’ (mean 3.48 [SD 1.14]). Three of the 12 statements 
achieved the consensus criteria for agreement (categories 1&2): ‘mild 
respiratory recession may be observed but acceptable’ (90.3%; mean 1.84 [SD 
0.76]); ‘tolerating 50-75% of oral feeds during preceding 24 hours’ (84.5%; 
1.94 [0.89]); ‘infant is alert and active’ (98.1%; mean 1.53 [SD 0.53]). Within 
the comments it was suggested that in an improving infant “one accepts 
different endpoints” in comparison to an infant in the early stages of the 
disease course. When deciding to discharge a clinically stable infant there was 
disagreement with regards to the minimum length of observation time with 
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suggestions ranging between 12 and 24 hours. A further consideration 
highlighted was the type or quality of care available following discharge. For 
example, would the infant be discharged home solely into the parents’ care or 
with support from an NHS community service?  
The statements from round three were revised and included in to the round 
four Delphi survey (Appendix 33). Statements for oxygen saturation 
thresholds were separated into whether the infant was asleep or awake and 
settled. The statement relating to the time period of observation for oxygen 
saturations in air before considering discharge was changed from a Likert 
scale to choosing one of five time periods. Similarly to oxygen saturation 
thresholds, the statements for last documented apnoea were separated into 
whether the apnoea was self-correcting or required intervention. The 
statement with the lowest mean score and the only one to achieve consensus 
for agreement (categories 1&2) was ‘saturations >94% in room air – asleep’ 
(81.2%; mean 1.81 [SD 1.04]). The statement with the highest mean score and 
the only one to achieve consensus for disagreement (categories 4&5) was 
‘>12 hours since last documented apnoea – requiring intervention’ (88.2%; 
mean 4.20 [SD 1.09]).  
 Conclusion 6.11
A total of 195 multi-disciplinary stakeholders participated with a four round 
Delphi questionnaire as ‘expert’ panel members. Following the first two Delphi 
rounds 47 out of 101 signs symptoms and risk factors achieved consensus for 
importance when assessing bronchiolitis severity. These 47 signs, symptoms 
and risk factors were incorporated into the LIBSS-PRO ready to be further 
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assessed in clinical field-testing. Criteria achieving consensus in rounds three 
and four for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis, were included into a 
proforma. This proforma will be used by the clinically agreed reference 
standard in the construct and criterion validity and paediatrician inter-rater 
reliability testing in Chapter 9.  
The strength of the Delphi questionnaire was the engagement of a 
comprehensive group of experts located across the UK and Ireland to ensure 
the applicability of the LIBSS-PRO for use in a variety of healthcare contexts. 
However, a limitation of the expert group was that a large proportion of the 
Delphi panel members were nursing staff (AfC pay bands 5 or 6). There was 
an under-representation of other HCP groups or pay grades. Furthermore, 
parents were not included in the Delphi questionnaire. This could have been a 
missed opportunity to further engage with this important stakeholder group. 
The reason for not including parents was to do with the timing of the study in 
respect to the bronchiolitis season. The study commenced towards the end of 
the bronchiolitis season. The Delphi questionnaire was conducted outside the 
bronchiolitis season, which made recruitment of parents or carers more difficult 
and also raised issues around recall bias.  
Another limitation was with the amount of attrition observed between Delphi 
rounds one and four especially amongst nursing staff. These attrition rates 
may have been due to the length of survey and the number of rounds resulting 
in survey fatigue. Some of the participants may not have appreciated fully the 
commitment involved in becoming a Delphi panel member and having to 
complete all the Delphi rounds. With hindsight it may have been beneficial to 
have undertaken a consensus meeting with stakeholders involved in the two 
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focus groups and the study steering group members prior to the Delphi survey. 
A consensus meeting could have been used to further reduce and achieve a 
level of agreement over which items and domains to include into the Delphi 
survey. This would have made the survey less burdensome for Delphi panel 
members and may have led to a reduction in attrition rates. Furthermore, 
having a degree of prior agreement over items and domains may make it more 
likely that that those included will achieve the Delphi consensus criteria for 
importance. Moreover, increased consensus could have also possibly 
improved the development of the reference standard used within the construct 








7  Content validity 
The 47 items that achieved consensus in the Delphi survey were included in 
the LIBSS-PRO instrument. Various iterations of the instrument were 
developed and shown to the study steering group and several HCP groups for 
comment to establish face validity. It was confirmed that the LIBSS-PRO 
appeared to measure bronchiolitis severity. The LIBSS-PRO instrument was 
revised further based on suggestions to improve clarity and the layout prior to 
content validity testing (Figure 8). Content validity is the extent to which the 
instrument measures the concept of interest (61). It had partly been 
established during phase one of this study through the identification of 
important items underlying the concept of bronchiolitis. This chapter describes 
the methods used to confirm content validity of the LIBSS-PRO (Version 7.0) 
(Appendix 34) in clinical practice. Through this, the relevance of the domains 
and items contained in the LIBSS-PRO will be determined in a clinical setting.  
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i) To evaluate whether the domains and items contained within the 
LIBSS-PRO (Version 7.0) were representative of the concept 
bronchiolitis severity. 
ii) To identify redundant domain and/or items for removal from the LIBSS-
PRO. 
 Methods 7.2
Eligible HCPs located within five study sites (one paediatric tertiary centre 
and four DGHs) were identified via the Cheshire and Merseyside CLRN to 
participate with the content validity testing. The HCPs were asked to 
administer the LIBSS-PRO (Version 7.0) instrument to eligible infants whose 
parents (including carers or legal guardians) had previously signed informed 
consent to participate with the clinical testing. The LIBSS-PRO (Version 7.0) 
had 12 domains: risk factors; professional concern/’gut’ feeling; apnoea; effort 
of breathing; respiratory rate; saturations and supplemental oxygen 
requirement; air entry on auscultation; blood gas analysis; heart rate; 
neurological assessment; appearance and behaviour; hydration and perfusion 
(feeds, urine output, perfusion, dehydration). Using a structured evaluation 
form (Appendix 35), HCPs were asked to rate each domain/item on a Likert 
scale from one to four for clinical relevance, with one being extremely relevant 
and four being completely irrelevant. HCPs were also asked to provide 
additional information on ease of administration, interpretation, layout and 
timeliness, and to identify redundant domains/items. The completed LIBSS-
PRO was assessed for completeness of data and score distributions. Criteria 
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for acceptability included missing data for summary scores of less than 5% and 
even distribution of endorsement frequencies across response categories. 
Items were considered for elimination if judged clinically impractical by five or 
more HCPs. HCPs were encouraged to make suggestions on how to improve 
the LIBSS-PRO (Version 7.0). The ‘rule of thumb’ used to determine sample 
size was between 10 and 15 participants for each included domain/item (52). 
The LIBSS-PRO contained 12 domains therefore a minimum sample size of 
n=120 infants was required for the content validity testing.  
 Results 7.3
Content validity testing was undertaken during the 2011/12 bronchiolitis 
season. 114 content validity tests were undertaken. The characteristics of 
participating HCPs and infants can be found in Table 20. 62.8% of 
participating HCPs were nurses, whilst 37.2% were doctors. Nearly half of the 
nurses were AfC band 5 staff nurses. There were slightly more males (54.0%) 
compared to female infants (46.0%). There were more infants aged under 
three months of age (53.1%). The mean time for HCPs to complete the LIBSS-
PRO (version 7.0) was 9.47 (SD 4.79) minutes. The mean LIBSS-PRO 




Table 20: Content validity – participant characteristics (HCPs and infants) 








2 (1.8)  
1 (0.9) 
1  
Clinical grade n (%) 
Consultant  7 (6.3) 
Associate specialist  3 (2.7) 
SpT 4/5/6/7 5 (4.5) 
SpT 1/2/3 15 (13.4) 
F1/2 11 (9.8) 
AfC 8a/b 3 (2.7) 
AfC 7 4 (4.5) 
AfC 6 8 (7.1) 
AfC 5 52 (46.4) 
AfC 4 2 (1.8) 
AfC 3 1 (0.9) 
Infant age  mean (SD) 
Under three months 
age 
60 (53.1) 
Three months and 
over 
53 (46.5) 
Infant gender n (%) 
Male  61 (54.0) 
Female 52 (46.0) 
 
Of the 114 completed tests, two evaluation forms were not completed due 
the staff being busy. A further six evaluation forms were excluded from the 
analysis because six HCPs completed an evaluation form on two separate 
occasions thus providing duplicate data. This left 106 evaluation forms 
included in the analysis. All domain and items, with the exception of one 
(reduced air entry (79.7%)), achieved consensus of 80% or greater for clinical 
relevance for assessment of bronchiolitis severity (Appendix 36). In spite of 
this, a significant amount of missing data was noted for two domains on the 
completed LIBSS-PRO scores: air entry on auscultation and blood gas 
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analysis. The collated free text comments for each of these domains are 
summarised below.  
  Professional concerns / ‘gut’ feeling  7.3.1
‘Free text’ opinion was divided on the professional concerns/ ‘gut’ feeling 
domain. Some HCPs thought professional concerns/ ‘gut’ feeling to be 
“subjective” and dependent on “experience”, and that “concern” could be 
determined by “clinical signs”. Others thought the usefulness of this domain 
would be limited. Conversely, other HCPs reported how they “trust their gut” 
even if there were no obvious concerning clinical signs as they believed it to be 
more “reliable”.  
  Apnoea 7.3.2
One HCP queried whether this domain was referring to apnoea “observed” 
at the time of the score or a “history” or apnoea. Another HCP recommended 
apnoea being a “red flag” with apnoea of any description requiring a “senior 
review”. Two HCPs felt that infants who have apnoea requiring bag and mask 
ventilation should not be nursed on a ward but looked after in a critical care 
area. 
  Effort of breathing 7.3.3
Four HCPs suggested there should be an option to score zero for ‘effort of 
breathing’. One HCP recommended the domain of ‘apnoea’ should have a 
higher weighting than the items contained under the domain of ‘effort of 
breathing’. Three HCPs were unsure as to how ‘dyspnoea’ differed from “work 
of breathing” and reported that this was a “subjective symptom”. One HCP 
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believed that ‘see saw chest movement’ should have a higher weighting whilst 
another HCP felt it was “subjective” and “non-specific”. One HCP advised 
including an instruction to indicate more than one item can be circled. One 
HCP thought the domain of ‘effort of breathing’ was “useful to think through all 
aspects of increased WOB [work of breathing]”.  
  Respiratory rate 7.3.4
Three HCPs commented on how ‘respiratory rate’ being divided into two 
age categories was “confusing”. Furthermore, the age category labels being 
written vertically were “unclear” and caused HCPs to circle the incorrect age 
group for ‘respiratory rate’. It was also noted by five HCPs that ‘respiratory rate’ 
could be affected by “crying”, “activity” or “fever”. One HCP thought that the 
range 20-55 for the three months and older age group was “slightly inaccurate” 
and believed “30-56 would provide a far more accurate picture”.  
  Oxygen and saturations  7.3.5
Five HCPs reported this domain to be “confusing”. One HCP thought they 
could only score the infant if the infant was receiving 50% oxygen or greater. 
Other HCPs reported only being familiar with recording oxygen in litres as 
opposed to percentage. Two HCPs recommended including oxygen ranges to 
improve clarity and one HCP suggested further training may be required. 
  Air entry on auscultation 7.3.6
Within the free text comments a large proportion of nurses (n=37) reported 
they were not trained in undertaking auscultation. This domain within the 
LIBSS-PRO was either left blank or the nurses reported obtaining the 
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information from either consulting the medical notes or a HCP trained in 
auscultation. One HCP felt that it was unlikely that air entry assessment would 
change the “management [of the infant] in isolation unless there was 
significant poor air entry”. However, other HCPs (n=7) reported that changes to 
‘air entry’ may indicate “infection”, “worse disease” or the need to “escalate 
care”. Finally, one HCP suggested that “prolonged expiration” may be a finding 
that was not currently covered by the score. 
  Blood gas analysis 7.3.7
There was missing data from 31 LIBSS-PRO scores for this domain. Twelve 
nurse HCPs reported either not being trained in blood gas analysis or it was 
not considered part of their role. There were missing data from a further seven 
HCPs who did not comment as to why they did not complete this domain. 
Three HCPs stated that they did not understand the question. The remaining 
nine HCPs felt this domain was not “relevant” to the particular infant under 
assessment. Sixteen HCPs remarked on how blood gas analysis was only 
“relevant” and clinically indicated in “severe” bronchiolitis. To improve the 
clarity of this domain it was suggested by eight HCPs to provide a range of 
“values” to make blood gas results “easier to interpret”.  
  Heart rate 7.3.8
The majority of comments were related to either how heart rate is a good 
indicator of the “patients’ condition” or how the heart rate was obtained 
(palpation or monitor) and the result. Seven HCPs highlighted that an elevated 
heart rate may be linked to activities such as feeding and/or crying or when an 
infant has a “fever”.  
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  Neurological assessment 7.3.9
In most cases the comments described observations of what the infant was 
doing at the time of the score, for example, “they were alert and playful”. It was 
thought by some HCPs (n=5) that neurology was difficult to assess due to their 
young age or when the infant was asleep. Three HCPs reported obtaining 
information on neurology from parents or family members when the infant was 
asleep. One HCP was unsure how “lethargic differed from quiet”. One HCP 
proposed merging neurological assessment with appearance. Whereas 
another HCP thought there was an “overlap with ‘gut’ feeling”. One HCP noted 
that “irritability” was missing from the score and that “bronchs” were are “often 
irritable”.  
  Appearance and behaviour 7.3.10
The majority of the comments described the appearance and behaviour of 
the infant. Four HCPs suggested merging appearance and behaviour with 
neurology as it was felt to be “repetitious”. One HCP believed “paleness 
doesn’t tell you a baby is sick”. Two HCPs felt that this domain included 
“subjective assessments” which could change “quickly” and would only be 
helpful when the infant was “severe”. Finally, one HCP reported that it 
“provides a quick assessment which can be done at the end of the bed”.  
  Hydration and perfusion 7.3.11
This was split into four sub-domains: feeds; urine output; perfusion; 
dehydration. A large proportion of comments were associated with the mode of 
feeding and urine volumes of individual infants. ‘Hydration and perfusion’ was 
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regarded as an important domain by six HCPs to assess the need for 
admission to and discharge from hospital or clinical improvement or 
deterioration. Eight HCPs reported involving parents with the assessment of 
this domain, although one HCP acknowledged “there may be a discrepancy 
between what mum is actually telling you and the clinical picture”. Urine output 
was considered “subjective” (n=1); “difficult to assess” (n=1); and the score of 
two was “too high” (n=1). Two HCPs queried the value of including 
“2mLs/kg/hr” in the score as it is not always calculated. One HCP 
recommended by removing “2mL/kg/hr” would “simplify” the score. Three 
HCPs noted there was no zero score option for perfusion and dehydration. 
Furthermore, two HCPs suggested removing the wording “greater than” from 
the perfusion sub-domain and substituting it with the following “<2 or >2”. One 
HCP advised including an instruction as to where capillary refill time (CRT) 
should be taken, whilst another HCP suggested the CRT score should have a 
greater weight than a score of two. The sub-domain dehydration was 
considered irrelevant by one HCP due to the “age of the child”. Furthermore 
another HCP proposed that “skin turgor” should be included in the assessment 
as “research indicates poor inter-rater reliability between sunken eyes 
/fontanelle – whereas skin turgor was good”.  
When asked if the LIBSS-PRO was easy or hard to complete only five 
HCPs reported difficulties. One HCP thought it was hard because “subjective 
symptoms are difficult while ticking boxes”. Another HCP found it difficult due 
to the fact that the infant did “not just have bronchiolitis”. The scoring for the 
‘effort of breathing domain’ was found “confusing” by one HCP. It was judged 
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that “repeated assessments” of the LIBSS-PRO may be “time consuming”. The 
LIBSS-PRO was felt to be “too wordy”.  
When asked if the LIBSS-PRO was clear or confusing 24 HCPs reported 
some domains that were confusing. Five HCPs were confused by the 
respiratory and heart rate domains being divided by age. Other domains 
identified as being confusing included: ‘oxygen and saturations’ (n=1); ‘blood 
gas analysis’ (n=1); ‘effort of breathing’ (n=1); ‘appearance and behaviour’ 
(n=1). In addition, it was felt that ‘young age’ and ‘gestational age less than 37 
weeks’ in the ‘risk factor’ box were unclear. The shading of the font to indicate 
severity and the “time period” over which to undertake the score were also 
found confusing.  
When asked which domains and/or items should be removed from the 
LIBSS-PRO the following eight domains/items were recommend: ‘professional 
concerns/’gut’ feeling’ (n=1); ‘air entry on auscultation’ (n=10); ‘blood gas 
analysis’ (n=5); ‘neurology’ (n=1); ‘appearance and behaviour’ (n=2); 
‘dehydration’ (n=2); ‘dyspnoea’ (n=1); ‘see saw chest movement’ (n=1). It was 
suggested that ‘neurological assessment’ and ‘appearance and behaviour’ 
were merged together by five HCPs. When asked about the layout of the 
LIBSS-PRO most of the HCPs reported to like it. Five HCPs did not like the 
font size or how the font was shaded to indicate increasing severity of 
bronchiolitis. This caused reading difficulties. Furthermore, it was postulated 
that the font may be more “difficult to see at night” during night shifts. Other 
suggestions to improve the layout included: a legend for symbols; more colour; 
fitting the LIBSS-PRO onto one page; using both percentage and litres for 
oxygen and linking to a treatment pathway. The following four items were 
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suggested for consideration for inclusion into the LIBSS-PRO: subcostal 
recession, skin turgor, social and family history. 
 Conclusion 7.4
Most of the domains and items were considered clinically relevant for the 
concept of bronchiolitis severity. Furthermore, most HCPs were able to 
complete the LIBSS-PRO but a number of issues with the content were 
identified. Following clinical testing two domains (air entry on auscultation and 
blood gas analysis) were deemed impractical by more than five HCPs and 
were removed from the LIBSS-PRO. Based on HCP comments ‘dyspnoea’ and 
‘see saw chest movement’ were also removed. Two domains (‘neurological 
assessment’ and ‘appearance and behaviour’) were merged together to 
become a new domain i.e. ‘appearance’ and ‘level of consciousness’. Two 
sub-domains within the domain of ‘hydration and perfusion’ were merged 
together i.e. ‘perfusion’ and ‘dehydration’. Of the four items suggested for 
inclusion, one further item was included into the LIBSS-PRO: ‘subcostal 
recession’.  
There were limitations with regards to the sampling strategy. Firstly, the 
sample size of 120 infants was not achieved. The majority of HCPs who were 
involved with the content validity testing were nursing staff. Therefore, 
including other HCP groups may have discerned different insights. It became 
apparent that some nursing staff when approached was reluctant to participate 
with the content validity testing. Further inquiry found they perceived their 
knowledge and skills of bronchiolitis and clinical assessment were under 
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scrutiny as opposed to the LIBSS-PRO being evaluated. Reassurance was 





8 Cognitive interviews 
Cognitive psychology challenges the assumption that respondents 
understand the questions being asked of them and can provide accurate 
responses when completing health measurement instruments (128-130). 
(130). The social knowledge and cultural models to which an individual is 
exposed determines cognitive processes and these directly influence 
interpretation of the questions posed (131). Cognitive interviewing reveals that 
participants may not understand questions or may interpret them differently 
from how they were intended. Respondents may also interpret questions 
differently to other respondents or be unable or unwilling to complete questions 
(129, 132). For example, one study reported that respondents, when asked 
about the type of “work” engaged with during the previous week, failed to 
report activities such as voluntary work and/or casual work such as babysitting 
(133). Cognitive interviews were used to pre-test the LIBSS-PRO to expose 
issues which could lead to measurement error if not identified and adequately 
addressed (130). This chapter describes the cognitive interview methods used 
to identify potential problems with the LIBSS-PRO prior to clinical field-testing.  
 Aims 8.1
The overall aim of cognitive interview testing was to investigate the 
likelihood of response error with the bronchiolitis scoring instrument and 
specifically to:  
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i) To evaluate how HCPs comprehend, interpret and respond to each 
section of the scoring instrument. 
ii) To check understanding of medical terminology used within the scoring 
instrument. 
 Sample and setting 8.2
Recruitment of HCPs was undertaken between May and September 2012. 
All participants were identified through the Cheshire and Merseyside CLRN. 
Interview participants were doctors, nurses or health care assistants (HCAs) 
who had recent experience in caring for infants with bronchiolitis. HCPs were 
identified from five hospitals (one paediatric tertiary and four DGHs). These 
hospitals represent a range of specialities including; accident and emergency, 
critical care, and general medical wards. A purposive sample frame was 
devised (Appendix 37) to ensure adequate representation of a wide range of 
professional clinical experience. Eligible HCPs were stratified by profession 
type, employment grade and hospital. CLRN research nurses approached 
eligible HCPs with information about their potential involvement in a cognitive 
interview.   
 Informed consent  8.3
Written information about the study was provided to participants prior to the 
interviews and either CvM or a CLRN research nurse obtained informed written 
consent. At the beginning of each interview CvM went through the consent 




The method chosen was audio-recorded, semi-structured cognitive 
interviews using a ‘think aloud’ technique (128, 132). These interviews focused 
on the recent version of the scoring instrument (LIBSS-PRO 7.7) (Appendix 
38).  
 Development of the vignettes 8.5
Four hypothetical vignettes were developed and used as part of the 
cognitive interview process (128, 133). The purpose of the vignettes was 
twofold. Firstly, the vignettes provided contextual information on infant 
behaviour with bronchiolitis as an aide memoir. This was particularly important 
as the interviews were conducted outside the bronchiolitis seasonal epidemic. 
Secondly, the vignettes were used to prompt discussion in order to explore 
cognitive processes when participants considered how they would arrive at 
their response for each domain and item. The vignettes were developed 
through examining the patient data collected during content validity testing. 
Each vignette contained a scenario that described varying severities, signs 
and symptoms of disease, risk factors, interventions and clinical settings 
(Table 22). The table with all four vignettes were given to the participants at 
the beginning of the interview.  
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Table 21: Bronchiolitis vignettes 
Vignette one 
Four week old male infant with a two day history of cough and runny nose was 
diagnosed in A&E with bronchiolitis.  
Past Medical History (PMH): previously fit and well; normal vaginal delivery at term.  
On examination: 
Respiratory: saturations high 90’s in air, respiratory rate 55 BPM, wheeze on 
auscultation 
Cardiovascular System (CVS): heart rate 150 BPM, capillary refill less than 2 
seconds, apyrexial. 
Neurology: alert but irritable 
Fluids: noticeably reduced amount of oral intake and has vomited feeds. Passing 
urine. 
Senior House Officer decides to admit for observation 
Vignette two 
Two week old female infant on medical ward who is RSV positive. Parents report 
infant has been unwell for approximately three days. 
PMH: previously fit and well, normal vaginal delivery at term 
On examination: 
Respiratory: Requires oxygen to maintain saturations above 92%. Oxygen has 
recently increased to one litre via nasal cannula. Increased work of breathing, 
respirations around 60 BPM, mild intercostal recession. Nasal suction has helped. 
CVS: tachycardic after feeds. Capillary refill less than two seconds. Temperature 
37.9C 
Neurology: alert but irritable at times especially after feeds.  
Fluids: 3 hourly tube feeds, wet nappies  
Vignette three 
Six month old male infant in HDU who is RSV positive with a two day history of 
decreased feeds and snuffles.  
PMH: atrial septal defect.  
On examination: 
Respiratory: requiring CPAP for apnoea. Positive End Expiratory Pressure (PEEP) 4-6 
cms H2O, 50% oxygen to maintain saturations above 92%. Continues to have self-
correcting apnoea that does not require stimulation. Increased respiratory rate at 
times. Blood gases satisfactory. Tolerating 5 minute pressure relief off NCPAP.  
CVS: tachycardic at times, apyrexial,  
Fluids: on intravenous fluids, nil by mouth, passing good amounts of urine   
Vignette four 
Six week old female infant, born via caesarean section, at 32 weeks gestation. 
Diagnosed with RSV positive bronchiolitis. Weight 2.4kg. History of apnoea requiring 
24 hours of CPAP on HDU. Currently in the process of being discharged from HDU to 
the medical ward 
Respiratory: 31% humidified oxygen via incubator to maintain saturations high 90’s. 
No increased work of breathing, respiratory distress or apnoea. Respiratory rate 22-52 
BPM 
CVS: Heart rate 140-165 BPM, apyrexial, capillary refill time less than 2 seconds 
Neurology: behaving appropriately for age 
Fluids: tolerating NG feeds, passing normal amount of urine 
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 Undertaking the Interviews 8.6
A “think aloud” technique was employed during the interview to further 
explore cognitive thought processes (128, 132). As the name suggests 
participants were asked to “think aloud” when they reflected on each section 
and when considering their answers/responses. This technique enabled 
participants to verbalise their thoughts whilst they were problem solving or 
responding to questions. A standard set of probe questions (Table 23) were 




Table 22: Cognitive interview probe questions 
 Probe questions Exemplars 
Comprehension/Interpretation 
probe 
What do you believe 
this section to be 
asking of you? 
“Basically it is asking 
you whether this is a 






What do you think is 
meant by the 
following term(s)...? 
“tracheal tug is erm 
the collapsing of the 
trachea as the baby’s 
breathing hard” (HCP-
N07) 
General probe How do you think you 
would assess for this 
and arrive at your 
response? 
“You would look at the 
chest movement and 
feel for the chest 
movement […] you 
can do it […] with a 
stethoscope erm so 
you can hear the 
breaths going in and 
out or just do it with 
your eyes…” HCP-
N14 
General probe How sure are you of 
your answer? 
“I think I am pretty 
sure…all four of them 
are in different stages 
of their illness and 
that’s pretty obvious” 
(HCP-D02) 
General probe Based on your 
experience what 
would make this 
section easy or 
difficult to complete? 
“I think it’s subjective 




Specific probe Does the question 
have any particular 
features that would 
make it likely not to 
be understood? 
“that is quite a tricky 
one especially with 
the differential 
between the short 






All interviews were arranged at the convenience for the participant. At the 
beginning of each interview CvM provided information on the overall research 
aims and the purpose of the interview. Participants were supplied with the four 
vignettes and the most recent version of the LIBSS-PRO (Version 7.7 
(Appendix 38)). This version contained nine domains: ‘risk factors’, 
‘professional concerns/ ‘gut’ feelings’, ‘apnoea’, ‘effort of breathing’, 
‘respiratory rate’, ‘oxygen requirements’, ‘heart rate’, ‘appearance and level of 
consciousness’ and ‘hydration and perfusion’. One domain ‘professional 
concerns/ ‘gut’ feelings’ covered a subjective concept only relevant to the 
individual respondent completing the LIBSS-PRO (Version 7.7). The remaining 
eight domains were related to a physical reality observed in an infant with 
bronchiolitis. There were two response formats. The first section, ‘risk factors’ 
provided an option for the respondent to tick all applicable ‘risk factors’ the 
infant may have. The remaining eight sections provided a numerical response 
option. The scores for these eight sections were then summed together to 
obtain a score total. Following the first six interviews, Version 7.7 was revised 
in light of participant comments. LIBSS-PRO (Version 8.0 (Appendix 39)) was 
used with the remaining ten cognitive interviews. CvM conducted all of the 
interviews (either telephone or face-to-face) in a standardised manner. All 
interviews were digitally audio recorded (Tascam DR-100). The recordings 
were transcribed verbatim and anonymised for analysis (CvM). 
 Analysis 8.7
Cognitive interviewing falls within the paradigm of qualitative research and a 
qualitative analysis approach was used (124). As with the workshops and 
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parent interviews, the process of analysis was iterative and the interview 
transcripts were examined and re-examined several times during the course of 
the analysis. Initial examination of the transcripts was used to obtain an 
overview – at the content level – of what the HCPs talked about and to record 
any general impressions, key ideas, themes and concepts arising from the 
content. A modified data coding scheme was developed a priori and manually 
applied to the raw data (Table 24) (128). Categories 1-3 were concerned with 
comprehension, whilst category 4 was concerned with retrieval, decision 
making/judgement or response. A descriptive thematic analysis of the data 
was then undertaken. QRS NVIVO (Version10) software was used to support 
the coding and synthesis of the data. Field notes were used to support the 
analysis and enabled the researcher to reflect on the interviews and record 
any thoughts and insights. 
Table 23: Data coding scheme 
1. The participant has difficulty understanding the section 
2. The participant has difficulty understanding the meaning of particular 
words or concepts  
3. Different participants have different understandings of the section 




The interviews lasted 30-60 minutes. The target was to recruit 15 
participants to take part with the cognitive interviews; 16 HCPs consented to 
participate (see Table 25 for HCP characteristics). The sample comprised 
doctors (n=7), nurses (n=7) and HCAs (n=2). The majority of participating 
162 
 
doctors were speciality trainees in paediatrics. Of the two consultants, one was 
a general paediatrician and one a paediatric intensivist. Most nurses (n=4) 
worked on paediatric general medical wards, although there was one ED 
nurse, one ANP and one PHDU nurse. Twelve interviews were conducted 
face-to-face and three over the telephone. Technical problems with the audio 
recorder meant that one interview was only partially recorded (HCP-N14). 
Quotations are linked to generic labels to increase anonymity: HCP-H01, HCP-
D02, through to HCP-D16.  
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Table 24: Cognitive interviews – HCP characteristics 









HCP-H01 Male HCA* Band 3 Telephone DGH* 1 
HCP-D02 Male Doctor >ST4 Face DGH* 1 
HCP-D03 Male  Doctor Consultant Face DGH* 1 
HCP-D04 Female Doctor <ST4 Telephone DGH* 3 
HCP-N05 Female Nurse  Band 6 Face DGH* 3 
HCP-N06 Female Nurse Band 5 Telephone DGH* 3 
HCP-N07 Male Nurse Band 7 Face DGH* 2 
HCP-A08 Female ANP* Band 8 Face DGH* 2 
HCP-N09 Female Nurse  Band 6 Face PTC* 
HCP-D10 Male Doctor Consultant Face PTC* 
HCP-D11 Female Doctor <ST4 Face DGH* 2 
HCP-H12 Female HCA Band 3 Face DGH* 4 
HCP-N13 Female Nurse Band 5 Face DGH* 4 
HCP-N14 Female  Nurse  Band 5 Face DGH* 4 
HCP-D15 Female Doctor <ST4 Face PTC* 
HCP-D16 Male Doctor >ST4 Face PTC* 
*HCA: Health Care Assistant; *ANP: Advanced Nurse Practitioner; *DGH: 
District General Hospital; *PTC: Paediatric Tertiary Centre 
 
The results for the cognitive interviews were aggregated under the nine 
domain headings which reflect those found on the LIBSS-PRO (Versions 7.7 
and 8.0): ‘risk factors’, ‘professional concerns/ ‘gut’ feelings’, ‘apnoea’, ‘effort of 
breathing’, ‘respiratory rate’, ‘oxygen requirements’, ‘heart rate’, ‘appearance 
and level of consciousness’ and ‘hydration and perfusion’.  
  Risk factors 8.8.1
This domain asks the participant ‘Does the infant have any of the following 
‘risk factors’ for severe disease?’. The participant has to tick either the ‘yes’ or 
‘no’ box and is then asked to tick all applicable ‘risk factors’ from the following 
options: ‘CLD’; ‘CHD’; ‘neurological disorder’; ‘immunodeficiency’; ‘Down’s 
Syndrome’; ‘gestational age less than 37 weeks’; ‘low birth weight <2.5kg’ or 
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‘young age (corrected age less than six weeks)’. In general, HCPs considered 
the purpose of this domain was “to identify a group of children who […] are at 
high risk of having severe disease” which may lead to “poor outcomes” (HCP-
D10). HCPs reported ‘risk factors’ could be easily identified from past medical 
history, by asking the parents and/or carer or by reading the infant’s clinical 
documentation. For those HCPs working in either the medical profession or 
ANP roles, certain ‘risk factors’ may also be discerned following a clinical 
examination. Participants highlighted specific comprehension issues with a 
number of the ‘risk factors’ listed. Participants considered whether CLD was 
restricted to “chronic lung disease of prematurity” or whether this term 
encompassed other chronic respiratory diseases such as “cystic fibrosis” or 
“bronchiectasis”. ‘Gestational age less than 37 weeks’ was found to be “not 
specific enough” and should be accompanied with a “definition”. One HCP 
questioned whether this referred to the infants’ age at the time of the score 
only or whether this also applied to older infants whose gestational age was 
less than 37 weeks. If this applied only to infants who were less than 37 weeks 
gestation at the time of the score it was felt this would be covered by 
‘prematurity’. It was felt that an infant with a gestational age of 36 weeks may 
not have any more “increased risk” of severe bronchiolitis than an infant with a 
gestational age of 37 weeks. Lower thresholds for gestational age were 
suggested. Participants commented on there being an overlap between a 
number of ‘risk factors’ such as ‘CLD’, ‘gestational age less than 37 weeks’, 
‘low birth weight’ and ‘prematurity’. Despite this overlap, HCP (HCP-D03) felt 
by keeping these ‘risk factors’ separate it would make HCPs “assess the 
patient more closely”. It was felt that ‘neurological disorders’ covered a “broad 
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spectrum” including “developmental delay” or “epilepsy”. It was suggested it 
should be changed to “neuromuscular disorders” as one participant recalls: 
“…children with cerebral palsy or muscular skeletal problems […] are more 
prone to developing severe bronchiolitis…”  (HCP-H01) 
Other suggestions to improve the ‘risk factor’ domain included: list the ‘risk 
factors’ in order of importance; include a box under ‘CLD’ to document home 
oxygen requirements and include a box to indicate whether the infant met the 
criteria for and received Palivizumab. Overall, the participants found this 
section “easy to complete” although it was proposed that junior staff, HCAs 
and adult trained HCPs working in DGHs may find this section difficult to 
complete.  
  Professional concerns/ ‘gut’ feelings 8.8.2
For the ‘professional concerns/ ‘gut’ feelings’ domain, participants had to 
choose one of three categories: ‘no concerns: (0)’; ‘mild to moderate concerns: 
(2)’; ‘extremely concerned: (4)’. ‘Professional concerns/ ‘gut’ feelings’ were 
largely thought to be a culmination of HCP experience together with initial 
thoughts or impressions following a quick assessment of the infant. It was 
further suggested that the level of concern might prompt an urgent action or 
intervention. Overall, ‘professional concerns/ ‘gut’ feelings’ was considered to 
be a “subjective” assessment.  
The use of the four vignettes highlighted particular features of concern for 
the HCPs. The vignettes also emphasised difficulties with comprehension and 
response categories. For vignette one, increased concern was related to the 
young age of the infant, day of illness and reduced oral intake. Some of the 
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HCPs reported that the ‘SHOs’ decision to admit the infant’ increased concern. 
This might indicate that concern could also be influenced by the decision 
making of others, introducing a response bias. Overall, HCPs were not unduly 
concerned with this infant but acknowledged that they had the potential to 
deteriorate. This infant was scored as ‘mild to moderate concerns: (2)’ by all 
HCPs: with some HCPs stating their concerns to be more “mild”.  
HCPs identified the following features as being of concern for vignette two: 
RSV positive diagnosis, young age, increased oxygen requirements, increased 
effort of breathing, tachycardia and naso-gastric feeds. When looking at 
vignette two, the term ‘concern’ was questioned by two of the HCPs. One 
proposed the term ‘concern’ was not “the right word” and should be replaced 
with “level of severity”, whilst another HCP queried what was meant by the 
term ‘concern’:  
“…when we say concerned…is it concerned with my ability to care for 
the child or concerned about how unwell the child is…” (HCP-N07). 
This response uncertainty indicates that further clarification of the term 
‘concern’ may be required. HCPs perceived the infant in vignette two as having 
more severe bronchiolitis than the infant in vignette one. Despite this the HCPs 
generally scored this infant as ‘mild to moderate concerns: (2)’. Thirteen HCPs 
declared their level of ‘concern’ for this infant to be “moderate”, whilst one 
HCP, who worked within critical care, reported having “mild” concerns. 
However, two HCPs (HCP-N13; HCP-N14) were ‘extremely concerned: (4)’. 
One of these HCPs (HCP-N13) wanted to score the infant “severe” even 
though this category was not available, whilst the other HCP found it difficult to 
use the score with the vignettes provided, as she explained: 
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 “…it’s hard though isn’t it without the baby in front of you…” (HCP-
N14). 
When determining the level of ‘concern’ an important consideration discussed 
was with supportive therapies received and the perceived stability of the infant, 
as HCP-A08 described: 
“…I mean technically this child is sicker than child [in vignette] one but 
sort of has more things in place like a bit of oxygen so you’d be happy 
[…] so again I wouldn’t be desperately concerned…” (HCP-A08). 
Vignette three appeared to be more of a challenge for HCPs to come up 
with a definitive response. Three HCPs gauged their level of ‘concern’ for this 
infant to be ‘mild to moderate concerns: (2)’ whilst the remaining 13 HCPs 
opted for ‘extremely concerned: (4)’. Despite recognising the infant in vignette 
three was more severe than the previous two infants, the three HCPs who 
scored ‘mild to moderate concerns: (2)’ felt the infant was receiving appropriate 
supportive therapy, was clinically stable and was being cared for in a safe 
environment. Several HCPs who scored ‘extremely concerned: (4)’ stated they 
would have liked an additional response category between the second and 
third response categories, as HCP-D11 explained: 
“…I think that one’s difficult…they don’t sound mild or moderate but they 
don’t sound like… you know… really severe…life threatening kind of 
category…” (HCP-D11).  
One of the primary characteristics identified to cause ‘concern’ was with the 
infant still having a degree of self-correcting apnoea in spite of receiving 
CPAP. Other attributes deemed ‘concerning’ by the HCPs included: CHD, day 
of illness, being cared for in a critical care environment and high oxygen 
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requirements. HCP-H01 conceded having a knowledge deficit with regards to 
CPAP and found it problematic to provide a “better answer”.  
Finally, most HCPs (n=11) appraised vignette four as ‘mild to moderate 
concerns: (2)’. The rationale for this score was that despite having a number of 
‘risk factors’ the baby appeared to be improving and care was being “stepped 
down”. HCP-D15 scored ‘no concerns: (0)’ again for the same reasons 
previously stated by those HCPs who scored ‘mild to moderate concerns: (2)’. 
HCP-N07, who scored the infant ‘extremely concerned: (4)’, reasoned that this 
was due to the infant being born preterm, having a corrected age of 38 weeks 
gestation with the infant requiring a period of CPAP to treat apnoea. In light of 
vignette four, HCP-A08 wanted to revise the score for the first vignette from 
‘mild to moderate concerns: (2)’ to ‘no concerns: (0)’. 
It was highlighted during the interviews that the term ‘professional concerns’ 
was found to be “nebulous” and could be confused with other ‘concerns’ such 
as “safeguarding”. It became apparent that some HCPs responses were 
influenced by external factors other than how the infant presented in the 
vignette. For example, some HCPs appeared to be swayed by the clinical 
setting where the infant was situated as HCP-D11 explained: 
 “…because they’re in HDU […] I supposed your gut feeling would be 
extremely concerned…” (HCP-D11). 
When working through the vignettes, it became evident to HCPs that three 
infants were being largely categorised as ‘mild to moderate concerns: (2)’ in 
spite of HCPs perceiving them to have different severities of illness.  
In order to capture these different severities HCPs suggested dividing the ‘mild 
to moderate concerns: (2)’ category in to two categories, although, it was 
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suggested there should be a maximum of three response categories. 
Regardless of some of the uncertainty around completing the response 
categories, the majority of HCPs reported to find this section “easy” to 
complete. Conversely, HCP-D16 described this section to be “fake” and 
“difficult” to complete. Furthermore, he described how he would probably 
“ignore” this section when assessing an infant.   
  Apnoea 8.8.3
The ‘apnoea (plus or minus bradycardia)’ section had five response 
categories to choose from: ‘no apnoea: (0)’; ‘short pauses/irregular breathing: 
(2)’; ‘self-correcting apnoea (increasing in frequency and/or duration): (4)’; 
‘apnoea requiring stimulation (increasing in frequency and/or duration): (6)’ 
and ‘apnoea requiring bag and mask ventilation: (8)’. Response categories (4) 
and (6) were colour coded yellow: consider urgent review by a senior doctor 
and category (8) was colour coded red: issue an arrest call.  
None of the HCPs experienced many difficulties in understanding what this 
section was asking of them or what was meant by the term ‘apnoea’. The 
general opinion was this section expected HCPs to assess and score the 
infant on the presence and severity of apnoea observed, with ‘apnoea’ being 
described by HCP-N09 as: 
“…where […] the baby stops breathing for a period of time…some babies 
might be self-correcting and then they will start again…others might need a 
bit of stimulation and […] the worst one’s are obviously when the babies 
stop breathing and doesn’t start breathing…” (HCP-N09). 
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Some HCPs (n=6) suggested the “pause” in breathing had to be a certain 
length of time before being considered an apnoea, with estimates ranging 
between five and 20 seconds. Apnoea would be assessed either by: parental 
reports (although the accuracy of these reports were questioned), direct 
observation or the use of apnoea monitoring. When reflecting on the “different 
stages” of apnoea, HCPs reacted positively towards the five apnoea response 
categories presented in the LIBSS-PRO. They were asked to explain each of 
the response categories in turn to assess their understanding. The HCPs 
found the following categories: ‘no apnoea: (0)’; ‘apnoea requiring stimulation 
(increasing in frequency and/or duration) (6)’; and ‘apnoea requiring bag and 
mask ventilation: (8)’ were relatively objective and easy to complete. HCP-D10 
queried the description in brackets, ‘increasing frequency/duration’, for 
category (6) and felt it required further clarification as he explained: 
“…what do we mean by increasing frequency and duration […] so you 
could say more than two per hour or the chart …it’s less than two at this 
hour and then they look at it the next hour […] so maybe define what 
that means …” (HCP-D10). 
Some HCPs suggested response categories (6) and (8) may not always be 
completed: in this scenario it was considered more important to “get help” than 
to “add up a score”. The response category that appeared to create the most 
difficulties was ‘short pauses/irregular breathing: (2)’. HCP-N09 thought 
category (2) revealed possible impending respiratory failure. As she explained: 
“…that could be an indication of increasing work of breathing […] the 




Six HCPs reported “periodic”, irregular breathing being part of the young 
infants “normal breathing pattern” but would “take it seriously” if associated 
with other symptoms such as “desaturations” or “high temperature”. It was 
suggested that “periodic breathing” could easily be “misinterpreted as apnoea” 
by inexperienced HCPs. Furthermore, it was suggested it may be difficult to 
differentiate between response categories ‘short pauses/irregular breathing: 
(2)’ and ‘self-correcting apnoea (increasing in frequency and/or duration): (4)’. 
As HCP-D03 explained: 
“…what’s a short pause and when does it become a self-correcting 
apnoea?”  (HCP-D03). 
HCP-A08 recommended that ‘short pauses/irregular breathing: (2)’ should 
be removed completely. Despite there being an overlap between these two 
response categories, HCP-D04 thought it to be acceptable to include both 
response categories in the context of bronchiolitis. With the exception of HCP -
H01, all the HCPs found this section “easy to complete”.  
  Effort of breathing 8.8.4
For this section HCPs were provided with a list of symptoms associated with 
‘effort of breathing’: tracheal tug, sub/intercostal recession, sub-sternal 
recession, head bobbing, grunting, nasal flare, accessory muscle use 
abdominal breathing and central cyanotic episodes (LIBSS-PRO Version 7.7). 
For the first two symptoms, HCPs had to decide between three response 
categories: ‘absent: (0)’; ‘mild: (1)’; or ‘marked: (2)’. For the remaining seven 
symptoms there were two response categories: ‘absent: (0)’ or ‘present: (1 or 
4)’. ‘Central cyanotic episodes’ was given a greater score weighting for the 
172 
 
response category ‘present: (4)’ and colour coded red: issue an arrest call. For 
those HCPs who received Version 8.0 the following symptoms had been 
removed: accessory muscle use; abdominal breathing. The response 
categories had changed to: ‘absent: (0)’, ‘present: (1)’ for tracheal tug, sub-
sternal recession, head bobbing, grunting and nasal flare. For central cyanotic 
episodes the answer responses were either: ‘absent: (0’), ‘present: (4). There 
were three answer options for sub/intercostal recession: ‘absent: (0)’; ‘present: 
(1)’ or ‘severe: (2)’. 
‘Effort of breathing’ was described as “how much extra work” the infant had 
to undertake to maintain “normal respiratory function” using “respiratory and 
accessory muscles”. It was judged that collecting information on these 
symptoms would provide useful information on trends. Some of the symptoms 
were considered more important than others. HCP-D10 felt “grunting” was an 
“important sign” and not only should it be given a “higher score” but it should 
be removed from the ‘effort of breathing’ section and classified as a “separate 
risk factor”. Two HCPs found the term ‘sub-sternal recession’ difficult to 
comprehend and wanted further clarification. ‘Tracheal tug’ was believed to be 
difficult to detect in a young infant “who doesn’t have a neck”. It was suggested 
by HCP-D10 that the response category ‘present: (4)’ for ‘central cyanotic 
episodes’ should be weighted similarly to the response category ‘apnoea 
requiring bag and mask ventilation: (8)’ for ‘apnoea’.  
The HCPs identified a number of areas of overlap within this section. It was 
thought that ‘accessory muscle use’ could be removed as this was already 
covered by ‘tracheal tug’ and ‘recession’. ‘Abdominal breathing’ was judged 
redundant for two reasons: firstly “most neonates are abdominal breathers” 
173 
 
and secondly it was deemed to “overlap with accessory muscle use”. 
Furthermore, it was considered that ‘central cyanotic episodes’ was partly 
covered by an alternative section in the scoring instrument (% of oxygen to 
maintain saturations >92%). Overall, the ‘effort of breathing’ section in Version 
7.7 was found to be particularly confusing by HCPs. This was due to the 
response categories being inconsistent between the first two symptoms and 
the remaining seven symptoms. Changes were made to the score responses 
in Version 8.0 and in general HCPs found this section “straight forward to 
complete”.  
  Respiratory rate 8.8.5
The ‘respiratory rate’ section was sub-divided into two age groups each 
having three response categories: under three months ‘‘25-59 bpm: (0)’; ‘60-
70bpm: (2)’; ‘>70 or <25 bpm: (4)’; or three months and older ‘20-55 bpm: (0)’; 
‘50-65: (2)’; ‘>65 or < 20 bpm: (4)’. The third response category for both age 
groups was colour coded yellow: consider urgent review by senior doctor. 
HCPs understood what this section was asking about and HCP-D04’s 
response was typical: 
“[this section is]…inquiring about the child’s rate of breathing and how 
appropriate it is in relation to the child’s age…” (HCP-D04). 
This domain was reported to be “objective” and the reference ranges were 
considered reasonable. It was noted by HCP-03 that respiratory rate is 
“dynamic” and is dependent on the activity of the infant at the time of the 




  % Oxygen to maintain saturations >92% 8.8.6
This domain required HCPs to choose one of four response categories 
related to the infant’s oxygen requirements as follows: ‘room air (21%): (0)’; 22-
40% (nasal cannula up to 2 litres; face mask without reservoir bag; head box; 
Optiflow; CPAP): (2)’; 41-50% (head box; Optiflow; CPAP), ‘6’ >51% 
(facemask with reservoir bag; Optiflow; CPAP): (4)’. The fourth response 
category was colour coded yellow: consider urgent review by senior doctor. 
Underneath the response categories there was a box with the following caveat: 
‘In chronic lung or congenital heart disease substitute saturations of 92% for 
accepted level of saturations when well’. HCPs believed this section was 
asking them to assess whether the child needed supplemental oxygen to 
maintain oxygen saturations greater than 92%. HCP-D10 postulated: 
“the more oxygen you need the more severe the illness is likely to be” 
(HCP-D10). 
‘Optiflow’ was the only term that a significant number of HCPs had difficulty 
in understanding. This was due to it being a relatively new intervention for 
oxygen therapy delivery: not all hospitals had introduced this intervention into 
clinical practice. HCP-D03 raised an issue of uncertainty as to how to score 
“wafting” oxygen. This is when an infant will not tolerate a mask or nasal specs 
being directly applied to the face and a mask is positioned a few inches away 
from the face. It is thus difficult to accurately assess how much oxygen the 
infant is actually receiving to provide a score. When asked how they think they 
might score an infant with “wafting oxygen” HCP-D03 stated:  
“I would probably score that as a two” (HCP-D03). 
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HCP-N06 raised an issue with how oxygen was usually recorded in litres as 
opposed to percentages in her clinical setting and how this may cause some 
difficulties with completing the score, as she explained: 
“…for example, we’ve had one [infant] on cpap and a lot of people have 
been a bit unsure how to work out the litres to percentage […] so we 
would probably need a bit of training in that” (HCP-N06). 
Two HCPs (HCP-D03 and HCP-D16) suggested for infants with CLD you 
would be “aiming for saturations at 92 plus” and a lower cut-off value was 
considered “more important” for infants with CHD. Therefore it was suggested 
by one HCP (HCP-D16) that CLD should be removed from the caveat. A 
further HCP (HCP-A08) felt that including the caveat “makes the whole section 
look a bit complicated”. Whilst another HCP (HCP-D04) suggested the caveat 
should be moved to the beginning of the domain for clarity. All HCPs (n=16) 
felt overall this section was “objective” and “easy” to complete, although one 
HCP (HCP-A08) felt it was a little “wordy”.  
  Heart rate 8.8.7
‘Heart rate’ was sub-divided into two age groups each with three response 
categories: under three months ‘105-165 bpm: (0)’; ‘166-180 bpm: (2)’; ‘>180 
or <105 bpm: (4)’and three months and over ‘95-145 bpm: (0)’; ‘146-160 bpm: 
(2)’; ‘>160 or <95 bpm: (4)’. The third response category for both age groups 
was colour coded yellow: consider urgent review by senior doctor. It was felt 
that heart rate was an “important marker” to determine how “unwell” an infant 
is. ‘Heart rate’ would be assessed either by “monitoring”, “checking a pulse” or 
“listening at the apex with a stethoscope”. HCP-D03 suggested ‘heart rate’ 
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should be “measured directly” at the apex and proposed adding the following 
instruction, “taken at the apex” as he described:  
 “…because when people are doing observations they should do them 
properly…” (HCP-D03).  
When this instruction was incorporated into LIBSS-PRO (Version 8.0) the 
response was unenthusiastic. Most of the HCPs (n=11) reportedly used 
monitoring to assess ‘heart rate’ and it was believed “unrealistic” to auscultate 
‘heart rate’ at the apex. Furthermore, the accuracy of auscultation at the apex 
for ‘heart rate’ was questioned, especially when heart rates are greater than 
166 beats per minute (bpm) as HCP-D11 explained: 
“…it’s very quick and you are never going to be so accurate…you’re 
always going to be […] guestimating…” (HCP-D11). 
However, auscultation of ‘heart rate’ was considered useful to check the 
accuracy of the monitoring equipment. Most of the HCPs (n=9) judged the 
reference ranges within the three response categories to be reasonable. Yet 
HCP-D10 had a reservation about the upper threshold of 180 bpm for infants 
less than three months of age. He suggested having an additional category 
with an upper threshold of 200 bpm as he explained: 
 “…if you asked me to come and review a child and I see 185 [bpm] I 
wouldn’t differentiate much with this group …but when I look at the child 
it might tell us a lot more […] if it’s 200 [bpm]…my alarm bells will ring” 
(HCP-D10). 
A recommendation from HCP (HCP-A08) was to have a LIBSS-PRO 
instrument developed specifically for the two different age groups rather than 
having to “ignore a section” within the score because it is for a “different age 
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group”. Another issue identified was with the use of “adult probes” for pulse 
oximetry in some clinical settings, for example, “GP practices”. HCP-N07 
proposed: 
“…this could produce a ridiculous set of observations which doesn’t tally 
with the infant” (HCP-N07). 
It was also noted that ‘heart rate’, like ‘respiratory rate’, was dynamic and could 
alter significantly in relation to activity of the infant at the time. Overall the 
section on ‘heart rate’ was considered “easy to complete” by the HCPs.  
  Appearance/level of consciousness 8.8.8
For this section of the score HCPs were required to assess appearance, 
behaviour and neurology and score against one of four response categories: 
‘alert & active/normal sleep: (0)’; ‘irritable/fractious/restless: (2)’; 
‘lethargic/floppy/no interaction: (4)’; ‘unresponsive: (6)’. The third category was 
colour coded yellow: consider urgent review by senior doctor and the fourth 
category was colour coded red: issue an arrest call.  
The HCPs were in agreement about what this section aimed to be assessing. 
HCP-D15’s response was typical: 
“…the consciousness level of the infant […] whether or not they [the 
infant] are irritable or […] not acting as they usually do or in extreme 
situations not responding at all…” (HCP-D15).  
Some HCPs (n=3) believed some response categories were objective whilst 
other categories appeared “ambiguous” or open to “interpretation”. It was 
proposed that “outside influences”, for example, painful procedures, could 
induce certain behaviour changes in infants. Furthermore, it was suggested 
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that there may be overlap between the response categories, which require 
further “clarification”, as HCP-D03 observed: 
“…well ‘no interaction’ suggests to me that they are ‘unresponsive’ 
‘cause they are not interacting to anything that you are doing …so they 
are not responding…” (HCP-D03). 
HCP-N13 suggested merging the two middle categories so the ‘appearance 
and behaviour’ has a sum total of three categories. HCPs contrasted this 
section with other neurological scoring instruments that are widely used in 
clinical practice and considered objective, such as GCS and AVPU score. 
Although these scores were well received it was thought they may be “too 
simplistic”, particularly AVPU for use in infants. HCP-N07 commented: 
“…when we write out nursing kardex…you know… will write happy 
interactive baby…we don’t just put the baby is alert…we make a 
comment on how they are actually handling…” (HCP-N07).  
Despite the identified issues with subjectivity this section of the LIBSS-PRO it 
was reported to be “easy to complete” and thought to be useful to identify 
“trends” with the illness progression.  
  Hydration and perfusion 8.8.9
The ‘hydration and perfusion’ section was sub-divided into ‘feeds’, ‘urine 
output’ and ‘perfusion’. The ‘feeds’ section had three response categories: 
‘usual amount of feeds: (0)’; ‘50-75% of feeds: (2)’; ‘<50% of feeds: (4)’. The 
third category was colour coded yellow: consider urgent review by senior 
doctor. ‘Urine output’ had three response categories: ‘usual amount of wet 
nappies: (0)’; ‘reduction in number of wet nappies: (2)’; ‘small volumes of 
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concentrated urine or anuric: (4)’. The third category was colour coded yellow: 
consider urgent review by senior doctor. ‘Perfusion’ had two response 
categories: ‘central capillary refill time > 2 seconds: (2)’ (colour coded yellow: 
consider urgent review by senior doctor) and ‘sunken eyes/fontanelle: (2)’. 
HCPs reported understanding what this domain is asking them to assess, and 
HCP-H01 summed this up: 
“…how much fluids they [the infants] are taking on board …how much 
they are passing out and whether their capillary refill is as you would 
expect…or whether they are dehydrated…” (HCP-H01). 
HCPs recounted how they would ask the parents for information on the 
amount of feed the infant usually takes and then estimate how much feed the 
infant was actually taking. An issue highlighted by this process was that 
parental reports were reported often to be “unreliable” or “wrong”. Detailed 
questioning of the parents may uncover infants are taking an adequate volume 
of feed over the day but are taking “smaller amounts more frequently”. It was 
suggested that “explicit questioning” of the parents is required to obtain an 
accurate reflection of feed intake. HCP-H01 noted the incongruity between the 
volume of feed provided by the parents at home and the volume of hospital 
maintenance feeds calculated by weight: 
“…what we tend to do is work them out on the 150 or 120/kg […] per 
day […] the parents might think they’re not taking their usual amount of 
fluids but as far as we’re concerned their intake is absolutely perfect for 
their weight…” (HCP-H01).  
For those infants who are admitted to hospital, HCPs reported that hydration 
status becomes easier to assess as the infant has a “fluid balance chart filled 
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out”. It was also reported that maintenance fluid intake would be restricted to 
75% if the infant was thought to be “working hard” to breathe.  It was 
suggested by one HCP that it may be difficult to use the score with an infant 
who is receiving either nasogastric (NG) feeds or intravenous (IV) fluids with 
the current response options, as he explained: 
“…if you are being NG fed […] you are getting 100% of your feeds…do 
you score a zero or do you score a four…I think you should probably 
score a four […] so I would say less than 50% or requiring NG feeds 
stroke IV fluids […] the very fact that they are needing NG feeds would 
mean to me that they are more severe…” (HCP-D03).  
HCP-A08 highlighted that there was an “expectation” that those infants 
receiving IV fluids were sicker than those who receive NG feeds when the 
route of fluid administration is influenced by the personal preference of the 
HCP assessing the infant: 
“…they may just have a penchant for IV fluids …somebody might have 
gone for an NG […] but doesn’t mean the kid’s any less sick…” (HCP-
A08).  
In some circumstances an infant may receive both NG and IV fluids as HCP-
N05 explained: 
“…sometimes […] we feed them a smaller amount of feeds again so 
they get the calories and […] we give them a ratio of part IV fluids and 
part tube feed…” (HCP-N05).  
Furthermore, it was questioned whether the term “oral feeds” needs to be 
included into the wording of the response categories. It was suggested that 
including the term ‘oral feeds’ may cause some ambiguity for those infants who 
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are receiving percutaneous endoscopic gastrostomy (PEG) feeding tubes and 
not being fed orally. After some deliberation, HCP-D03 suggested including: 
“…usual amount of feeds and usual route of feeding…” (HCP-D03).   
Urine output was initially assessed from taking a history from the parents 
and then for those infants admitted to hospital, urine output would be 
documented on the fluid balance chart. HCP-N07 suggested including a time 
frame when assessing urine output to improve clarity: 
“…you could ask the question to someone… have they passed urine in 
the last four hours? and the answer is no…the level of concern would 
raise […] if you are putting a time frame that’s black and white…not 
passing urine could be potentially interpreted different …by different 
people…” (HCP-N07).  
It became apparent that assessment of urine output differed depending on 
the clinical environment in which the infant was situated. HCPs on general 
medical wards recorded urine output in terms of number of wet nappies over 
24 hours, whilst HCPs in critical care areas weigh the nappy to obtain a more 
accurate measure of urine (mLs/kg/hour). Three HCPs either reported that 
they did not understand the term ‘anuric’ or highlighted that other HCPs may 
not necessarily understand this term. Although it was thought that ‘feeds’ and 
‘urine output’ were both “equally important”, it was judged they were both 
providing similar information on hydration status. HCPs contemplated whether 
these two sections could be merged together or whether one of these two 
sections should be removed. The general consensus was that both sections 
should remain unchanged with HCP-N14 explaining:   
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“I think even though one is dependent on the other they probably still 
need to be separate …’cause even the respiratory and heart rate are 
dependent on the other but they are very separate aren’t they…”(HCP-
N14).  
Assessing capillary refill time (CRT) was considered to be straight forward 
and thought that, with training it could be undertaken by HCPs “across the 
board”. More senior HCPs recognised that to obtain an accurate CRT it should 
be taken over a bony prominence, on a central region of the body, such as the 
sternum. Some more junior HCPs reported assessing CRT by applying 
pressure at a peripheral location, a digit, for instance. It was suggested that the 
term “central” should be included as a prefix to CRT to avoid CRT being 
undertaken at a peripheral location. It was understood by some HCPs (n=5) 
that in addition to dehydration, a prolonged CRT could be due to a “cold 
environment”, “sepsis”, “hypoxia” or “acidosis”.  
Sunken eyes and fontanelle were believed to be more difficult to assess, 
being not that “accurate” or “subjective”. Some HCPs (n=2) judged ‘sunken 
eyes’ and ‘sunken fontanelle’ as being a “late sign” of “moderate to severe 
hydration”. Despite indicating severe dehydration it was noted that that this 
section only scored a ‘2’, the same as ‘reduction in number of nappies’: an 
early sign of dehydration. Conversely, one HCP (HCP-D02) preferred it to have 
a lower score as it was a subjective measure. To gauge whether the infants’ 
eyes were sunken, HCP-D02 stated they would ask the parents “does his eyes 
look normal to you?” Other HCPs (n=7) reported looking for: “dark circles”, 
“eyes look like they’re going into the back of the head”, “eyes look tired” or 
infants looking “droopy”, “pinched”, “anxious” or “worried”. Furthermore, HCP-
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D03 described how sunken eyes may not be identified until the infant has 
improved: 
“…I don’t appreciate that a child has got sunken eyes or had sunken 
eyes until their better and you go back and see them again and you 
think you know he did have sunken eyes…” (HCP-D03).  
Two HCPs felt that there was “a wide range” in how a normal fontanelle 
feels making assessment difficult, especially for more junior HCPs. It was 
suggested by three HCPs that ‘sunken eyes and fontanelle’ should be 
considered for removal from the final version of the LIBSS-PRO, although one 
HCP reported that sunken fontanelle should be included. 
Finally, following completion of each of the sections, HCPs understood they 
had to add the scores together to arrive at a sum total. Other comments made 
to improve the score included: adding a section for parental concern and 
including assessment of skin turgor into the hydration and perfusion section.  
 Conclusion 8.9
In summary, the cognitive interviews identified a number of issues with 
regards to comprehension and terminology, which required further clarification 
and modification. It was also suggested that a number of domains and items 
should be either merged together or removed. A clearer definition of 
‘professional concerns/ ‘gut’ feeling’ emerged although, external factors, such 
as clinical location of the infant and decision making by other HCPs, could 
influence responses. The LIBSS-PRO was revised and modified in light of 
these suggestions and identified issues (LIBSS-PRO Version 9.2) (Appendix 
40). The strength of these interviews was with the inclusion of a diverse range 
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of HCPs of varying experience and grades. These interviews highlighted the 
importance of including HCP stakeholders to aid further refinement of the 
LIBSS-PRO. The aim of cognitive interviews is to identify problems with 
questionnaires that can introduce error. Due to the subjective nature of 
cognitive interviews potential error can occur through the conduct of the 
interview (130). To increase objectivity and reduce the potential for error, each 
interview was conducted in a standardised manner using the same format by 
one interviewer. Although the vignettes were useful to help HCPs to help think 
about a child with bronchiolitis it may have been more useful to have shown 
videos. Having a video may have solved the issues raised with finding it “hard” 











9  Clinical field testing 
 Introduction 9.1
This chapter describes the methods used to establish construct and criterion 
validity and reliability of the LIBSS-PRO (Version 9.2). Construct validity aims 
to establish important relationships between the domains and items included in 
a scoring instrument and how they measure a hypothetical construct (52, 61, 
134). For instance, the LIBSS-PRO purports to measure the construct of 
bronchiolitis severity. In order to gauge severity of illness in infants when using 
the LIBSS-PRO, cut-off values were determined for ‘mild’, ‘moderate’ and 
‘severe’ bronchiolitis. However, construct validity cannot be proven definitively: 
continued testing is required to provide evidence in order to understand the 
underlying construct of interest (135). 
Criterion validity testing assesses how well the new instrument correlates 
with another accepted measure, usually a reference ‘gold’ standard in the field 
(52). There is currently no instrument available that is widely accepted as 
being a reference standard to measure bronchiolitis severity. Therefore the 
reference standard used here was clinical examination by senior HCP, using 
guidelines/criteria that achieved consensus from the Delphi survey. Prior to 
using, the reference standard underwent inter-rater reliability testing for 
agreement to ascertain the level of objectivity.  
Reliability testing establishes the amount of random and systematic 
measurement error that occurs when using the instrument (52). The reliability 
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of a measure can be assessed by the same rater applying the instrument at 
different time points (test–retest) (136), or by multiple raters applying the 
instrument at the same time point (inter-rater reliability) and obtaining similar 
scores (61, 136). 
 Aims 9.2
i) To develop cut-off values for a range of values within the score to 
classify ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis. 
ii) To determine whether there is good agreement between the LIBSS-
PRO and the agreed clinical reference standard for bronchiolitis severity 
categories: ‘mild’, ‘moderate’, ‘severe’.  
iii) To determine the inter-rater reliability of the LIBSS-PRO instrument 
iv) To determine the test-retest reliability of the LIBSS-PRO instrument 
 Sample and setting 9.3
The field-testing was undertaken during two bronchiolitis seasons: 2011/12 
and 2012/13. A convenience sample of eligible HCPs and infants located 
within 11 study sites (four paediatric tertiary centres and seven DGHs) were 
identified via the CLRN to participate. The ‘rule of thumb’ to determine sample 
size for each of the clinical field-tests is 10 and 15 participants for each 
included domain/item (52). The LIBSS-PRO contained 12 domains therefore a 
minimum sample size of n=120 infants was calculated for each of the three 
clinical field tests. 
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 Informed consent 9.4
Informed consent was obtained from all participating HCPs and parents 
and/or carers of eligible infants prior to the clinical field-testing.  
 Methods 9.5
Prior to the clinical field-testing, all HCPs were provided with verbal training 
on how to complete the LIBSS-PRO. For all three clinical field-tests, HCPs 
were kept ‘blind’ to each other’s LIBSS-PRO score or the assessment of ‘mild’, 
‘moderate’ or ‘severe’. Immediately following field-testing the completed 
paperwork was filed in an opaque folder until data entry and analysis. 
 Construct validity testing 9.6
The construct validity testing involved an HCP being asked to administer the 
LIBSS-PRO instrument to an eligible infant. The reference standard was a 
clinical examination, independently undertaken, by one or two senior HCPs 
(paediatrician ST3 or above and/or ANP). The clinical examination took place 
within 15 minutes of the HCP administering the LIBSS-PRO. It was recognised 
that clinical examination is subjective. Therefore, following the clinical 
examination the senior HCP was asked to complete a proforma (Appendix 
41). This proforma contained the definition/criteria for ‘mild’, ‘moderate’ and 
‘severe’ bronchiolitis that had achieved expert consensus through the Delphi 
survey. The proforma was used to increase the objectivity of the reference 
standard. Where possible a second senior HCP was also asked to 
independently undertake a clinical examination of the eligible infant and 
complete a proforma. The purpose of the second examination was to enable 
inter-rater reliability testing to be undertaken to ascertain the level of 
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agreement for the bronchiolitis severity categories. The inter-rater reliability 
testing would provide evidence of consistency for the reference standard.  
 Criterion validity testing  9.7
Criterion validity of the LIBSS-PRO was assessed concurrently by 
comparing it to a clinically agreed reference standard: clinical examination by a 
senior HCP. HCPs were asked to administer the LIBSS-PRO instrument to 
eligible infants. The LIBSS-PRO summed score was calculated, placing the 
infants in one of the three pre-defined categories: ‘mild’, ‘moderate’ or ‘severe’. 
Within a 15 minute timeframe the infant was assessed using the clinically 
agreed reference standard as described in the construct validity testing 
(Section 9.6). The senior HCP was asked to allocate the infant to one of the 
three bronchiolitis severity categories on the proforma.  
 Reliability Testing  9.8
Two HCP raters were invited to independently apply the LIBSS-PRO to the 
same eligible infant within 15 minutes of each other at two different time points. 
A time interval (minimum 30 minutes up to a maximum of two hours) was 
required between time points. Both sets of observations were undertaken in 
similar clinical conditions. 
 Analysis 9.9
Data analysis for all three clinical field tests was conducted using SPSS 
(Version 22). Frequencies were used to examine infant and HCP 
characteristics. Descriptive statistics (mean (SD)) were used to inspect the 
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time taken to complete the LIBSS-PRO, the total score values and day of 
illness.  
Ordered categorical data (three categories) were collected for all three 
clinical field tests. The level of agreement was estimated using the weighted 
Kappa co-efficient. The Kappa coefficient measures the level of agreement 
between the screening tool and gold standard when the outcome is measured 
using either a binary or categorical scale. In the simplest case when there is a 
binary (yes/no) outcome exact agreement occurs when both the screening tool 
and gold standard identify the same response. Chance agreement occurs 
because there are limited (in this example 4) possible outcomes, so even 
using a random process, such as, tossing a coin some agreement would occur 
by chance. The kappa coefficient is designed to provide an estimate of the true 
agreement, which is the exact agreement adjusted for the chance agreement. 
In this application the outcome measure had three response categories, mild 
moderate and severe. Consequently the kappa coefficient is expanded to allow 
for full agreement, for example, mild/mild, disagreement by one category, for 
example, mild/moderate and full disagreement, for example, mild/severe. 
These responses are then weighted with full agreement having a weighting of 
one, disagreement by one category a weighting of 0.5 and full disagreement a 
weighting of zero. Chance agreement is also calculated in a similar manner. 
Intra-class Correlation Coefficient (ICC) was used to determine agreement for 
continuous data using a two-way mixed model for reliability testing. The 
weighted Kappa and the ICC were interpreted as follows: poor agreement 
(<0.20); fair agreement (0.21-0.40); moderate agreement (0.41-0.60); good 
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agreement (0.61-0.80); excellent agreement (0.81-1.0) (137). The weighted 
Kappa and the ICC co-efficient are presented with 95% CIs. 
 Results 9.10
  Construct validity testing  9.10.1
One hundred and twenty eight construct validity tests were undertaken 
during the 2011/12 bronchiolitis season. The characteristics of the eligible 
infants are found in Table 26. The majority of HCPs who applied the LIBSS-
PRO to infants were nurses (78.8%) with most being employed on AfC grades 
5 (56.6%), 6 (14.8%) and 7 (18.9%). Thirteen (10.4%) clinical tests were 
undertaken either by CvM or a research nurse due to there being no available 
clinical HCP to apply the LIBSS-PRO. The characteristics of senior HCPs 
undertaking the first clinical examination were: consultant (60.6%); specialist 
trainee (31.3%); associate specialist (4.7%); staff grade (2.4%); ANP (0.8%). A 
total of n=128 clinical tests were undertaken. The mean time taken to complete 
the LIBSS-PRO was 7.6 (SD 5.4) minutes. The mean LIBSS-PRO score total 
was 10.5 (6.4). For the paediatrician inter-rater reliability testing n=75 second 
clinical examinations were undertaken. The characteristics of the senior HCPs 
undertaking the second clinical examination were: consultant (5.4%); specialist 




Table 25 Construct validity testing – infant characteristics 
Infant Gender   Male 76 (59.4%);  
Female 52 (40.6%) 
Infant Ethnicity White British 111 (87.4%) 
Asian or Asian British 2 (1.6%) 
White European 1 (0.8%) 
Black or Black British 5 (3.9%) 
Other 8 (6.3%) 
Clinical Setting  Assessment unit 12 (9.4%) 
General medical ward 88 (68.8%)  
PHDU 15 (11.7%) 
PICU 6 (4.7%) 
Other 7 (5.5%) 
Age group Under three months 68 (53.1%) 
Three months and over 60 (46.9%) 
 
There was agreement for 57/75 inter-rater reliability tests for ‘mild’, 
‘moderate’ and ‘severe’ categories. Inter-rater reliability for the reference 
standard raters when assessing for ‘mild’, ‘moderate’ & ‘severe’ bronchiolitis 
showed good agreement (Weighted Kappa 0.61, 95% CIs [0.35-0.86]) (Table 
27). However, the 95% confidence intervals ranged between fair and excellent 
agreement. This imprecision was likely due to the small sample size and the 
low number of tests falling within the ‘severe’ category. The exact weighted 
agreement was 89% but chance agreement (how much agreement would be 
expected to be present by chance alone) was 73%. This was due to the sparse 
distribution of cases outside mild/mild and moderate/moderate categories. 
Table 26: Paediatrician inter-rater reliability testing 
 Mild Moderate Severe Totals 
Mild 23 9 0 32 
Moderate 4 35 1 40 
Severe 0 2 1 3 




Prior to developing the cut-off values within the score a decision had to be 
made with regards to which severity category to use for the 16 clinical 
assessments where the reference standard raters disagreed. CvM and a 
second researcher (PM) independently scrutinised the patient data and 
comments on the LIBSS-PRO and both reference standard proformas. This 
information was used to decide which category the infant should fall into. The 
two researchers then compared results. There was agreement for 10/16 tests 
whilst 6/16 tests still disagreed. Of these six tests disagreements occurred in 
four tests due to the infant receiving respiratory support. One infant received 
0.5L of oxygen via nasal specs. Three infants received NIV (nCPAP or HFNC) 
with two infants requiring less than 40% oxygen and one infant was in air. All 
four infants were in the improving phase of bronchiolitis with minimal 
symptoms. The remaining two infants did not require respiratory support but 
either had reduced feeds or tracheal tug. Following further discussion CvM and 
PM eventually agreed categories for the remaining six tests. 
The final stage of the construct validity was to develop an optimum cut-off to 
classify infants as being either ‘mild’ or ‘moderate’, and then a second cut-off 
to classify patients as being either ‘moderate’ or ‘severe’. Sensitivity and 
specificity was calculated for a range of cut-off values. The sensitivity and 
specificity curves were then plotted on a single graph for a range of cut-off 
values (Figure 8 & 9). Where the sensitivity and specificity curves crossed is 
the cut-off value which optimises sensitivity and specificity. The cut-off value 
for mild and moderate was a LIBSS-PRO score of 10, whilst the cut-off value 





Figure 9: Mild/moderate sensitivity and specificity plotted for range of 
cut-off values  
 




  Criterion validity testing  9.10.2
One hundred and twenty three criterion validity tests were undertaken. The 
mean time taken to apply the LIBSS-PRO was 5.7 (3.10) minutes. The mean 
day of illness of the infant at the time of testing was 5.1 (2.4) days. Infant 
characteristics can be found in Table 28. The mean LIBSS-PRO score was 
9.92 (8.14). The majority of HCPs who applied the score were nurses (70.7%), 
mainly AfC band 5 (61.8%); 6 (17.1%) or 7 (16.3%). Thirty (24.4%) tests were 
undertaken either by CvM or a research nurse because clinical HCPs were 
unavailable. The senior HCPs who undertook the clinical examination 
comprised consultants (34.1%), specialist trainees (40.7%), associate 
specialists (13.0%), staff grades (6.5%) and ANPs (5.7%).  
Table 27: Criterion validity testing- infant characteristics 
Gender  Male 65 (52.8%);  
Female 58 (47.2%) 
Ethnicity White British 112 (91.1%) 
Asian or Asian British 1 (0.8%) 
White European 1 (0.8%) 
Black or Black British 4 (3.3%) 
Other 5 (4.1%) 
Clinical Setting  Medical assessment unit 27 (22.1%) 
General medical ward 55 (45.1%)  
PHDU 32 (26.2%) 
PICU 8 (6.6%) 
Age group Under three months 75 (61.0%) 
Three months and over 48 (39.0%) 
 
Seventy-two out of 123 (58.5%) LIBSS-PRO scores agreed with the 
reference standard. The inter-rater reliability testing between the LIBSS-PRO 
and the reference standard indicated fair agreement. However, 95% CIs 
ranged between poor and moderate agreement (Kappa 0.38, 95% CIs [0.18-
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0.59]) (Table 29). The exact weighted agreement was 78% but chance 
agreement was high at 64%. 
Table 28: Agreement between the LIBSS-PRO and the reference standard 
 Mild Moderate Severe Totals 
Mild 45 30 3 78 
Moderate 4 23 7 34 
Severe 0 7 4 11 
Totals 49 60 14 123 
 
There are several possible explanations for this result. There were 
differences in recorded observations between the LIBSS-PRO and the 
reference standard for the following symptoms: recession; tracheal tug; 
respiratory rate; irritable and restless; feed volumes. This may highlight a 
training/education requirement. One of the proforma criteria for ‘moderate’ 
was: requiring supplemental oxygen to maintain saturations greater than 92%. 
From the documentation, it was observed that a number of infants who were 
improving had minimal symptoms but still required a small amount of oxygen 
(less than one litre) to maintain saturations above 92%. Despite the infant 
improving, the reference standard criteria categorised the infant as being 
‘moderate’ whilst the LIBSS-PRO score categorised the infant as ‘mild’. It was 
also discerned that interventions such as, suctioning, feeding, CPAP or HFNC 
could greatly affect the severity of the symptoms. This could lead to 
discrepancy between the LIBSS-PRO and the reference standard. Finally, the 
clinical area in which the infant was situated may have influenced the 
reference standard assessment. For example, one senior HCP assessed an 
infant on PHDU as ‘severe’ in spite of the child being in head box oxygen with 
a plan for ward discharge. 
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  Reliability testing 9.10.3
The number of eligible infants recruited to participate in the clinical testing of 
the LIBSS-PRO was 128. Their characteristics are in Table 30. The mean day 
of illness when the score was applied to the infant was 5.5 (4.7) days. Most 
HCPs participating as rater one were nurses (74%), mainly AfC band 5 
(62.7%) or 6 (17.5%). 9.4% of participants were doctors and 7.9% were health 
care assistants. For ten tests (7.9%) either CvM or a research nurse acted as 
rater one if other clinical staff were unavailable. The mean time taken for rater 
one to apply the LIBSS-PRO was: test one 6.4 (3.2); test two 4.8 (2.4) minutes. 
The mean LIBSS-PRO score total for rater one was: test one 8.7 (6.8); test two 
8.2 (6.7). Of those HCPs participating as rater two, nurses accounted for only 
38.1% of participants (AfC band 5 (28.2%) and band 6 (38.7%)). The 
remaining HCP participants were doctors (5.6%) or student nurse (0.8%). For 
70 (55.6%) tests, either CvM or a research nurse acted as the second rater 
due to clinical staff being unavailable. The mean time taken for rater two to 
apply the LIBSS-PRO was: test one 6.0 (2.7); test two 8.3 (7.0) minutes. The 




Table 29: Reliability testing – infant characteristics 
Gender  Male 71 (55.5%);  
Female 57 (44.5%) 
Ethnicity White British 124 (96.9%) 
Asian or Asian British 2 (1.6%) 
Chinese or Chinese British 1 (0.8%) 
Black or Black British 1 (0.8%) 
Other 5 (4.1%) 
Clinical Setting  Medical assessment unit 17 (13.3%) 
General medical ward 97 (78.8%)  
PHDU 6 (4.7%) 
PICU 6 (4.7%) 
Age group Under three months 71 (55.5%) 
Three months and over 57 (44.5%) 
9.10.3.1 Inter-rater reliability 
For inter-rater reliability, the ICC for the overall LIBSS-PRO score total at 
both time points showed excellent agreement, with 95% CIs ranging between 
good and excellent: Time point 1(T1) 0.83, 95% CIs [0.75-0.88]; Time point 2 
(T2) 0.84, 95% CIs [0.77-0.89]. The scores for individual domains and items 
can be found in Appendix 42. Two domains had excellent agreement: 
‘saturations and oxygen supplementation’ (T1 0.97, 95% CIs [0.96-0.98]; T2 
0.97, 95% CIs [0.96-0.98]); ‘feeding’ (T1 0.80, 95% CIs [0.72-0.86]; T2, 95% 
CIs 0.80 [0.71-0.86]). Three domains had good agreement: ‘effort of breathing’ 
(T1 0.65, 95% CIs [0.50-0.75]; T2 0.67, 95% CIs [0.53-0.77]); ‘heart rate’ (T1 
0.71, 95% CIs [0.59-0.79]; T2, 95% CIs 0.70 [0.57-0.79]); ‘urine output’ (T1 
0.73, 95% CIs [0.62-0.81]; T2 0.72, 95% CIs [0.60-0.80]). Of the six items 
within the ‘effort of breathing’ domain only two items achieved good 
agreement: ‘recession’ (T10.61, 95% CIs [0.44-0.73]; T2 0.69, 95% CIs [0.56-
0.78]); ‘head bobbing’ (T1 0.62, 95% CIs [0.46-0.73]; T2 0.71, 95% CIs [0.58-
0.80]). Three domains had moderate agreement: ‘professional concerns’ (T1 
0.49, 95% CIs [0.28-0.64]; T2 0.46, 95% CIs [0.23-0.62]); ‘respiratory rate’ (T1 
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0.43, 95% CIs [0.19-0.60]; T2 0.41, 95% CIs [0.41-0.41]); ‘appearance’ (T1 
0.54, 95% CIs [0.35-0.68]; T2 0.41, 95% CIs [0.16-0.59]). Finally there was 
poor agreement for two domains: ‘apnoea’ (T1 -0.12, 95% CIs [-0.59-0.20]; T2 
-0.97, 95% CIs [-0.56-0.23]); ‘CRT’ (T1 -0.14, 95% CIs [-0.63-0.19]; T2 0.22, 
95% CIs [-0.11-0.45]).  
The moderate agreement within the ‘respiratory rate’ domain was 
unexpected. There is a dynamic association between heart rate and 
respiratory rate. It was assumed that any increase or decrease in respiratory 
rate would have a similar effect on heart rate, and thus similar levels of 
agreement would be observed, but this was not the case. One explanation for 
this observed difference might be that respiratory rate was largely assessed 
manually whereas heart rate was more likely to be obtained from the 
monitoring equipment. This premise might also account for the poor agreement 
for CRT which also relied on manual assessment. 
Agreement between the two raters at time point one for the categories 
‘mild’, ‘moderate’ and ‘severe’ was moderate (weighted kappa 0.43, 95% CIs 
[0.22-65]). However the 95% CIs ranged between fair and good. The exact 
agreement was 0.83 and the chance agreement 0.69 (Table 31). 
Table 30: Agreement for LIBSS-PRO categories ‘mild’, ‘moderate’ and 
‘severe’ (Time point 1) 
 Mild Moderate Severe Totals 
Mild 64 13 3 80 
Moderate 16 18 6 40 
Severe 0 3 4 7 




Agreement between the two raters at time point two for the categories ‘mild’, 
‘moderate’ and ‘severe’ was moderate (weighted kappa 0.49, 95% CIs [0.27-
0.72]). However 95% CIs ranged between fair and good. The exact agreement 
was 0.86 with chance agreement being 0.73 (Table 32). 
Table 31: Agreement for LIBSS-PRO categories ‘mild’, ‘moderate’ and 
‘severe’ (Time point 2) 
 Mild Moderate Severe Totals 
Mild 71 12 1 84 
Moderate 14 15 5 34 
Severe 0 1 4 5 
Totals 85 28 10 123 
 
Seventy tests were undertaken by a member of the research team (CvM or 
a research nurse) on more than one occasion. Therefore the research team 
members could be considered as being ‘expert’ in comparison to the clinical 
staff who were involved with the testing on one occasion. The data was further 
analysed to explore the differences between the tests undertaken by an 
‘expert’ and a ‘novice’ rater and those tests undertaken by two ‘novice’ raters. 
There was fair agreement between two ‘novice’ raters at time point one for 
the categories ‘mild’, ‘moderate’ and ‘severe’ although the 95%CIs ranged 
between poor and good agreement (weighted kappa 0.33 95%CIs [-0.03-
0.69]). The exact agreement was 0.79 and the chance agreement was 0.69. 
Moderate agreement was found between the ‘novice’ and ‘expert’ raters with 
95% CIs ranging between fair and good agreement (weighted kappa 0.51 
95%CIs [0.25-0.77]). The exact agreement was 0.85 and the chance 
agreement was 0.69.  
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For time point two there was fair agreement between the two ‘novice’ raters 
for the categories ‘mild’, ‘moderate’ and ‘severe’ although the 95%CIs ranged 
between poor and good agreement (weighted kappa 0.31 95%CIs [-0.13-
0.75]). The exact agreement was 0.84 and the chance agreement was 0.77. 
Whilst moderate agreement was found between the ‘novice’ and ‘expert’ raters 
with 95% CIs ranging between fair and excellent agreement (weighted kappa 
0.51 95%CIs [0.25-0.77]). The exact agreement was 0.85 and the chance 
agreement was 0.69.  
Although the ‘expert’/ ‘novice’ raters have a better weighted kappa 
compared to the ‘novice’/ ‘novice’ raters it would be difficult to draw a 
conclusion that this was largely due to expertise alone. Firstly, one half of the 
‘expert’/ ‘novice’ dyad was a ‘novice’. Ideally, to make a clean comparison for 
agreement the dyads should not mix ‘expert’ and ‘novice’ raters. Secondly 
dividing these two groups for analysis reduces the sample size particularly for 
the ‘novice’/ ‘novice’ dyad group. The reduction in sample size for this group 
could account for the wide 95% CIs observed.  
9.10.3.2 Test re-test reliability 
For test re-test reliability, the ICC for the overall LIBSS-PRO score for both 
raters showed excellent agreement: rater one (R1) 0.92, 95%CIs [0.89-0.94]; 
rater two (R2) 0.93, 95%CIs [0.91-0.95]. The scores for individual domains and 
items can be found in Appendix 43. The test re-test reliability for the following 
domains was excellent for both raters: ‘professional concerns’ (R1 0.86, 
95%CIs [0.80-0.90]; R2 0.86, 95%CIs [0.80-0.90]); ‘effort of breathing’ (R1 
0.89, 95%CIs [0.85-0.92], R2 0.87, 95%CIs [0.82-0.91]); ‘saturations and 
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oxygen supplementation’ (R1 0.95, 95%CIs [0.93-0.96], R2 0.95, 95%CIs 
[0.93-0.96]); ‘feeding’ (R1 0.96, 95%CIs [0.94-0.97], R2 0.94, 95%CIs [0.92-
0.96]); ‘urine output’ (R1 0.93, 95%CIs [0.90-0.95]; R2 0.93, 95%CIs [0.90-
0.95]). For one domain, ‘apnoea’, there was fair agreement for R1 (0.35, 
95%CIs [0.07-0.54]) whilst R2 had excellent agreement (0.83, 95%CIs [0.76-
0.88]). The following domains achieved good agreement: ‘respiratory rate’ (R1 
0.62, 95%CIs [0.46-0.73], R2 0.68, 95%CIs [0.54-0.77]); ‘appearance’ (R1 
0.72, 95%CIs [0.60-0.80], R2 0.69, 95%CIs [0.56-0.78]). One domain – ‘CRT’ 
– had good agreement for R1whilst there was fair agreement for R2 (0.26, 
95%CIs [-0.04-0.48]). Finally one domain – ‘heart rate’ – had moderate 
agreement (R1 0.50, 95%CIs [0.28-0.65]; R2 0.50, 95%CIs [0.28-0.65]). 
 Conclusion 9.11
Following clinical field-testing, cut-off values were established for ‘mild’ (0-
10); ‘moderate’ (11-20) and ‘severe’ (>21) bronchiolitis for the LIBSS-PRO. For 
criterion validity, the LIBSS-PRO was found to have fair agreement when 
compared to the reference standard. Although we attempted to employ 
rigorous methods to develop an objective reference standard it was still found 
to be subjective which more than likely affected the agreement. It became 
apparent during the clinical field testing there were problems with the reference 
standard proforma. A number of children who were improving and had ‘mild’ 
symptoms of bronchiolitis were being incorrectly classified as ‘moderate’. This 
was due to them being on small amounts of oxygen (<0.5L/min) to maintain 
oxygen saturations at 92% or greater. Furthermore, a proportion of children 
would meet the criteria for oxygen saturations in air when awake but would 
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immediately drop their saturations to approximately 89-90% when asleep and 
would require oxygen. According to the reference standard proforma being on 
oxygen immediately categorises the child as being ‘moderate’ and did not take 
into account those children with improving symptoms. A further issue found 
with the reference standard was that it was operator dependent. The clinician 
completing the proforma was found to be influenced by the location of infant 
and their clinical experience. For example, a consultant intensivist assessed 
an infant located on PHDU on nCPAP as being ‘mild’. Whereas a general 
paediatrician assessed a similar infant as being ‘severe’ despite the infant 
being weaned from nCPAP with a plan for ward discharge.  
The LIBSS-PRO was found to have good reliability (inter-rater and test-
retest) for the overall score total. However, the agreement for individual 
domains and items ranged between excellent and poor. This is probably due to 
the subjective nature of some of the domains and items. In a future revision of 
the score those domains and items with less than good agreement may need 
to be considered for removal. For 70 (55.6%) of the tests CvM or a research 
nurse acted as rater 2 when no ward nurse was available. This may have 
introduced an element of bias. CvM and the research nurses were undertaking 
the testing on a regular basis. Therefore were more familiar and experienced 
with completing the LIBSS-PRO. In comparison to a clinical health care 
professional who may have completed the LIBSS-PRO once. In spite of this 
difference in experience the inter-rater agreement for the LIBSS-PRO score 
total between the ‘novice’ and ‘expert’ raters was still excellent. In spite of the 
excellent agreement for the LIBSS-PRO score total the agreement for 
individual items was variable. When looking at the paperwork for the construct 
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and criterion validity testing differences were also noted between what was 
scored on the LIBSS-PRO and what was recorded on the reference standard 
proforma. For example, the senior paediatrician may have recorded that 
recession was observed yet this may not have been scored on the LIBSS-
PRO. These observed differences for individual items by the various health 
care professionals may highlight an educational or training need in clinical 
assessment.    
In conclusion, the clinical field-tests were able to establish validity and 
reliability of the LIBSS-PRO particularly for those infants with ‘mild’ or 
‘moderate’ bronchiolitis. Further evidence may be required to establish validity 
and reliability in the more ‘severe’ bronchiolitis group. Additional longitudinal 
research may be required to compare agreement between ‘novice’ and ‘expert’ 
raters to determine the variability between scores and how this impacts on the 








Rigorous methods were used to develop and validate the LIBSS-PRO 
instrument to assess severity of illness in infants with a clinical diagnosis of 
bronchiolitis. A conceptual framework was derived from the literature and from 
stakeholder consultation using workshop groups with NGT and in-depth 
interviews. The conceptual framework comprised five domains: respiratory; 
feeding/hydration; appearance/behaviour; risk factors; miscellaneous signs 
and symptoms. A total of 101 signs, symptoms and risk factors were 
categorised under the five domain headings. Selection over which of the pre-
identified signs, symptoms and risk factors to use as items in the LIBSS-PRO 
was obtained through Delphi expert consensus methods. Forty eight items 
achieved consensus and were included in the LIBSS-PRO. Various iterations 
of the LIBSS-PRO were shown to several HCP groups and the study steering 
group to establish face validity. Based upon comments and feedback from 
these groups, the LIBSS-PRO (Version 7.0) contained the following domains: 
‘risk factors’; ‘professional concerns/’gut’ feeling’; ‘apnoea’; ‘effort of breathing’; 
‘respiratory rate’; ‘chest auscultation’; ‘blood gas analysis’; ‘supplemental 
oxygen requirements’; ‘heart rate’; ‘appearance/behaviour’; 
‘hydration/perfusion’ (feeds, urine output, capillary refill, sunken 
eyes/fontanelle). Content validity field-testing was undertaken in eligible infants 
(n=114) and HCPs (n=6). All items were evaluated as being clinically relevant 
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but two items were removed due to substantial missing data: auscultation; 
blood gas analysis. The outcome of the cognitive interviews with HCPs (n=16) 
led to items being merged together, and changes to wording and answer 
responses. Furthermore a more objective definition of professional 
concerns/’gut’ feeling was developed. The LIBSS-PRO (Version 8.0) was 
revised prior to the clinical field-testing. Construct validity testing (n=128) 
enabled cut-off values to be determined in the score for ‘mild’, ‘moderate’ and 
‘severe’ bronchiolitis. Paediatrician inter-rater reliability testing (n=75) was 
undertaken to establish the level of agreement for the clinically agreed 
reference standard prior to criterion validity testing. Criterion validity testing 
(n=123) found good agreement between the LIBSS-PRO (Version 9.2) and the 
clinically agreed reference standard although the 95% CIs range between poor 
and excellent agreement. Finally there was excellent agreement for inter-rater 
reliability and test-retest reliability testing (n=128).  
 Challenges with developing and validating the LIBSS-10.2
PRO 
There is no standardised definition of bronchiolitis. For this study we used 
the definition developed by the SIGN Bronchiolitis guideline group (17). This 
guideline limited bronchiolitis to infants up to 12 months of age to minimise 
bias from including older children with other wheezing phenotypes. The SIGN 
Bronchiolitis guideline was published in 2006 (17). This guideline has since 
been superseded by the National Institute for Health and Care Excellence 
(NICE) Bronchiolitis guideline (138). The definition of bronchiolitis proposed in 
the NICE guideline extends the age group beyond 12 months to include 
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children up to 24 months. The LIBSS-PRO will be restricted for use in infants 
aged up to 12 months. This change in definition by the NICE guideline may 
preclude the uptake of the LIBSS-PRO in clinical practice and restrict its use 
as an outcome measure in clinical research. 
Bronchiolitis being a seasonal condition presented a challenge. Stakeholder 
groups and clinical field-testing could only be conducted during the 
bronchiolitis season (October to March). The study was carefully planned over 
a three year period. For each of the three phases, critical time points were 
identified to commence or complete key aspects of the study. This was to 
prevent study phases from over-running, and causing delays. It was 
anticipated that if delays occurred they may impact on achieving the study 
recruitment targets for the clinical field-testing. Bronchiolitis admissions peak 
during the months of November and December. To achieve the recruitment 
target during this short time period it became necessary to open other sites 
across England. CLRN research nurses facilitated with the recruitment and 
clinical field-testing to ensure recruitment targets were met. Over this period 
there were also increased admissions for other illnesses in addition to 
bronchiolitis, and increased staff sickness. These two factors created 
increased workload for clinical ward staff. At times it was difficult to get clinical 
staff to participate with field-testing because of this increased workload. 
Consequently, CvM or the CLRN research nurses would participate with the 
clinical testing instead.  
To facilitate the involvement of doctors as the reference standard for 
criterion validity and the inter-rater reliability testing, clinical field-testing was 
undertaken during the morning ward rounds. However, this presented several 
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problems. Firstly, the morning ward rounds commenced between eight and 
nine in the morning. Some infants would have been in hospital for a few days 
and it was often possible for parents and/or carers to be approached the day 
before the ward round to obtain informed consent. However, for those infants 
admitted during the night, obtaining informed consent proved more difficult. 
The research team were mindful that these parents were potentially exhausted 
due to sleep deprivation and anxious with regards to their infants’ acutely ill 
condition. Ward staff were consulted first to ascertain whether it was 
appropriate to approach these parents to provide information and obtain 
informed consent before the ward round. Due to bed shortages, severity of 
illness, infection control policy and volume of admissions, infants were placed 
in a wide variety of geographical locations across the hospital including 
general medical and surgical wards; neuro-medical ward; medical and surgical 
assessment units, ED; PHDU; PICU. The volume of infants and the distribution 
across such a large hospital as Alder Hey made obtaining informed consent 
prior to wards rounds difficult. Furthermore, several ward rounds would often 
be undertaken simultaneously making clinical field-testing difficult. These ward 
rounds did not have a set starting point or route around the hospital: it was 
down to individual preference and workload of the person leading the ward 
round. Additionally, it was common for two or more ward rounds to occur at the 
same time on the same ward or the same time on different wards, and to arrive 
at consented infants contemporaneously. 
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 Study strengths 10.3
The study used rigorous methodology, not previously employed in the 
development and validation of any other bronchiolitis scoring instrument. The 
overall sample size exceeded 1,300 participants (infants, parents and/or 
carers, HCPs). The 11 hospital study sites were located across England and 
were a mix of paediatric tertiary centres and DGHs, to try and ensure a 
representative sample. No other study validating a bronchiolitis scoring 
instrument has compared the instrument to a clinically agreed reference 
standard where the reference standard was subjected to robust investigation 
to determine objectivity and standardisation. A range of different qualitative 
methods was used within the study. This triangulation of data increased the 
study validity and adds depth to the data collected. A unique aspect of this 
study was the involvement of a wide range of parent and HCP stakeholders in 
all aspects of the study. This study was pragmatic. Clinical staff rather than 
researchers participated with the clinical field-testing of the LIBSS-PRO. This 
engagement ensured the LIBSS-PRO was clinically relevant and acceptable to 
HCPs, which will aid future implementation into clinical practice. Moreover, the 
study sought to engage clinical staff with the research process with certificates 
of participation being provided for personal development portfolios. 
Stakeholders were not just involved with the development of the LIBSS-PRO 
and clinical field-testing. They were also involved in study design, reviewing 
the protocol, participating in the study steering group and advising on a 
stakeholder engagement newsletter.  
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 Study limitations 10.4
Despite the number and location of the study sites, there was still an under-
representation of infants and parents and/or carers from different ethnic 
backgrounds. HCPs applying the LIBSS-PRO to infants during clinical field-
testing tended to be from the nursing profession. This was because nursing 
staff were more available than other HCP groups and the previously described 
seasonal pressures. The acute, labile nature of bronchiolitis rendered it difficult 
to identify, recruit and undertake clinical field-testing in the ‘severe’ group of 
infants. To try and improve recruitment in this group, an ethics amendment 
was successfully submitted for deferred consent. Parents and/or carers of an 
infant in extremis were provided with a brief verbal explanation of the study 
and that observational data was being collected. At an appropriate time once 
the infant had been stabilised; parents were provided with detailed written and 
verbal information about the study. Parents were given time to consider the 
information and whether the collected data could be included into the study. If 
agreeable, parents and/or carers were asked to sign deferred consent. If they 
disagreed, the data collected would be destroyed. Even with deferred consent, 
capturing those ‘severe’ infants remained difficult. It became apparent that 
some infants, transferred to either PICU or PHDU and commenced on either 
nCPAP or HFNC for their symptoms, would rapidly improve. The LIBSS-PRO 
would often categorise these infants as ‘moderate’.  
The clinical premise of the LIBSS-PRO was to have thresholds for ‘mild’, 
‘moderate’ and ‘severe’ bronchiolitis in order to standardise care, support 
clinical decision making, for example, escalation or weaning of treatment and 
be a mechanism to improve patient safety with the early detection of 
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deteriorating infants. Furthermore, these thresholds were to aid HCPs with 
interpretation of the score. However, through undertaking this research it has 
become apparent that a number of difficulties/tensions arose through trying to 
develop these thresholds. Particularly, tensions occurred with individual HCP 
perceptions of what constitutes ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis and 
how this was influenced by factors, such as, level of seniority, clinical 
experience and clinical location of the infant. Due to these tensions, having 
thresholds for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis may be questionable 
and could be considered superfluous. An alternative to using thresholds to 
guide severity of illness and treatment decision making could be with the use 
of LIBSS-PRO score trends. For example, if the LIBSS-PRO score increases 
on two consecutive occasions maybe this would trigger the need for a medical 
review or an escalation in treatment.  
The original objective of this study was to develop a scoring instrument 
which had both clinical utility and could be used as an outcome measure. It is 
debatable whether one scoring instrument can have a dual purpose within 
clinical practice and research. The LIBSS-PRO does have the potential to 
achieve this objective. The LIBSS-PRO is a standardised objective measure 
which can provide quantifiable data on trends in clinical condition to facilitate 
decision making. Furthermore, the LIBSS-PRO could be used to evaluate the 
effectiveness of treatment interventions given to individual patients as part of 
their management. This is particularly important when the treatment under 
investigation does not have a strong evidence base, such as, nCPAP and 
HFNC. However, the LIBSS-PRO may be perceived by HCPs as time 
consuming, burdensome and difficult to interpret, particularly if the thresholds 
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for ‘mild’, ‘moderate’ and ‘severe’ bronchiolitis are considered redundant. This 
may preclude the clinical uptake of the LIBSS-PRO and restrict its use to being 
a research outcome measure.  
 Comparison of the LIBSS-PRO with other scoring 10.5
instruments 
There are several differences between the content of the LIBSS-PRO 
(Version 9.2) and the seven scoring instruments which were appraised in 
Chapter 1 (1, 33, 56, 58-60, 62). None of these instruments considered risk 
factors, professional concerns, urine output or capillary refill time for inclusion. 
Interestingly, only one instrument included apnoea as an item despite apnoea 
being perceived by most HCPs as an important symptom of ‘severe’ 
bronchiolitis in young infants (33). Five instruments included items related to 
effort of breathing (33, 56, 58, 59, 62): this was usually restricted to recession. 
In addition to recession the LIBSS-PRO (version 9.2) also assessed for 
tracheal tug, nasal flare, head-bobbing, grunting and central cyanosis. Two 
instruments included oxygen saturation with thresholds of 90% (33) and 97% 
(1) to score an infant. The oxygen saturation threshold used within the LIBSS-
PRO (Version 9.2) are 92% based on current UK guidance (17, 138), which is 
slightly higher than the thresholds of 90% recommended for use in American 
guidelines (139). Using higher saturation thresholds of 97% may skew the 
score total and lead to a greater number of hospital admissions and/ or 
prolonged length of hospital stay. Four instruments included respiratory rate (1, 
33, 58, 62). Two instruments developed respiratory rate thresholds based on a 
review of clinical records (1, 33), whilst two instruments did not report how the 
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respiratory thresholds were developed (58, 62). Two instruments included 
thresholds for heart rate (1, 59). One instrument developed heart rate 
thresholds following a review of clinical records (1), whilst one instrument 
reported using a heart rate greater than 97th centile (59). The thresholds for 
respiratory rate and heart rate used in the LIBSS-PRO (Version 9.2) were 
based on a systematic review of observational studies of normal heart and 
respiratory rate ranges in children from birth to 18yrs (140). The upper 
thresholds were based on the 75th and 90th centiles whilst the lower threshold 
was based on the 10th centile. Four instruments included items related to 
appearance (33, 58, 60, 62) and used adjectives similar to those used in the 
LIBSS-PRO (version 9.2) to describe appearance. Four instruments included 
items related to feeding/fluid requirements (33, 55, 59, 60). Amongst these 
instruments the assessment for feeding was largely subjective with no clear 
thresholds describing poor fluid intake. The LIBSS-PRO provides objective 
thresholds for both fluid intake and urine output. The thresholds used for fluid 
intake were developed from the stakeholder consultation and are comparable 
to those thresholds recommended in the recently published UK bronchiolitis 
guidance (138). The thresholds for urine output were based on Advanced 
Paediatric Life Support guidance (141). This comparison of the LIBSS-PRO 
(Version 9.2) with other scoring instruments emphasises how the LIBSS-PRO 
(Version 9.2) provides a comprehensive assessment of an infant with 
bronchiolitis. Furthermore, objective threshold criteria based on research 
evidence or stakeholder consensus, where no evidence exists, were used to 
provide an overall objective score to assess severity of illness in infants with 
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bronchiolitis. This is particularly advantageous for use by those HCPs with less 
clinical experience of managing infants with bronchiolitis.  
 Research and innovation recommendations 10.6
Developing a measurement instrument is an iterative process (61) which 
involves testing the instrument, making changes then evaluating these 
changes (61). Although there was excellent agreement for LIBSS-PRO score 
total in the inter-rater reliability testing, agreement for individual items was 
variable. Further research may involve removing these poorly performing items 
from the LIBSS-PRO and re-evaluating its performance in clinical field tests. 
To facilitate implementation into clinical practice the LIBSS-PRO may need 
further development and evaluation in an older patient population group. 
Although the LIBSS-PRO has already undergone psychometric tests to confirm 
validity and reliability there are a number of other tests needed to fulfil the 
validation process. A longitudinal study is required to assess the LIBSS-PROs 
responsiveness to change. For instance, can the instrument detect 
improvement or deterioration over time or following a treatment intervention? 
Assessment of responsiveness is a prerequisite if the score is to be used as an 
outcome measure in clinical trials (52, 53). Despite the clinical field-testing 
being undertaken in sites across England, ethnic groups were under 
represented in the sample. Therefore more research needs to be undertaken 
to ensure the LIBSS-PRO has clinical relevance and is generalisable to these 
patient groups. Prior to being used in clinical practice outside the UK and/or as 
an outcome measure in international research, cross-cultural validation is 
essential to identify important differences in language and cultural practices 
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(53). The clinical field-testing of the LIBSS-PRO was restricted to secondary 
and tertiary health care settings. Research is required to validate its use in 
primary health care settings. The qualitative research with parents identified 
reduced knowledge of bronchiolitis, symptom recognition and when to 
appropriately seek help from HCPs. A future planned project will try to address 
this knowledge deficit. Parents will be consulted to identify the most effective 
methods to raise awareness and access health information. This will culminate 
with the development of an application for a phone or tablet for use by both 
parents and HCPs which will contain links to NICE bronchiolitis guidelines, 
parent information and video capture of infants displaying different bronchiolitis 
signs and symptoms.  
Finally, a heterogeneous group of PEW scoring instruments are commonly 
used within clinical practice. The premise of these instruments is to help 
identify the deteriorating child, with any medical or surgical condition (including 
bronchiolitis), in order to respond quickly and escalate treatment to improve 
outcomes. It is therefore questionable as to whether the LIBSS-PRO is 
required in clinical practice if a generic instrument is available. Furthermore, it 
would become burdensome for HCPs if the LIBSS-PRO was introduced into 
clinical practice alongside the PEW scores. This is due to overlap and 
duplication of certain items and domains contained within both instruments. 
However, none of these PEW scoring instruments appear to have been 
rigorously developed and validated across diverse acute patient population 
groups. Hence, a single universal PEW score has not been implemented 
nationwide across the NHS. Moreover, a number of issues have been 
identified with the use of PEW scores through local audits. Firstly, a large 
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proportion of hospitalised children still have unplanned admissions to critical 
care and do not always ‘trigger the PEW’. This highlights either a HCP training 
need with the use of the PEW or the PEW is not sensitive enough to identify all 
deteriorating children. Secondly, particular groups of children will constantly 
trigger the PEW thresholds. For example, in children with cyanotic heart 
lesions accepted oxygen saturation thresholds are considerably lower than 
PEW oxygen saturation thresholds. This is due to PEW thresholds being 
based on data which comes from otherwise healthy children. This supports the 
argument for the need of sensitive, disease specific measurement instruments. 
Hospitals are starting to move more towards electronic patient documentation. 
A third way forward could be to have a standard electronic PEW where a 
disease specific component, such as bronchiolitis, could be activated as 
required. Further research is needed to help decide what would be the best 
way forward with regards to clinical severity score use. In particular, research 
is required in infants with bronchiolitis to evaluate the sensitivity of the LIBSS-
PRO in comparison to a PEW scoring instrument to detect clinical deterioration 
and/or improvement. 
In conclusion the LIBSS-PRO has been developed and validated as a 
standardised outcome measure to assess severity of illness for infants with 
bronchiolitis. Current Government policies focus on improving safety and 
outcomes for patients with the recognition of clinical deterioration of a child 
being a key safety indicator (142, 143). Incorporating the LIBSS-PRO into an 
evidence based care pathway might aid prompt detection of those infants at 
risk of developing severe bronchiolitis leading to early intervention, reducing 
harm and improving patient outcomes. Furthermore, a standardised measure 
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of bronchiolitis severity may reduce variation in clinical practice and has 
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Appendix 1: Summary of properties of published scoring instruments 
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Appendix 2: Search strategy 
#1 expBRONCHIOLITIS/ OR bronchiolitis.ti,ab OR exp RESPIRATORY SYNCYTIAL VIRUS INFECTIONS/ OR exp RESPIRATORY 
SYNCYTIAL VIRUS, HUMAN/ OR exp RESPIRATORY SYNCYTIAL VIRUSES/ OR (respiratory adj3 syncytial adj3 virus).ti,ab OR 
rsv.ti,ab OR exp RESPIRATORY TRACT INFECTIONS/ OR (respiratory adj3 tract adj3 infection*).ti,ab OR (lower adj3 respiratory 
adj3 tract adj3 infection*).ti,ab OR exp METAPNEUMOVIRUS/ OR (human adj3 metapneumovirus).ti,ab OR exp ADENOVIRUS 
INFECTIONS, HUMAN/ OR adenovirus.ti,ab 
#2 exp CHILD, PRESCHOOL/ OR exp INFANT/ OR infant*.ti,ab 
#3 exp HEART DEFECTS, CONGENITAL/ or ((heart OR coronary OR cardiac) adj2 (defect* OR disease* OR disorder* OR abnormalit* 
OR congenital)).ti,ab OR exp INFANT, EXTREMELY LOW BIRTH WEIGHT/ OR exp INFANT, EXTREMELY PREMATURE/ OR exp 
INFANT, LOW BIRTH WEIGHT/ OR exp INFANT, NEWBORN/ OR exp INFANT, PREMATURE/ OR exp INFANT, PREMATURE, 
DISEASES/ OR exp INFANT, SMALL FOR GESTATIONAL AGE/ OR exp INFANT, VERY LOW BIRTH WEIGHT/ OR (premature 
adj3 infant).ti,ab OR exp BRONCHOPULMONARY DYSPLASIA/ OR(bronchopulmonary AND dysplasia).ti,ab OR chronic adj3 lung 
adj3 disease OR (chronic adj3 lung adj3 disease*).ti,ab OR exp SMOKING/ OR exp TOBACCO SMOKE POLLUTION/ OR 
smoking.ti,ab OR exp AIR POLLUTION/ OR exp AIR POLLUTION, INDOOR/ OR Medline exp BREAST FEEDING/ OR (breast adj3 
f?ed*).ti,ab OR exp MULTIPLE BIRTH OFFSPRING/ OR exp SIBLING RELATIONS/ OR exp SIBLINGS/ OR sibling*.ti,ab OR exp 
ETHNIC GROUPS/ OR (ethnic adj3 group*).ti,ab OR ethnicity.ti,ab OR exp NURSERIES/ OR nurser*.ti,ab OR exp CHILD CARE/ OR 
exp CHILD DAY CARE CENTERS/ OR (child adj3 care adj3 cent*).ti,ab OR exp DOWN SYNDROME/ OR (down's adj3 
syndrome).ti,ab OR (trisomy adj3 21).ti,ab OR (neuromuscular adj3 disorder*).ti,ab OR exp ASTHMA/ OR asthma.ti,ab OR exp 
ECZEMA/ OR eczema.ti,ab OR atopy.ti,ab OR  
#4 #1 AND #2 AND #3 
Title (ti); abstract (ab) 
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Appendix 3: Signs and symptoms of bronchiolitis extracted from the 
literature (including existing published or unpublished clinical scoring 
instruments) 
No. Sign or Symptoms References 
1. Abnormal chest radiograph 
findings 
Norwood (2010); SIGN (2006); Wilson (2000); Lukić-Grlić (1999) 
2. Abnormal cry Hewson (1990); 
3. Accessory respiratory muscles Daugbjerg (1993); Dobson (1998); Roosevelt (1996); Schuh (1990); van Woensel (1997); Tal (1983); Bierman (1974); Wood (1972); 
4. Age Walsh (2006); Marlais (2011); Wood (1972); 
5. Agitated Lui (2004); Wood (1972); 
6. Air entry Gadomski (1994a); Gadomski (1994b); 
7. Air hunger Gadomski (1994a); Gadomski (1994b); 
8. Airway obstruction  Simon (2006); AAP (2006) 
9. Anxious Gadomski (1994a); 
10. Apathetic Gadomski (1994a); 
11. Apnoea Papenberg  (2012); Simon (2006);  SIGN (2006); AAP (2006); Wilson (2000); Marlais (2011); Durani (2008); Lukić-Grlić (1999); Al-
Sonboli (2006); Hewson (1990); 
12. Asleep Dobson (1998);  
13. Auscultatory  breath sounds  Kristjansson (1993); Wilson (2000); 
14. Blood in stools Hewson (1990); 
15. Blood gases SIGN (2006); Wilson (2000); 
16. Blood gases (PCO2) Marlais (2011); 
17. Blood gases (pH) Marlais (2011); 
18. Blood gases (HCO3) Marlais (2011); 
19. Blue lips Al-Sonboli (2006); 
20. Calm Dobson (1998) 
21. Cannot be comforted Gadomski (1994a); 
22. Cervical adenopathy Durani (2008); 
23. Chest indrawing Gadomski (1994b); Al-Sonboli (2006); 
24. Clingyness Jacobs (1999); 
25. Conjunctivitis von Linstow (2008); Chan (2006); Durani (2008); Chan (2007); 
26. Cold peripheries Hewson (1990); 
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27. Content Dobson (1998); Gadomski (1994a);  
28. Congested pharynx Chan (2007); 
29. Convulsions Papenberg  (2012); Meury (2004); Gombojav (2009); Hewson (1990); 
30. Coryza Durani (2008); 
31. Cough Marguet (2009); Norwood (2010); von Linstow (2008); Papenberg  (2012); SIGN (2006); AAP (2006) Jacobs (1999); Chan (2006); Khuri-
Burlos (2010); Marlais (2011); Meury (2004); Durani (2008); Al-Sonboli (2006); Hewson (1990); Chan (2007);  
32. Crackles Dobson (1998); Al-Sonboli (2006); 
33. Cranky Jacobs (1999); 
34. Crepitations SIGN (2006); Goh (1997); Chan (2006); Chan (2007); 
35. Crying Gadomski (1994a); 
36. Crying more than usual Jacobs (1999); Hewson (1990); 
37. Cyanosis SIGN (2006); Can (1998); Kristjansson (1993); van Woensel (1997); Wilson (2000); Tal (1983); Wood (1972); Al-Sonboli (2006); 
Gombojav (2009); Hewson (1990); 
38. Cyanosis (circumoral on 
crying) 
Tal (1983); 
39. Cyanosis (circumoral at rest) Tal (1983); 
40. Cyanosis (generalised) Tal (1983); 
41. Decreased activity Durani (2008); Hewson (1990); 
42. Decreased sleeping Hewson (1990); 
43. Decreased vocalisations Lui (2004); 
44. Dehydration Walsh (2006); Marlais (2011); 
45. Diarrhoea von Linstow (2008); Papenberg  (2012); Chan (2006); Marlais (2011); Meury (2004); Hewson (1990); Chan (2007); 
46. Difficulty breathing Durani (2008); Gombojav (2009); Hewson (1990); Khuri-Bulos (2010); 
47. Difficulty feeding Lui (2004); 
48. Difficult to console Dobson (1998); 
49. Difficulty waking Al-Sonboli (2006); 
50. Drowsy SIGN (2006); Marlais (2011); Hewson (1990); 
51. Duration of illness/symptoms von Linstow (2008); Papenberg  (2012); Gilca (2006); Khuri-Burlos (2010); Marlais (2011); 
52. Dyspnoea Marguet (2009); SIGN (2006); Lui (2004); Wilson (2000); Meury (2004); Lukić-Grlić (1999) 
53. Dyspnoea (rest) Wilson (2000); 
54. Dyspnoea (exertion) Wilson (2000); 
55. Earache Khuri-Bulos (2010); 
56. Ear problem Gombojav (2009); 
57. Extremely irritable  Gadomski (1994a); 
58. Eye problem Gombojav (2009); 
59. Febrile Lukić-Grlić (1999) 
60. Feeding difficulties SIGN (2006) 
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61. Feels hot Hewson (1990); 
62. Feels unwell Jacobs (1999); 
63. Fever von Linstow (2008); SIGN (2006); Jacobs (1999); Khuri-Burlos (2010); Durani (2008); Al-Sonboli (2006); Gombojav (2009);  
64. Fever/chills Papenberg  (2012) 
65. Fine inspiratory crackles SIGN (2006) 
66. Flaring Goebel (2000); 
67. Floppy Gombojav (2009); 
68. Full blood count Wilson (2000); 
69. Fussy Jacobs (1999); 
70. General condition/appearance Cengizlier (1997); Dobson (1998) Gadomski (1994a); Gadomski (1994b); 
71. Glascow Coma Score Marlais (2011); 
72. Grunting SIGN (2006); AAP (2006); Gadomski (1994a); Gadomski (1994b); Wilson (2000); Marlais (2011); Durani (2008); 
73. Grunting (intermittent) Gadomski (1994a); 
74. Grunting (audible and 
persistent) 
Gadomski (1994a); 
75. Haemoptysis Wilson (2000); 
76. Happy Dobson (1998); Gadomski (1994a); 
77. Headache Jacobs (1999); 
78. Heart rate Cade (2000); Walsh (2006); Marlais (2011) 
79. Hepatomegaly Al-Sonboli (2006); 
80. Hoarseness von Linstow (2008) 
81. Hoarse voice Papenberg  (2012) 
82. Hypoxia (O2 saturations <94%) Calvo (2008) 
83. Hyperactivity Lui (2004); 
84. Hypoxaemia Simon (2006)  
85. Ill at ease Gadomski (1994a); 
86. Increased coughing after play Lui (2004); 
87. Increased respiratory effort AAP (2006) 
88. Increased sleep Hewson (1990); 
89. Increased work of breathing Papenberg  (2012); SIGN (2006); Marlais (2011); 
90. Intravenous infusion Goh (1997); Richter (1998); 
91. Interactive Dobson (1998); Gadomski (1994a); 
92. Intercostal 
recession/retraction/in-drawing 
SIGN (2006); AAP (2006) Can (1998); Dobson (1998); Gadomski (1994a); Gadomski (1994b); Lui (2004); Lowell (1987); Richter (1998); 
Schuh (1990a); Wang (1992); Wilson (2000); 
93. Intermittent crying  Gadomski (1994); 
94. Irritable SIGN (2006); Cengizlier (1997); Jacobs (1999); Wang (1992); Wilson (2000); Gombojav (2009); Hewson (1990); 
95. Jaundice Hewson (1990); 
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96. Laboratory tests Norwood (2010) 
97. Length of hospital stay Calvo (2008) 
98. Less interactive Dobson (1998); Gadomski (1994a); 
99. Less urine Hewson (1990); 
100. Lethargy Papenberg (2012); SIGN (2006); Cengizlier (1997);  Gadomski (1994a); Wang (1992); Wilson (2000); Gombojav (2009); 
101. Loss of appetite von Linstow (2008); Papenberg  (2012) 
102. Low energy Jacobs (1999); 
103. Malaise von Linstow (2008) 
104. Mechanical ventilation Evarard (2001); Khuri-Burlos (2010); 
105. Mildly irritated when touched Dobson (1998); Gadomski (1994a); 
106. Moderately irritable Dobson (1998); Gadomski (1994a); 
107. Mottled SIGN (2006) 
108. Mucous plugging AAP (2006) 
109. Muscle aches/pains Jacobs (1999); 
110. Nasal congestion/runny nose Jacobs (1999); Chan (2006); Khuri-Burlos (2010); Hewson (1990); Chan (2007);  
111. Nasal discharge von Linstow (2008); SIGN (2006); AAP (2006); Lukić-Grlić (1999); Gombojav (2009); 
112. Nasogastric tube feeds Richter (1998); 
113. Nasal flare AAP (2006); Can (1998); Gadomski (1994a); Gadomski (1994b); Richter (1998); Schuh (1990a); Wilson (2000); Durani (2008); 
114. Nasal flow Wang (1992); 
115. Nebulisation Goh (1997); 
116. Needing extra care Jacobs (1999); 
117. Neurology  Wilson (2000); 
118. Noisy breathing Gombojav (2009); Hewson (1990); 
119. No symptoms Everard (2001); 
120.  Normal activity Lui (2004); 
121. Normal play Lui (2004); 
122. Normal vocalisations Lui (2004); 
123. Not themselves Hewson (1990); 
124. Not interactive Gadomski (1994a); 
125. Not interested in what’s going 
on 
Jacobs (1999); 
126. Not playing well Jacobs (1999); 
127. Not sleeping well Jacobs (1999); 
128. Not quiet Gombojav (2009); 
129. Obtunded Wilson (2000); 
130. Occasional crying but 
consolable 
Dobson (1998); Gadomski (1994a); 
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131. Oral intake Norwood (2010) 
132. Otitis media Papenberg  (2012); Khuri-Burlos (2010); Meury (2004); Durani (2008); Lukić-Grlić (1999); 
133. Oxygen duration Khuri-Burlos (2010); 
134. Oxygen saturations Norwood (2010); SIGN (2006); De Boeck (1997); Goebel (2000); Richter (1998); Wilson (2000); Dayan (2006); Marlais (2011); Wood 
(1972); Al-Sonboli (2006); 
135. Pale SIGN (2006) 
136. Pallor Kristjansson (1993); Hewson (1990); 
137. Pharyngitis Meury (2004); Durani (2008); Lukić-Grlić (1999) 
138. Phlegm Gombojav (2009); 
139. PICU admission Gilca (2006); 
140. Poor feeding/appetite Cengizlier (1997); Jacobs (1999); Wang (1992); Wilson (2000); Khuri-Burlos (2010); Marlais (2011); Meury (2004); Durani (2008); 
Gombojav (2009); Hewson (1990);  
141. Poor feeding due to 
tachypnoea 
Wilson (2000); 
142. Post-tussive emesis Khuri-Burlos (2010);  
143. Prolonged expiration Daugbjerg (1993); 
144. Rales  Papenberg  (2012); Kristjansson (1993); Wilson (2000); Durani (2008); Lukić-Grlić (1999) 
145. Rales (<50% or <3 lobes)  Wilson (2000); 
146. Rales (50% or >3 lobes) Wilson (2000); 
147. Rash von Linstow (2008); Chan (2006); Durani (2008); Al-Sonboli (2006); Gombojav (2009); Hewson (1990); Chan (2007); 
148. Recession SIGN (2006); Kristjansson (1993); Richter (1998); Gombojav (2009); 
149. Recurrent wheeze  Calvo (2008) 
150. Resists comforting Gadomski (1994a); 
151. Respiratory rate Norwood (2010); SIGN (2006); AAP (2006); Bertrand (2001); Cade (2000); Can (1998); Kristjansson (1993); Can (1998); Cengizlier 
(1997); Goebel (2000); Goh (1997); Kristjansson (1993); Lui (2004); Richter (1998); van Woensel (1997); Wang (1992); Wilson (2000); 
Tal (1983); Bierman (1974); Dayan (2006); Marlais (2011); Al-Sonboli (2006); Gombojav (2009); 
152. Respiratory distress SIGN (2006); AAP (2006) 
153. Retraction Norwood (2010); Bertrand (2001); Cade (2000); Cengizlier (1997); Dobson (1998); Goebel (2000); Lui (2004); Lowell (1987); Wang 
(1992); Wilson (2000); Walsh (2006); Durani (2008); 
154. Rhinitis Marguet (2009) 
155. Rhinorrhea Papenberg  (2012); SIGN (2006); AAP (2006); Meury (2004); Durani (2008); 
156. Rhonchi Kristjansson (1993); Lukić-Grlić (1999) 
157. Seizures Simon (2006); Chan (2006); Chan (2007); 
158. Serum CRP  SIGN (2006) 
159. Skin colour Kristjansson (1993); 
160. Sleeping problem Gombojav (2009); 
161. Sore throat Papenberg  (2012); Jacobs (1999); Khuri-Burlos (2010);  
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162 Sputum/secretions (white, thin, 
yellow, mucoid) 
Wilson (2000); 
163. Sputum/secretions (blood 
tinged/purulent/frothy) 
Wilson (2000); 
164. Sternal retractions AAP (2006) 
165. Sternoclidomastoid muscles Wilson (2000); 
166. Stridor Durani (2008); 
167. Subcostal recession/retraction SIGN (2006); AAP (2006); Can (1998); Dobson (1998); Goh (1997);  Lui (2004); Lowell (1987); Wilson (2000); 
168. Supplemental oxygen 
requirement 
Norwood (2010); Bertrand (2001); Cade (2000); Goh (1997); Lowell (1987); Richter (1998); Gilca (2006); Khuri-Burlos (2010); Marlais 
(2011); Meury (2004); 
169. Supraclavicular 
recession/retraction 
SIGN (2006); Can (1998); Dobson (1998); Gadomski (1994a); Gadomski (1994b); Lui (2004); 
170. Substernal recession  Wilson (2000); 
171. Sweating Hewson (1990); 
172. Tachycardic SIGN (2006) 
173. Tachypnoea von Linstow (2008); Simon (2006); AAP (2006); Al-Sonboli (2006); 
174. Temperature Wilson (2000); Khuri-Burlos (2010); Marlais (2011); Al-Sonboli (2006); 
175. Temperature >38°C Calvo (2008); Ricart (2013);  Meury (2004); 
176. Temperature >39°C Meury (2004); 
177. Tired Jacobs (1999); 
178. “Toxic” appearance SIGN (2006); Dayan (2006); 
179. Tracheosternal retractions Richter (1998); Schuh (1990a); Wang (1992); 
180. Trouble breathing Khuri-Burlos (2010); 
181. Unable to control secretions Wilson (2000); 
182. Unable to get out of bed Jacobs (1999); 
183. Unresponsive Wilson (2000); Wood (1972); 
184. Vomiting von Linstow (2008); Papenberg  (2012); Jacobs (1999); Wilson (2000); Chan (2006); Marlais (2011); Meury (2004); Gombojav (2009); 
Hewson (1990); Chan (2007); 
185. Vomiting (persistent) Wilson (2000); 
186. Vomiting (bilious) Wilson (2000); Hewson (1990); 
187. Weight at presentation Marlais (2011); 
188. Wheeze Marguet (2009); Norwood (2010); von Linstow (2008); Papenberg  (2012); SIGN (2006); AAP (2006); Bertrand (2001); Can (1998); 
Cengizlier (1997); Daugbjerg (1993); Dobson (1998); Gadomski (1994a); Gadomski (1994b); Goebel (2000); Goh (1997); Kristjansson 
(1993); Lui (2004); Richter (1998); Schuh (1990a); van Woensel (1997); Wang (1992); Wilson (2000); Tal (1983); Bierman (1974); Chan 
(2006); Khuri-Burlos (2010); Khuri-Burlos (2010); Durani (2008); Lukić-Grlić (1999); Al-Sonboli (2006); Al-Sonboli (2006); Chan (2007); 
189. Wheeze (audible without 
stethoscope) 
Gadomski (1994a); Goebel (2000); Lowell (1987); Schuh (1990a); Wang (1992); Wang (1992); Tal (1983); Marlais (2011); 
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190. Wheezing on auscultation Papenberg  (2012); Bertrand (2001); Can (1998); Cengizlier (1997); Goebel (2000); Wang (1992); Tal (1983); Bierman (1974); 
191. Wheezing (expiratory) Can (1998); Cengizlier (1997); Dobson (1998); Gadomski (1994a); Goebel (2000); Lui (2004); Lowell (1987); Schuh (1990a); Tal (1983); 
Bierman (1974); Wood (1972); 
192. Wheeze (duration) Gadomski (1994a);  
193. Wheeze (inspiratory) Can (1998); Cengizlier (1997); Dobson (1998); Gadomski (1994a); Lowell (1987); Schuh (1990a); Wang (1992); Tal (1983); Bierman 
(1974);  
194. Wheeze location (segmental<2 
of 4 lung fields) 
Gadomski (1994a); Lowell (1987); 
195. Wheeze location (Diffuse >3 of 
4 lung fields) 
Gadomski (1994a); Lowell (1987); 






Appendix 4: Atopy 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 












Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 
> 37 weeks 
gestation 
0-12 months 























































Appendix 5: Chronic lung disease (including prematurity and cystic 
fibrosis) 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 
< 5 years Hospital admission OR: 3.12 [2.19-
3.78] 




<3 years Hospital admission IRR: 10.7 [8.4-13.6] 
Carbonell-Estrany 
et al (2000)  
Spain Prospective cohort n= 680 Ex preterm infants 
born <32weeks 
0-12 months 
Hospital admission  OR: 5 3.1 [1.22-
7.91]; P < 0.016 
Eriksson et al 
(2002) 
Sweden Cohort  n=1503 RSV Hospital admission OR: 2.83 [1.08-
7.42] 









































Liese et al (2003) Germany Cohort  n=717 Ex preterm < 35 
weeks gestation 
RSV 
Hospital admission OR: 3.99  [1.4-
11.2]; p=0.009 
Murray et al (2014) UK Prospective cohort n= 296618 0-12 months Hospital admission CLD Prematurity 
RR: 1.6 [1.4-1.8] 
 
CF 
RR = 2.5 [1.4-4.4] 




n=269 0-24 months Hospital admission OR: 2.2 [1.0-5.1]; 
p=0.06 
Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407 Ex-preterm 





Hospital admission IRR: 1.70 [0.68 -
4.28] p=0.26 





OR: 7.2; [1.2–43.3]; 
P =0.031 
Rietveld et al (2006) Netherlands Retrospective 
cohort  
n=2469 0-24 months Hospital admission OR: 2.2 [not 
reported] 











OR: 4.53 [2.19 to 
8.92] p=0.0001 
 






Appendix 6: Congenital heart disease 
 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 
< 5 years Hospital admission OR: 1.11 [0.85-
1.95] 
Boyce et al (2000) USA Retrospective 
cohort study 
n=3553  <3 years Hospital admission IRR: 2.8 [2.3-3.3] 
Cilla et al (2006) Spain Retrospective study n=357 <2 years Supplemental 
oxygen  
OR: 12.77 (3.89 to 
41.89) 


























OR: 2.77 [1.89 to 
4.05] 
Hervas et al (2012) Spain Retrospective 
cohort 












OR: 3.08 [1.14–8.3] 
p<0.0001 









Kristensen et al 
(2009) 
































UK Prospective cohort N= 296618 0-12 months Hospital admission RR: 3.4 [2.9–3.8] 
Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
 
7.58 [2.44 -23.50] 





4.7 [1.1 to 19.9] 







OR: 2.97 [1.81 to 
4.82] p<0.001 
 
OR: 3.69 [0.36 to 
20.92] p=0.27 
Thornburn et al 
(2009) 





Appendix 7: Day Care attendance 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Law et al (2004) Canada Prospective cohort n=1832 Pre-term infants 33-












0-12 months Hospital admission OR: 0.53 [0.15–
1.95] 
Figueras-Aloy et al 







Hospital admission OR: 1.25 [0.67 to 
2.34] 
Rossi et al (2007)
  
Italy Case control  Cases: n=145 
Controls: n=292 
<4 years  
RSV 




Appendix 8: Down’s syndrome 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Bloemers et al 
(2007) 





Cases: n= 241 
Controls:n=276 
0-24 months RSV hospital 
admission 
Without CHD 
OR: 12.6 [2.9-54.5] 
 
With CHD 
OR: 10.5 [2.2-49.5] 




<2 years Oxygen 
requirement  
 






Kristensen et al 
(2009) 





Hospital admission  OR: 3.24 [1.80-
5.80] 










Murray et al (2014) UK Prospective cohort n= 296618 0-12 months Hospital admission RR 2.5 [1.7–3.7] 
241 
 
Appendix 9: Air pollution 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 


















 increase in  
particulate matter 
Lagged 1-2 days 
OR: 0.96 [0.94-0.99 
Lagged 3-5 days 
OR:0.98 [0.96-1.0] 
Lagged 6-8 days 
OR: 0.96 0.93-0.98] 









Lives within 150m 






Appendix 10: Ethnicity 
Reference Location Design Number of 
Participants 
Age Outcome(s) Results 
[95% Confidence 
Intervals] 







Hospital admission Full Inuit Race 
OR: 3.77 [1.12-
12.75] 
Boyce et al (2000) USA Retrospective 
cohort study 
n=3553  <3 years Hospital admission White race 
IRR: 1.3 [1.2-1.4] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 



































































































Grimwood et al 
(2008) 
New Zealand Retrospective 
cohort 










Mansbach et al USA Cohort m/d 0-24 months Hospital admission Hispanic 
244 
 
(2005) OR: 2.3 [1.1-5.0] 
Black 
OR: 1.6 [0.9-3.2] 
Other 
OR: 0.3 [0.03-3.4] 
Norwood et al 
(2010)  
USA Prospective cohort n=722 0-24 months Unscheduled ED 
visit 
African American 
OR: 0.6 [0.4-1.1] 
Hispanic 
OR: 1.3 [0.8-2.1] 
Other 
OR: 1.02 [0.4-2.7] 
245 
 
Appendix 11: Gender 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results  
[95% Confidence 
Intervals]  




<3 years Hospital admission Male 
IRR: 1.3 [1.2 to 1.4] 
Bockova et al 
(2002) 
USA Prospective cohort n=1837 Navajo and White 
Mountain 
Apache Children 
0-24 months  
Hospital admission Male 
OR: 1.2 [0.6–2.2] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 








Cilla et al (2006) Spain Retrospective study n=357 0-24 months Hospital admission Male 
OR: 1.07 [0.86–
1.32] 
Doering et al (2006) Germany Prospective cohort n=1158 Ex preterm infants 
of 29–35 weeks 
 
Hospital admission Male 
OR: 2.8 [1.6 - 5.5] 
Gavin et al (2007) USA Retrospective 
cohort 
n=2098 Ex pre-term infants 
born 32 to 35 weeks 
of gestation 
0-12 months 
Hospital admission  Male 
OR: 1.07 (0.70 to 
1.64) 




<2 years Supplemental 
oxygen  
 
OR: 0.80 [0.71 to 
0.91 
 
Hervas et al (2012) Spain Retrospective 
cohort 
n= 2889 0-24 months Hospital admission Male 
OR: 0.68 [0.51 to 
0.91] 









Kristensen et al 
(2009) 





Hospital admission  Male 
OR: 1.14 [0.81-
1.59] 
Law et al (2004) Canada Prospective cohort n=1832 Pre-term infants 33-








Liese et al (2003) Germany Cohort  n=717 Ex preterm < 35 
weeks gestation 
RSV 
Hospital admission Male  
OR: 8.7 [2.6-29.1]; 
p<0.001 
Mansbach et al 
(2005) 
USA Cohort m/d 0-24 months Hospital admission Male 
OR: 1.2 [0.7-2.3] 
Norwood et al 
(2010)  
 
USA Prospective cohort n=722  0-24 months Unscheduled ED 
visit 
Male 
OR: 1.7 [1.1-2.5] 
Paranjothy et al 
(2013) 
UK Cohort n=318 613 Ex-preterm 
infants born <36 
weeks gestational 
age 
Hospital admission Female 
HR: 0.77 [0.75–
0.80] 




n=269 0-24 months Hospital admission Male 
OR: 1.4 [0.7-2.6] 
Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
Male 
5.54 [4.48 -6.85] 
Rietveld et al (2006) Netherlands Retrospective 
cohort 
n=2469 0-12 months Hospital admission Male 
OR: 1.4 1.3–1.5 
Thorburn et al 
(2009) 
UK Prospective cohort n=406  RSV Death Male 




Appendix 12: Immunodeficiency 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 





Appendix 13: Infection (viral and/or bacterial) 
Reference Location Design Number of 
Participants 
Age Outcome(s) Results 
[95% Confidence 
Intervals] 
Calvo et al (2008) Spain Prospective cohort n= 749 RSV 










RSV vs RSV + co-
infection 
 
OR: 1.12 [1.0-1.23] 
 
 
OR: OR: 2.90 [1.45- 
5.94] 






























Marguet et al (2009) France Prospective cohort n=209 0-12 months Hospital duration >5 
days 










RSV vs hMPV 
OR: 0.09 [0.01-
0.69] 
Papenberg et al 
(2012) 
Canada Prospective cohort n=>1000 0-36 months  




















0-24 months Mechanical 
ventilation 
RSV & hMPV  
RR: 10.99 [5.0–
24.12]; P < .001 
Thorburn et al 
(2006) 
UK Prospective cohort n=165 0-12 months Death Bacterial co-
infection 
OR:1.3 [0.57-2.95] 
Thorburn et al 
(2009) 
UK Prospective cohort n=406  RSV PICU Admission Bacterial co-
infection 





Appendix 14: Low birth weight 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 




























 OR: 0.71 [0.57-
0.89] 
Gavin et al (2007) USA Retrospective 
cohort 
n=2098 Ex pre-term infants 
born 32 to 35 weeks 
of gestation 
0-12 months 
























Controls: 5 matched 















Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
<1000g 
9.26 [5.58 -15.36] 
1000-2000 
6.58 [5.11 -8.48] 
>2000 
3.37 [2.63 -4.32] 
 
Rossi et al (2007)
  
Italy Case control Cases: n=145 
Controls: n=292 
<4 years  
RSV  







Rietveld et al (2006) Netherlands Retrospective n=2469 0-12 months Hospital admission <2.5kg 
252 
 
cohort  OR: 3.2 [2.1–4.8] 
 
2.5–3.0kg 
OR: 1.3 [1.1–1.4] 




















Birth weight <1500 
g 
 
OR: 3.73 [2.28 to 
5.96] 
 






Appendix 15: Month/ season of birth 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 









Gavin et al (2007) USA Retrospective 
cohort 
n=2098 Ex pre-term infants 
born 32 to 35 weeks 
of gestation 
Hospital admission Born within 6 








Grimwood et al 
(2008) 
New Zealand Retrospective 
cohort 





Law et al (2004) Canada Prospective cohort n=1832 Pre-term infants 33-










von Linstow et al 
(2008) 














Mansbach et al 
(2005) 
USA Cohort m/d 0-24 months Hospital admission Jan-March 
OR: 0.5 [0.2-1.6] 
April-June 
OR: 0.5 [0.1-1.6] 
October-December 
OR: 0.7 [0.2-2.1] 
Paranjothy et al 
(2013) 
UK Cohort n=318 613 Ex-preterm 
infants born <36 
weeks gestational 
age 












Appendix 16: Neuromuscular disorders 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 




<2 years Oxygen 
requirement 
 
PICU Requirement  
 





















Spina bifida and 
malformations of 
















Murray et al (2014) UK Prospective cohort n= 296618 0-12 months Hospital admission cerebral palsy  
256 
 





RR: 1.7 [1.3-2.4] 
257 
 
Appendix 17: Breastfed infants 
Reference Location Design Number of 
Participants 
Age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 






Non-breast fed  
OR: 2.51 [2.11-
3.73] 







Hospital admission Non-breast fed 
OR: 3.64 [1.16, 
11.46] 







Hospital admission Ever been breastfed 
more than half of 
feedings (infants 
aged <6 months)  
 
OR: 0.33; P =0.001 
Dornelles et al 
(2007) 
Brazil Prospective cohort n=175 0-6 months Length of oxygen 
use 
 
For each month of 
exclusive 
breastfeeding 
infants had an 11 











0-12 months Hospital admission Breast fed <2 
versus >2 months 
OR: 3.26 [1.96 to 
5.42] 
Figueras-Aloy et al Spain Prospective case- Cases: n=202 0-12 months RSV Hospital Breast fed <2 
258 
 
(2008)  control  
 
Controls: n=5239 admission versus >2 months 
OR: 1.24 [0.89 to 
1.72] 





n=1588 0-12 months Hospital admission Breast feeding 
initiation at hospital 
HRR1.33 [1.14–
1.54] 
von Linstow et al 
(2008) 
Denmark Prospective cohort n=217 0-12 months Hospital admission Exclusive breast 
feeding for first 14 
days of life  
OR 0.21 [0.06-0.79] 
Nishimura et al 
(2009) 
Japan Prospective cohort n=203 <4 months Hospital admission 
Oxygen therapy 
Not significant 
Full breast fed 
OR: 0.25 [0.07-
0.89] 
Partial breast fed 
OR: 0.61 [0.20-
1.87] 
Paranjothy et al 
(2013) 
UK Cohort n=318 613 Ex-preterm 
infants born <36 
weeks gestational 
age 
Hospital admission HR: 0.89 [0.88–
0.91] 
Papenberg et al 
(2012) 
Canada Prospective cohort n=>1000 0-36 months Hospital vs clinic OR: 0.55 [0.33–
0.92] 
Rossi et al (2007) 
 
Italy Case control Cases: n=145 
Controls: n=292 
<4 years  
RSV  










Appendix 18: Overcrowding 
Reference Location Design Number of 
Participants 
Age Outcome(s) Results 







Hospital admission OR: 2.49 [1.01-
6.14] 









crowding index >2 
(<6 months of age) 
OR: 2.41; P=0.007 






0-12 months Hospital admission OR: 1.79 [1.18–
2.72] 
Figueras-Aloy et al 







Hospital admission > 4 adult residents 
OR: 1.37 [0.85 to 
2.20] 
Law et al (2004) Canada Prospective cohort n=1832 Pre-term infants 33-









Appendix 19: Parental age 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 



















>35 years  
OR: 0.91 [0.69-
1.20]  











Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
<32 years 
5.00 [3.94 -6.34] 
>32 years  
4.44 [3.51 -5.63] 
Paranjothy et al UK Cohort n=318 613 Ex-preterm Hospital admission <20 years 
261 
 














Appendix 20: Parent education 
Reference Location Design Number of 
Participants 
Age Outcome(s) Results 
[95% Confidence 
Intervals] 




<3 years Hospital admission Maternal education 
<12 years 
IRR: 1.2 [1.1-1.3] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 


































Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
<8 years 
6.10 [4.90 -7.59] 
>8 years 




Appendix 21: Prematurity 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results [95% 
Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 
< 5 years Hospital admission OR: 3.44 [2.27-
4.33] 
Bockova et al 
(2002) 
USA Prospective cohort n=1837 Navajo and White 
Mountain 
Apache Children 
0-24 months  
Hospital admission <36 weeks 
gestation OR: 1.8 
[0.7–5.1] 




<3 years Hospital admission Gestational age in 
weeks 
≤28   
OR: 2.4 [1.8 to 3.3] 
 
29 to <33  
OR: 2.2 [1.8-2.7] 
 
33 to <36  
OR: 1.8 [1.6-2.1] 
Carbonell-Estrany 
et al (2000) 
Spain  Prospective cohort n=680 0-12 months 
RSV 





Hospital admission Increasing 
gestational age 
OR: 0.85 [0.72 to 
0.99]; P<0.047 
Carbonell-Estrany 
et al (2001) 







Hospital admission Increasing 
gestational age  
OR: 0.87 [0.77 to 
0.97]; P = 0.019 
264 
 












Cilla et al (2006) Spain Retrospective study n=357 0-24 months Hospital admission <37 weeks 
gestational age  
OR: 1.61 [1.07–
2.42] 


























Grimwood et al 
(2008) 
New Zealand Retrospective 
cohort 
n=141 0-24 months RSV Hospital 
admission 
<37weeks 
gestational age  
OR: 2.29 [1.48–
3.56] 
Hervas et al (2012) Spain Retrospective 
cohort 




PICU admission  
<32 weeks 
gestation age +/- 














Kristensen et al 
(2009) 












gestational age  
OR: 1.03 [0.65 to 
1.64] 
von Linstow et al 
(2008) 
Denmark Prospective cohort n=217 0-12 months Hospital admission <38 weeks 
OR: 2.56 [0.32-
20.57] p=0.38 
Murray et al (2014) UK Prospective cohort N= 296618 0-12 months Hospital admission RR: 1.9 [1.8–2.0] 




Controls: 5 matched 


















Norwood et al 
(2010)   
USA Prospective cohort n=722 0-24 months Unscheduled ED 
visit  
OR: 1.6 [0.8-3.2] 
Papenburg et al 
(2012) 






























Paranjothy et al 
(2013) 
UK Cohort n=318 613 Ex-preterm 
infants born <36 
weeks gestational 
age 











Pezzotti et al (2009) Italy Retrospective 
cohort 
n=2407  Ex-preterm 





Hospital admission Rate per 100 
person years 
<32 weeks 
5.81 [4.15 -8.13] 
 
32-35 weeks  
4.43 [3.65-5.37] 







<37 weeks  
OR: 2.6 [1.3–5.1]; 
P= 0.005 
Rietveld et al (2006) Netherlands Retrospective 
cohort  
n=2469 0-12 months Hospital admission <28 weeks 
gestation 
OR: 3.2 [2.1–4.8] 
 
29–32 weeks  
gestation 










OR: 1.6 [1.3–1.9] 
Rossi et al (2007)
  
Italy Case control Cases: n=145 
Controls: n=292 
<4 years  
RSV  


















need for mechanical 
ventilation (all 
p<0.002). 




















OR: 2.88 [0.53 to 
15.52] 
Thorburn et al 
(2009) 




Appendix 22: Previous RSV/ bronchiolitis episode 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Norwood et al 
(2010)   
USA Prospective cohort n=722 0-24 months Unscheduled ED 
visit 
OR: 1.7 [1.1-2.8] 
Rossi et al (2007)
  
Italy Case control  Cases: n=145 
Controls: n=292 
<4 years  
RSV 




Appendix 23: Siblings 
Reference Location Design Number of 
Participants 




et al (2000)  
Madrid Prospective cohort n= 680 Ex preterm infants 
born <32weeks 
0-12 months 
Hospital admission  OR: 1.86 [1.01-3.4]; 
P < 0.048 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 
> 37 weeks 
gestation 






Gavin et al (2007) USA Retrospective 
cohort 
n=2098 Ex pre-term infants 
born 32 to 35 weeks 
of gestation 
0-12 months 
Hospital admission  OR: 1.98 [1.18–
3.32] 
Grimwood et al 
(2008) 
New Zealand Retrospective 
cohort 
















Figueras-Aloy et al 







Hospital admission OR: 1.96 [1.47 to 
2.60] 
Law et al (2004) 
  
  
Canada Prospective cohort n=1832 Pre-term infants 33-





Liese et al (2003) Germany Cohort  n=717 Ex preterm < 35 
weeks gestation 
RSV 
Hospital admission OR: 3.9 [1.9-8.3]; 
p<0.001 
Papenberg et al 
(2012) 





Rossi et al (2007) Italy Case control  Cases: n=145 
Controls: n=292 
<4 years  
RSV 
Hospital admission >2 children  
OR: 1.83 [1.16-
2.88] 








Appendix 24: Tobacco smoke exposure 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 
< 5 years Hospital admission OR: 2.51 [2.11-
3.73] 









Boyce et al (2000) USA Retrospective 
cohort study 
n=3553  <3 years Hospital admission Maternal smoking 
(IRR: 1.3 [1.2-1.4]) 
Carroll et al (2007) USA Retrospective 
cohort 
n= 101 245 healthy infants 



















Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 














et al (2001) 




Hospital admission Tobacco smoke 
exposure  







Gavin et al (2007) USA Retrospective 
cohort 
n=2098 Ex pre-term infants 
born 32 to 35 weeks 
of gestation 
0-12 months 
Hospital admission  OR: 0.78 [0.38–
1.61] 
Grimwood et al 
(2008) 
New Zealand Retrospective 
cohort 




































Hospital admission Maternal smoking 
(in pregnancy) 
OR: 1.62 [1.17 to 
2.24] 








Law et al (2004) Canada Prospective cohort n=1860 Preterm infants 
born at 33-35 
weeks gestation 
Hospital admission >2 smokers in the 
home  




von Linstow et al 
(2008) 
Denmark Prospective cohort n=217 0-12 months Hospital admission OR: 5.06 [1.36-
18.76] p=0.015 
Paranjothy et al 
(2013) 
UK Cohort n=318 613 Ex-preterm 
infants born <36 
weeks gestational 
age 
Hospital admission HR: 1.04 [1.01–
1.06] 




Hospital admission OR: 0.81 [0.54-
1.12] 











(OR: 2.23 [1.21, 
4.10]) 
 




Appendix 25: Residence (suburban or rural) 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Carroll et al (2008) USA Retrospective 
cohort 
n= 103 670 healthy infants 










Cilla et al (2006) Spain Retrospective study n=357 <2 years Hospital admission Rural-suburban 
OR: 1.33 [1.06-
1.67] 




<3 years Hospital admission Rural residence 
IRR: 1.3 [1.2-1.4] 


















Appendix 26: Young age (less than 12 months) 
Reference Location Design Number of 
Participants 
Population/age Outcome(s) Results 
[95% Confidence 
Intervals] 
Al-Shehri et al 
(2005) 
Saudi Arabia Case control Cases: n=51 
Controls: n=115 
< 5 years Hospital admission < 1 year 
OR: 3.44 [2.27 to 
4.33] 
Bockova et at 
(2002) 
USA Prospective cohort n=1837 Navajo and White 
Mountain 
Apache Children 
0-24 months  
Hospital admission < 6 months 
OR: 6.6 [3.0–14.4] 
Carbonell-Estrany 
et al (2000)  
Madrid Prospective cohort n= 680 Ex preterm infants 
born <32weeks 
0-12 months 
Hospital admission  Increase in 
gestational 
age  
OR: 0.85 [0.72 to 
0.99]; P < 0.047] 
Carbonell-Estrany 
et al (2001) 





< 3 months 
OR: 0.44 [0.25 to 
0.77] 







0-12 months Hospital admission <10 weeks 
3.75 [2.59–5.45] 







0-12 months RSV Hospital 
admission 
<10 weeks 
OR: 2.81 [2.10 to 
3.75] 
Norwood et al 
(2010) 
USA Prospective cohort n=722 0-24 months Unscheduled ED 
visit 
< 2 months 
OR: 2.1 [1.1-4.3] 
Papenburg et al 
(2012) 
Canada Prospective cohort n=>1000 0-36 months Hospital admission 
RSV 
< 6 months 
OR: 2.26 [1.31–
3.89] 














Rossi et al (2007) Italy Case control  Cases: n=145 
Controls: n=292 
<4 years  
RSV 













Thorburn et al  
(2009) 
UK Prospective cohort n=406  RSV Death <6 weeks 















Boy Girl Boy Girl Boy Girl Boy Girl Totals 
Mild <3/12       * * N=2 
>3/12    *     N=1 
Moderate <3/12     *    N=1 
>3/12 * *       N=2 
Severe <3/12   *   *   N=2 
>3/12 * *       N=2 
Totals  N=2 N=2 N=1 N=1 N=1 N=1 N=1 N=1 N=10 
 
Mild: minimal interventions, short admission to hospital 
Moderate: NG feeds / IVI fluids + oxygen via head box / nasal specs 
Severe: none invasive ventilation (ncpap/HFNC) + NG feeds / IVI fluids 
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Appendix 28: HCP group workshop – sample 
frame 
Nursing Staff 
 Hospital 1 Hospital 2 Hospital 3 Hospital 4 
Nurse Band 5 6 7 8 5 6 7 8 5 6 7 8 5 6 7 8 
A&E/ Short 
Stay 
   *     *     *   
Medical 
Wards 
*    *            
Critical Care * *               
 
Medical Staff 

























A&E   *          
Critical 
Care 
  *          
Medical *     *  *     
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       * *  N=2 
>3/1
2 





   *   *   N=2 
>3/1
2 
 *      * * N=3 
Severe <3/1
2 
  * *  *    N=3 
>3/1
2 























Mild – minimal interventions, short admission to hospital 
Moderate – NG feeds / IVI fluids + oxygen via head box / nasal specs 
Severe – none invasive ventilation (nCPAP/HFNC) + NG feeds / IVI fluids 
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13. PaCo2 on 
BGA 




14. HCo3 on 
BGA 























19. Location of 
Wheeze 




20. Duration of 
Wheeze 














23. Head  
Bobbing 















26. Effort of 
Breathing 




27. Air Entry 177/195 (18) 
 




























32. See Saw 
Chest 
Motion 




Hydration and Perfusion 





























































































































54. Responds to 
pain 























57. AVPU scale  174/195 
(21) 













Risk Factors and Miscellaneous Items 





61.  Altered 170/195 (25) 41 (24.1) 93 (54.7) 31 (18.2) 4 (2.4) 0 (0) 1 (0.6) 78.8 (1&2) 2.01 2.0 
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Behaviour (0.78) (5.0) 
 





















































71. Day of 
Illness 


































76. Born second 
half of year 























































85. Low birth 
weight 


















88. Number of 
siblings in 
household 





















92. Bacterial or 
viral co-
infection 








94. Infection with 
RSV 












96. Infection with 
HMPV 

















































































1. Air Hunger 
 
131/136 (6) 41 (31.3) 40 (30.5) 22 (16.8) 12 (9.2) 8 (6.1) 8 (6.1) 61.8 (1&2) 2.46 
(1.47) 
2.0 (5.0) 
2. Nasal Discharge 
 










134/136 (2) 20 (14.9) 56 (41.8) 30 (22.4) 28 (20.9) 0 (0) 0 (0) 56.7 (1&2) 2.49 
(0.98) 
2.0 (3.0) 
5. HCo3 on BGA 
 











134/136 (2) 36 (26.9) 64 (47.8) 17 (12.7) 16 (11.9) 1 (0.7) 0 (0) 74.6 (1&2) 2.11 
(0.96) 
2.0 (4.0) 
8. Location of 
Wheeze 
133/136 (3) 6 (4.4) 36 (26.3) 39 (28.5) 45 (32.8) 11 (8.0)  0 (0) 42.1 (4&5) 3.15 
(1.04) 
3.0 (4.0) 
9. Duration of 
Wheeze 
134/136 (2) 12 (9.0) 43 (32.1) 48 (35.8) 29 (21.6) 2 (1.5) 0 (0) 41.0 (1&2) 2.74 
(0.94) 
3.0 (4.0) 
10. Wheeze Volume 
 
133/136 (3) 10 (7.5) 37 (27.8) 43 (32.3) 34 (25.6) 5 (3.8) 4 (3.0) 35.3 (1&2) 2.99 
(1.12) 
3.0 (5.0) 















132/136 (4) 9 (6.8) 36 (27.3) 45 (34.1) 30 (22.7) 2 (1.5) 10 (7.6) 34.1 (1&2) 3.07 
(1.23) 
3.0 (5.0) 
14. Blowing bubbles 
through mouth 
134/136 (2) 3 (2.2) 23 (17.2) 50 (37.3) 46 (34.3) 9 (6.7) 3 (2.2) 41.0 (4&5) 3.32 
(0.98) 
3.0 (5.0) 




16. Vomiting 133/136 (3) 14 (10.5) 57 (42.9) 38 (28.6) 23 (17.3) 1 (0.8) 0 (0) 53.4 (1&2) 2.54 
(0.92) 
2.0 (4.0) 
17. Diarrhoea 134/136 (2) 1 (0.7) 21 (15.7) 48 (35.8) 54 (40.3) 10 (7.5) 0 (0) 47.8 (1&2) 3.38 
(0.86) 
3.0 (4.0) 
18.  Temperature 133/136 (6) 19 (14.3) 68 (51.1) 30 (22.6) 16 (12.0) 0 (0) 0 (0) 65.4 (1&2) 2.32 
(0.86) 
2.0 (3.0) 
19. Smiling 131/136 (5) 14 (10.7) 50 (38.2) 39 (29.8) 24 (18.3) 3 (2.3) 1 (0.8) 48.9 (1&2) 2.65 
(1.02) 
3.0 (5.0) 
20. Curious 130/136 (6) 10 (7.7) 31 (23.8) 42 (32.3) 40 (30.8) 4 (3.1) 3 (2.3) 33.9 (4&5) 3.04 
(1.09) 
3.0 (5.0) 
21. Crying but 
consolable 
132/136 (4) 14 (10.6) 64 (48.5) 35 (26.5) 15 (11.4) 3 (2.3) 1 (0.8) 59.1 (1&2) 2.48 
(0.96) 
2.0 (5.0) 
22. Inconsolable 130/136 (6) 23 (17.7) 68 (52.3) 25 (19.2) 13 (10.0) 0 (0) 1 (0.8) 52.3 (1&2) 2.24 
(0.91) 
2.0  (5.0) 
23. Glasgow Coma 
Scale 
129/136 (7) 15 (11.6) 43 (33.3) 32 (24.8) 34 (26.4) 5 (3.9) 0 (0) 45.0 (1&2) 2.77 
(1.08) 
3.0 (4.0) 
24. Muscle tone 129/136 (7) 10 (7.8) 69 (53.5) 31 (24.0) 19 (14.7) 0 (0) 0 (0) 61.2 (1&2) 2.45 
(0.83) 
2.0 (3.0) 
25. Pitch of Cry 129 /136 
(7)  
9 (7.0) 53 (41.1) 33 (25.6) 29 (22.5) 4 (3.1) 1 (0.8) 48.1 (1&2) 2.75 
(1.02) 
3.0 (5.0) 
26. Pain 128/136 (8) 4 (3.1) 32 (25.0) 51 (39.8) 35 (27.3) 5 (3.9) 1 (0.8) 31.2 (1&2) 3.06 
(0.93) 
3.0 (5.0) 
27. Conjunctivitis 129/136 (7) 0 (0) 15 (11.6) 49 (38.0) 53 (41.1) 10 (7.8) 2 (1.6) 48.9 (4&5) 3.49 
(0.85) 
4.0 (4.0) 
28. Sore throat 127/136 (9) 1 (0.8) 19 (15.0) 46 (36.2) 49 (38.6) 10 (7.9) 2 (1.6) 46.5 (4&5) 3.42 
(0.92) 
3.0 (5.0) 
29. Otitis media 129/136 (7) 2 (1.6) 13 (10.1) 47 (36.4) 56 (43.4) 10 (7.8) 1 (0.8) 51.2 (4&5) 3.48 
(0.86) 
4.0 (5.0) 
30. Hoarseness 129/136 (7) 5 (3.9) 30 (23.3) 40 (31.0) 45 (34.9) 7 (5.4) 2 (1.6) 40.3 (4&5) 3.19 
(1.03) 
3.0 (5.0) 





129/136 (7) 0 (0) 11 (8.5) 38 (29.5) 53 (41.1) 12 (9.3) 15 (11.6) 50.4 (4&5) 3.86 
(1.08) 
4.0 (4.0) 
33. Hepatomegaly 129/136 (7) 5 (3.9) 37 (28.7) 41 (31.8) 33 (25.6) 3 (2.3) 10 (7.8) 32.6 (1&2) 3.17 
(1.21) 
4.0 (4.0) 
34. Laboratory tests 127/136 (9) 14 (11.0) 47 (37.0) 31 (24.4) 29 (22.8) 6 (4.7) 0 (0) 48.0 (1&2) 2.73 
(1.07) 
3.0 (4.0) 
35. Born second half 129/136 (7) 5 (3.9) 32 (24.8) 44 (34.1) 32 (24.8) 15 (11.6) 1 (0.8) 36.4 (4&5) 3.17 3.0 (5.0) 
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of year (1.07) 
36. Suburban 
residence 










127/136 (9) 19 (15.0) 63 (49.6) 29 (22.8) 13 (10.2) 3 (2.4) 0 (0) 64.6 (1&2) 2.35 
(0.93) 
2.0 (4.0) 
39. Downs’ Syndrome 129/136 (7) 9 (7.0) 58 (45.0) 39 (30.2) 18 (14.0) 5 (3.9) 0 (0) 51.9 (1&2) 2.62 
(0.94) 
2.0 (4.0) 






129/136 (7) 26 (20.2) 67 (51.9) 22 (17.1) 11 (8.5) 3 (2.3) 0 (0) 72.1 (1&2) 2.20 
(0.94) 
2.0 (4.0) 
42. Number of siblings 129/136 (7) 3 (2.3) 21 (16.3) 49 (38.0) 43 (33.3) 13 (10.1) 0 (0) 43.4 (4&5) 3.32 
(0.94) 
3.0 (4.0) 
43. Day care 
attendance 
128/136 (8) 5 (3.9) 27 (21.1) 43 (33.6) 37 (28.9) 15 (11.7) 0 (0) 40.6 (4&5) 3.25 
(1.06) 
3.0 (5.0) 
44. Environmental air 
pollution 
128/136 (8) 5 (3.9) 27 (21.1) 42 (32.8) 43 (33.6) 10 (7.8) 0 (0) 41.4 (4&5) 3.22 
(1.02) 
3.0 (5.0) 
45. Ethnicity 127/136 (9) 0 (0) 6 (4.7) 55 (43.3) 47 (37.0) 18 (14.2) 1 (0.8) 51.2 (4&5) 3.62 
(0.81) 
4.0 (4.0) 
46. Gender 129/136 (7) 1 (0.8) 12 (9.3) 48 (37.2) 49 (38.0) 19 (14.7) 0 (0) 52.7 (4&5) 3.56 
(0.88) 
4.0 (4.0) 





129/136 (7) 29 (22.5) 52 (40.3) 24 (18.6) 18 (13.2) 4 (3.1) 2 (1.6) 62.8 (1&2) 2.39 
(1.16) 
2.0 (5.0) 
49. HMPV infection 126/136 
(10) 
26 (20.6) 40 (31.7) 31 (24.6) 17 (13.5) 4 (3.2) 8 (6.3) 52.4 (1&2) 2.65 
(1.36) 
2.0 (5.0) 
50. Breastfed 129/136 (7) 5 (3.9) 19 (14.7) 57 (44.2) 33 (25.6) 13 (10.1) 2 (1.6) 35.7 (4&5) 3.27 
(1.01) 
3.0 (5.0) 
51. Parental age 127/136 (7) 2 (1.6) 12 (9.4) 52 (40.9) 44 (34.6) 17 (13.4) 0 (0) 48 (4&5) 3.48 
(0.89) 
3.0 (4.0) 
52. Educational needs 
of parents 
128/136 (8) 2 (1.6) 38 (29.7) 46 (35.9) 32 (25.0) 9 (7.0) 1 (0.8) 32 (4&5) 3.08 
(0.95) 
3.0 (5.0) 
53. Family transport 
issues 
128/136 (8) 0 (0) 31 (24.2) 43 (33.6) 40 (31.3) 14 (10.3) 0 (0) 42.2 (4&5) 3.28 
(0.95) 
3.0 (3.0) 
54. Family history of 
atopy 





Appendix 32: Delphi round three 
 








































Criteria for referral/admission to hospital 
1. Oxygen saturations 
less than 97% in air 
 




2. Oxygen saturations 
less than 95% in air 




3. Oxygen saturations 
less than 94% in air 




4. Oxygen saturations 
less than 92% in air 




5. Oxygen saturations 
less than 90% in air 




6. Respiratory rate 
>45bpm 




7. Respiratory rate 
>50bpm 




8. Respiratory rate 
>70bpm 




9. Presence of nasal 
flaring or grunting 




10. Moderate to severe 
intercostal or sub-
sternal recession 












13. <50% feeds in 
preceding 24 hrs 




14. < 4 wet nappies in 
preceding 24 hrs 






15.  Consideration of 
other risk 
factors/social issues 




16. Duration of symptoms 
<5days 




17. Age at presentation 
<18 weeks 




18.  Age at presentation < 
6 months 




Criteria for ‘mild’ bronchiolitis  
20. Would generally not 
be admitted to 
hospital 




21. May have some 
increased work of 
breathing that would 
be acceptable 




22. May have mild 
recession 








24. Will not have head 
bobbing 




25. Will not have 
cyanosis 




26. Will not have 
apnoeas or pauses in 
breathing 




27. May have an 
increased respiratory 
rate but will be no 
greater than 60bpm 




28. May have coughing 
spasms 




29. Will have oxygen 
saturations >92% in 
air 




30. Will have age 
appropriate heart rate 
<150 bpm 




31. Will be taking at least 103/103 (0) 26 (25.2) 63 (61.2) 10 (9.7) 4 (3.9) 0 (0) 0 (0) 86.4 (1&2) 1.92 2.0 
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50-75% of an 
appropriate feed 
intake for weight 
(0.70) (3.0) 
32. May have an element 
of vomiting but 
clinically hydrated  




33. Will have warm 
peripheries 




34. Will have CRT <2 
seconds 




35. Will have more than 
four wet nappies in 
preceding 24 hours 




36. Will be alert and 
active 




37. May be grumpy but 
not irritable  




38. May show some 
signs of improvement 
following 
administration of 
paracetemol or nasal 
pharyngeal suctioning 








Criteria for ‘moderate’ bronchiolitis 
40. May have saturations 
<92% in room air 
requiring 
supplemental oxygen 




41. May have increasing 
oxygen requirements 
(oxygen up to 50-
60%) to maintain 
oxygen saturations 
>92% 












43. May have moderate 103/103 (0) 25 (24.3) 62 (60.2) 3 (2.9) 13 (12.6) 0 (0) 0 (0) 84.5 (1&2) 2.03 2.0 
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tracheal tug (0.88) (3.0) 
44. May have a mild 
grunt 




45. May have self-
correcting apnoeas 
and/or pauses in 
breathing 




46. Will be alert but may 
be getting irritable or 
tired and 
or/exhausted 




47. May have normal 
responsiveness 




48. May have normal 
muscle tone 




49. May be consolable by 
parents 




50. May have a heart rate 
160bpm or just over 




51. May be taking <50% 
oral feeds 












53. May have < four wet 
nappies in preceding 
24 hours or urine 
output <2mLs/kg/hr 




Criteria for ‘severe’ bronchiolitis 








55. Apnoea (+/- 
bradycardia) 
increasing in 
frequency & duration, 
requiring bag and 
mask intervention 













57. Respiratory rate >70 
bpm 





respiratory rate with 
bradycardia 




59. Increased recession 
and effort of breathing 
at rest and or/ 
following naso-gastric 
feeds 






sub-sternal recession  
















64. Persistently raised or 
increasing carbon 
dioxide levels on 
blood gas analysis 
with decreasing pH 








66. Tire with poor 
laboured breathing 








68. Not respond to 
previous treatment 
interventions 




69. A complete inability  
take oral feeds 




70. Clinical signs of 103/103 (0) 59 (57.3) 39 (37.9) 4 (3.9) 1 (1.0) 0 (0) 0 (0) 95.1 (1&2) 1.48 1.0 
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dehydration (0.62) (3.0) 
71. Less an four nappies 
in preceding 24 hours 
or urine output 
<2mLs/kg/hr 




72. Toxic appearance 
(blue/white/grey/blue) 




73. No muscle 
tone/floppy 




74. Alert but inactive and 
or/passive 




75. Decreased level of 
consciousness or 
unresponsive 




76. Handling may cause 
cardiovascular 
instability 




77. Clammy, damp and 
sweaty 




78. Poor perfusion with 
mottled appearance 
























82. Saturations should be 
>90% 




83. Saturations should be 
>92% 




84. Saturations should be 
>93% 




85. Saturations should be 
>94% 




86. Oxygen saturations 
should be stable in 






room air 8-12 hrs 
minimum 
87. Mild respiratory 
recession may be 
observed but 
acceptable 




88. >12 hrs since last 
documented apnoea 




89. >24 hrs since last 
documented apnoea 




90. >48 hrs since last 
documented apnoea 




91. Tolerating 50-75% of 
oral feeds during 
preceding 24 hours 




92. Infant is alert and 
active 







Appendix 33: Delphi round four 
 








































Which of the following criteria should be used when considering referral/admission to hospital for an otherwise healthy infant with bronchiolitis…? 
1. Raised heart rate at 
rest >150bpm 




2. Parents report a 
noticeable reduction 
in number of wet 
nappies/UOP in 
preceding 12 hrs 




3. Consideration of 
other risk factors, 
such as young age, 
chronic lung disease, 
congenital heart 
disease 




4. Duration of symptoms 
<3 days in 
combination with 
other symptoms 




Do you agree or disagree with the following statement that describes an otherwise healthy infant with ‘mild’ bronchiolitis…?  
5. Will have near normal 
wet nappies/urine 
output over preceding 
12 hours 




Do you agree or disagree with the following statements that describe an otherwise healthy infant with ‘moderate’ bronchiolitis…? 
6. May require up to 
50% oxygen to 
maintain saturations 
>92% 








8. May breathe 
irregularly 






9. May have self-
correcting apnoea 




10. May be 
irritable/restless 








12. May appear unwell 
(pale) 




13. May have altered 
behaviour/routine 




In an otherwise healthy infant with bronchiolitis which of the following saturation levels should be used for hospital discharge? 
14. Saturations >90% in 
room air – asleep  




15.  Saturations >92% in 
room air – asleep  




16. Saturations >93% in 
room air – asleep 




17. Saturations >94% in 
room air – asleep  




18. Saturations >90% in 
room air – 
awake/settled 




19. Saturations >92% in 
room air – 
awake/settled 




20. Saturations >93% in 
room air – 
awake/settled 




21. Saturations >94% in 
room air – 
awake/settled 




22. >12 hours since last 
documented apnoea 
– self correcting 




23. >24 hours since last 
documented apnoea 
– self correcting 




24. >48 hours since last 
documented apnoea 
– self correcting 



























In an otherwise healthy infant who has required oxygen during hospital admission, how long should their saturations be stable in room air before discharge is 
considered? 












    




Which adjective best describes the appearance of a ‘severe’ infant?  




















Appendix 34: LIBSS-PRO (Version 7.0) 
 





Hospital:  Test Number:  
Time Test Started: 
 




   
Total Time Taken: 
 





Does the infant have any of the following risk factors for severe disease? 
Please tick all applicable boxes 
Chronic Lung Disease Congenital Heart Disease 
Neurological Disorders Immunodeficiency 
Down’s Syndrome Gestational age less than 37 weeks 












Instructions for use: Circle all applicable scores then total 
                  Symptoms                                 Score 
Professional 




None or mild concerns                                            
Mild concerns        Moderate concerns                                   
















No apnoeas observed                               
 
Short pauses / irregular breathing              
 
Apnoeas increasing in frequency  
and or/duration that are self correcting  
 
Apnoeas  increasing in frequency and or 
/ duration that require stimulation                                
 

















Tracheal Tug      









Head bobbing                                          
Grunting                                                 
Nasal Flare                                              
Accessory Muscle Use     
Sub-sternal recession                 
See saw chest movement                         
Dyspnoea    

























25-59 BPM                                              
60-70 BPM                                               
Greater than 70 BPM or less than 



















Greater than 65 BPM or less than 






Saturations 92% or above in air                    
 
Requires up to 50% oxygen to maintain 
saturations 92% or above  
 
Requires over 50% oxygen to 









If infant has chronic lung disease or congenital heart disease please substitute saturations of 92% for accepted level of 
saturations when well. 
Air Entry on  
Auscultation 
Good air entry                                         
Reduced air entry      







Not required  / normal values                                         
Rising PcO2 with normal pH                       






















105-165 BPM                                          
165-180 BPM                                          
Greater than 180 or less than 105 


















Greater than 160 BPM or less than 














Alert & Active                                          
 
Lethargic/restless/ reduced interaction       
 
Responds to voice / passive / quiet  
/ no interaction                                        
 
Responds to pain                                     
 




















Normal appearance,  
behaviour & routine                                 
 
Appears unwell (pale) & altered  
behaviour & routine                                 
 
Appears lifeless  
(floppy/grey/white/blue/mottled/ 



















Taking usual amount of feeds                   
 
Taking 50-75% of oral feeds                     
 
Taking less than 50% of oral feeds  
















Producing normal amount of wet 
nappies over preceding 12 hours  
(2mLs/kg/hr)                                           
 
Noticeable reduction in number of wet 
nappies in preceding 12 hours (1-
2mLs/kg/hr)                                            
 
Small volumes of concentrate urine 
or anuric in preceding 12 hours  























Central capillary refill time greater than 














 Sunken fontanelle                                    
Sunken eyes       
 
 







   
Overall Score  
Total 






Day of Illness: 
Date/TIME              
41.5 
                             
41 
            41.5 
                             
41 
41             41 
40.5             40.5 
40             40 
39.5             39.5 
39             39 
38.5             38.5 
38             38 
Temperature                
37.5 
            37.5 
C                                 
37 
            37 
36.5             36.5 
36             36 
35.5             35.5 
35             35 
              
230             230 
220             220 
210             210 
200             200 
190             190 
180             180 
170             170 
160             160 
150             150 
Blood                140                     
140  14-140140 
            140 
Pressure mmHg  130 
130 
            130 
120             120 
110             110 
100             100 
Pulse rate            90                       90 
80             80 
70             70 
60             60 
50             50 
40             40 
Respirations         30             30 
20             20 
10             10 
            5             5 
0             0 
O2 saturation  %               
Administered O2 % 
Litres / min or % 
             
Method of  O2 
Delivery 
Administration 
             
LIBS Score 
Effort of breathing 
             
Apnoea Score 
Capillary refill time 
secs 
             
*Activity 
Blood glucose 
             
*Activity at the time of score: Awake (A); Feeding (F); Sleeping (Sg); Crying (C); Paracetamol (Pl); Suction (Sn); Nebuliser (Nr)      






Appendix 35: Content validity evaluation form 
 
Hospital:  Test Number: 
How relevant are the following domains and items, to you, when assessing and infant with 


























If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 





Apnoea increasing in 
frequency and or/ 
duration that are self-
correcting (with or without 
bradycardia) 
 
Apnoea increasing in 
frequency and or/ 
duration that require 
stimulation (with or 
without bradycardia) 
 
Apnoea that require bag 
& mask ventilation (with 













































































If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 





Accessory muscle use 
Sub-costal recession 
See saw chest movement 
Dyspnoea 
















































If irrelevant or completely irrelevant why? 








Greater than 70 or less 





















Greater than 65 or less 
















If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 
Saturations & 
oxygenation 
Saturations 92% and 
above in air 
 
Requires up to 50% 
oxygen to maintain 
saturations 92% or above 
 






































If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 
Air entry on 
auscultation 
Good air entry 
Reduced air entry 













If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 
Blood gas analysis Not required/normal 
values 
Rising PCO2 with normal 
pH 






















If irrelevant or completely irrelevant why? 







Greater than 180 or less 
















Greater than 160bpm or 













If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 
Neurological 
assessment 




























































If irrelevant or completely irrelevant why? 




routine & behaviour 
 
Appears unwell (pale), 







































Mottled exhausted)  
 
If irrelevant or completely irrelevant why? 




Feeds Taking usual amount of 
feeds 
 
Taking 50-75% of oral 
feeds 
 
Taking less than 50% of 

































Normal amount of wet 
nappies over preceding 
12 hours (2mLs/kg/hr) 
 
Noticeable reduction in 
number of wet nappies in 
preceding 12 hours (1-
2mLs/kg/hr) 
 
Small volumes of 
concentrate urine or 
anuric in preceding 12 










































Perfusion Central capillary refill time 
greater than 2 seconds 


















If irrelevant or completely irrelevant why? 
Why did you assign the score that you did for this domain? 
Should any of the domains/items be removed from the score-if so which ones? 
How easy or hard was it for you to complete the scoring instrument? If hard – why? 
Did you find the scoring instrument to be clear or confusing? If confusing – why? 
Did you like or dislike the layout? If dislike – why? 
Do you feel the score can be completed in a reasonable amount of time? 
Do you have any suggestions that would help to improve the scoring instrument? 
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Appendix 36: Content validity testing – evaluation analysis 
























’gut feeling ’ 
























2. Apnoea  


































































3. Effort of 
breathing 
Tracheal tug 




Accessory muscle use 
Sub-costal recession 
See saw chest movement 
Dyspnoea 









































































Under three months  
25-59 bpm 
60-70 bpm 
>70 or <20 bpm 
 
Three months and over 
20-55 bpm 
56-65 bpm 




































































<50% oxygen  
























6. Air entry Good air entry 
Reduced air entry 






















7. Blood gas 
analysis 
Not required/normal values 
Rising PcO2 with normal 
pH 

























8. Heart rate Under three months 
105-165 bpm 
165-180 bpm 
>180 or <95bpm 
 
Three months and over 
95-45 bpm 
146-160 bpm 


































































Alert & Active 
Reduced interaction 
Responds to voice 







































































11. Hydration & 
perfusion 
Feeds 
Usual amount of oral feeds 
50-75% oral feeds 






























Normal amount of nappies 































CRT >2 seconds 







































































    *    *  N=2 
<ST4   *     *   N=2 
Intensivist Consulta
nt 




  *       N=1 
Band 7   *       N=1 
Band 6 *      *   N=2 
Band 5 *      *  * N=3 
HCA 3/ 
AP 
    *    *  N=2 








Date /Time              
Symptoms Scores             
Professional 
Concerns / ‘Gut 
feeling’ 
No concerns 0             
Mild to moderate 
concerns 
2             











No apnoeas  0             
Short pauses / irregular 
breathing 
 
2             
Self-correcting apnoeas  
(increasing in frequency 
/ duration) 




frequency / duration) 
6             
Apnoeas requiring 
bag & mask 
ventilation 















Tracheal Tug 0 1 2             
Sub/intercostal 
recession 
0 1 2             
Absent = 0; Mild = 1; Marked = 2 
Sub-sternal recession 0 1             
Head bobbing 0 1             
Grunting 0 1             
Nasal flare 0 1             
Accessory muscle use 0 1             
Abdominal breathing 0 1             
Central cyanotic 
episodes 
0 4             
Absent = 0; Present = 1 or 4 
Respiratory 
Rate: 
Under 3 months 
25-59 BPM 0             
60-70 BPM 2             
>70 or < 25BPM 4             
Respiratory 
Rate:  3 months 
and over 
20-55 BPM 0             
56-65 BPM 2             
>65 or <20 BPM 4             





Room air (21%)  0             
22-40% 
 Nasal cannula 
up to 2L 
 Face mask 
without 
reservoir bag 
 Head box / 
optiflow / CPAP 
2             
41-50% 
 Head box / 
Optiflow / CPAP 
4 
 




 Face mask with 
reservoir bag 





            
In chronic lung or congenital heart disease substitute saturations of 92% for 
accepted level of saturations when well. 
Heart Rate:  
Under 3 months 
105-165 BPM 0             
166-180 BPM 2             
>180 or <105 BPM 4             
Heart Rate: 
3 months and 
over 
95-145 BPM 0             
146-160 BPM 2             
> 160 or < 95 BPM 4             





Alert & active / normal 
sleep 
0             
Irritable / fractious / 
restless 
2             
Lethargic / Floppy / No 
interaction with parents 
4             




Usual amount of feeds        0             
50-75% of feeds 2             
<50% of feeds (NG 
feeds or IVI fluids) 




Usual amount of wet 
nappies 
0             
Reduction in number of 
wet nappies 
2             
Small volumes of 
concentrated urine or 
anuric 
4             
Hydration & 
perfusion 
Capillary refill time > 2 
seconds 
0 2             
Sunken eyes / 
fontanelle 
0 2             
Score Totals  
 
            
 Consider urgent review by senior Dr 











             
Symptoms Scores             
Professional 
Concerns / ‘Gut 
feeling’ 
No concerns 0             
Mild to moderate concerns 2             










No apnoeas  0             
Short pauses / irregular 
breathing 
2             
Self-correcting apnoeas  
 increasing 
frequency/duration  
 no bradycardia 







 +/- bradycardia) 
6             
Apnoeas  
 requiring bag & 
mask ventilation  
 +/- bradycardia 












Sub/intercostal recession 0 1 2             
Tracheal tug 0 1             
Sub-sternal recession 0 1             
Head bobbing 0 1             
Grunting 0 1             
Nasal flare 0 1             
Central cyanotic episodes 
(blue tongue/ mucous 
membranes) 
0 4             
Absent = 0; Present = 1 or 4; Severe = 2  
Respiratory 
Rate: 
Under 3 months 
25-59 BPM 0             
60-70 BPM 2             
>70 or < 25BPM 4             
Respiratory 
Rate:  3 months 
and over 
20-55 BPM 0             
56-65 BPM 2             
>65 or <20 BPM 4             











Room air (21%)  0             
22-40% 
 Nasal cannula up to 
2L 
 Face mask without 
reservoir bag 
 Head box / Optiflow 
/ CPAP 
2             
41-50% 











 Face mask with 
reservoir bag 




            
Heart Rate (at 
apex with 
stethoscope):  
Under 3 months 
105-165 BPM 0             
166-180 BPM 2             
>180 or <105 BPM 4             
Heart Rate (at 
apex with 
stethoscope): 
3 months and 
over 
95-145 BPM 0             
146-160 BPM 2             
> 160 or < 95 BPM 4             





Alert & active / normal sleep 0             
Irritable / fractious / restless 2             
Lethargic / floppy / poor 
interaction 
4             
 Responds to pain 
/unresponsive 




Usual amount of feeds        0             
50-75% of feeds 2             
<50% of feeds or 
requiring nasogastric 
feeds / intravenous fluids 
4             
Hydration & 
perfusion:  
urine output  
Usual amount of wet 
nappies 
0             
Reduction in number of wet 
nappies 
2             
Small volumes of 
concentrated urine / not 
passing urine 
4             
Hydration & 
perfusion 
Central capillary refill 
time > 2 secs 
0 4             
Sunken eyes / fontanelle 0 2             
Score Totals  
 
            
 Consider urgent review by senior Dr 




Appendix 40: LIBSS-PRO (Version 9.2): Under 
three months and Three months and over 
















Hospital:                      Test Number:  
Time Test Started: 
Time Test Completed: 
Total Time Taken: 
Liverpool Infant Bronchiolitis Severity 
Score 
Infant aged under 3 Months 
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Liverpool Infant Bronchiolitis Severity Score: Infant aged under three months 
Day of illness: 
1. Do you have any concerns relating to the infant’s overall condition? 
No concerns                 ( condition is stable or improving) 0  Comments: 
Some concerns (may become unstable/requires close observation) 4  
Extremely concerned (unstable requires immediate medical review) 8  
2. Apnoea 
None                                     0  Comments: 
Occasional self-correcting apnoea / short pauses                    2  
Apnoea’s increasing frequency & duration  4  
Apnoea’s requiring stimulation                6  
Apnoea’s requiring bag & mask ventilation                       8  
3. Increased work of breathing                                (Absent or Mild =0) Please complete all boxes 
Moderate/severe recession      0 2  Comments: 
Moderate/severe tracheal tug   0 2  
Moderate/severe nasal flare     0 2  
Moderate/severe head bobbing 0 4  
Grunting 0 4  
Central cyanosis (blue lips / tongue) 0 6  
4. % oxygen to maintain saturations >92% (or usual saturation level if infant has congenital heart defect) 
21%         (room air) 0  Comments: 
22 - 40%  (0.02 - 6L/min) 2  
41 - 50%  (7 - 10L/min) 4  
>50%       (>10L/min) 6  
Actual amount of oxygen administered  
Mode of oxygen delivery: Nasal specs (NS); Face Mask (FM); Head box 
(HB); HiFlow (HF); nCPAP (CP) 
 
5. Respiratory rate (breaths per minute) 
25 - 59 0  Comments: 
60 - 70 2  
<25 or >70 4  
6. Heart rate (beats per minute) 
105 - 165 0  Comments: 
166 - 180 2  
<105 or >180 4  
7. Appearance 
Alert & active / normal sleep  0  Comments: 
Irritable / fractious / restless 2  
Floppy / lethargic / poor interaction 4  
Only responds to pain / unresponsive 6  
AVPU   
8. Feeding 
>75% or normal amount of feeds via usual route 0  Comments: 
50 - 75% of feeds of normal feeds via usual route 2  
<50% of feeds or needing NG feeds / IV fluids 4  
9. Urine output 
Usual number of wet nappies                     (> 2 mLs /kg/hr) 0  Comments: 
    Reduction in number of wet nappies                        (1 - 2 mLs 
/kg/hr) 
2   
Small volumes of concentrated urine / no urine      (< 
1mL/kg/hr)  
4  
10. Central capillary refill time (preferably press on the sternum for 5 seconds) 
< 2 seconds 0  Comments: 
> 2 seconds 2  
Actual capillary refill time in seconds  
LIBSS Score Total: 






Liverpool Infant Bronchiolitis Severity Score: Infant aged three months and over 
Day of illness: 
1. Do you have any concerns relating to the infant’s overall condition? 
No concerns                (condition is stable or improving) 0  Comments: 
Some concerns (may become unstable/requires close observation) 4  
Extremely concerned (unstable requires immediate medical review) 8  
2. Apnoea 
None                                     0  Comments: 
Occasional self-correcting apnoea / short pauses                    2  
Apnoea’s increasing frequency & duration  4  
Apnoea’s requiring stimulation                6  
Apnoea’s requiring bag & mask ventilation                       8  
3. Increased work of breathing                                (Absent or mild =0)  Please complete all boxes in this section 
Moderate/severe recession        0 2  Comments: 
Moderate/severe tracheal tug        0 2  
Moderate/severe nasal flare  0 2  
Moderate/severe head bobbing       0 4  
Grunting 0 4  
Central cyanosis (blue lips / tongue) 0 6  
4. % oxygen to maintain saturations >92% (or usual saturation level if infant has congenital heart defect) 
21%          (room air) 0  Comments: 
22 - 40%   (0.02 - 6L/min) 2  
41 - 50%   (7 - 10L/min) 4  
>50%        (>10L/min) 6  
Actual amount of oxygen administered  
Mode of oxygen delivery: Nasal specs (NS); Face Mask (FM); Head box 
(HB); HiFlow (HF); nCPAP (CP) 
 
5. Respiratory rate (breaths per minute) 
20 – 55 0  Comments: 
56 – 65 2  
<20 or >65 4  
6. Heart rate (beats per minute) 
95 – 145 0  Comments:  
146 – 160 2  
<95 or >160 4  
7. Appearance 
Alert & active / normal sleep  0  Comments: 
Irritable / fractious / restless 2  
Floppy / lethargic / poor interaction 4  
Only responds to pain/unresponsive 6  
AVPU Score  
8. Feeding 
>75% of feeds or normal amount of feeds via usual route 0  Comments: 
50 - 75% of feeds via usual route 2  
<50% of feeds or needing NG feeds / IV fluids 4  
9. Urine output 
Usual number of wet nappies                                    (> 2 mLs /kg/hr) 0  Comments: 
Reduction in number of wet nappies                        (1 - 2 mLs /kg/hr) 2  
Small volumes of concentrated urine / no urine      (< 1mL/kg/hr)  4  
10.Central capillary refill time (preferably press on the sternum for 5 seconds) 
< 2 seconds 0  Comments: 
> 2 seconds 2  
Actual capillary refill time in seconds  
LIBSS Score Total 




Appendix 41: Senior paediatrician assessment proforma 
Please assign a category which best describes the ‘severity’ of illness of the infants’ condition 
Criteria for ‘mild’ bronchiolitis 
 Would generally not be admitted to hospital 
 Some increased work of breathing 
 Mild recession 
 Respiratory rate < 60 BPM 
 Oxygen saturations >92% in room air 
 Heart rate < 150 BPM 
 Coughing spasms 
 Taking usual feeds or at least 50-75% of an appropriate feed for 
weight  
 Maybe vomiting but clinically hydrated 
 Peripherally warm 
 Central capillary refill < 2 seconds 
 Usual amount of wet nappies 
 Alert & active 
Will not have grunting, head bobbing, cyanosis, apnoeas / irregular 
breathing 
In your opinion does the infant have ‘mild’ bronchiolitis?        
 
 Yes                  No 
 
Comments: 
Criteria for ‘moderate’ bronchiolitis 
 Saturations < 92% in room air – requiring supplemental oxygen 
 Moderate sub/inter-costal recession 
 Moderate tracheal tug 
 Mild grunt  
 Irritable / restless 
 Consolable by parents 
 Heart rate160 BPM or just over 
 Taking less than 50% of feeds orally (NG feeds / IVI fluids) 
 Reduction in urine output 
 Getting tired 
 Appears unwell  
 Altered behaviour routine 
 Normal responsiveness / muscle tone 
In your opinion does the infant have ‘moderate’ bronchiolitis?        
 





Criteria for ‘severe’ bronchiolitis  
 Significant hypoxia with oxygen requirements > 50%  
 Apnoeas (+/- bradycardia), increasing in frequency, requiring 
stimulation and or bag and mask ventilation. 
 Apnoeas (+/- bradycardia) increasing in frequency and or 
duration despite non-invasive ventilation 
 Respiratory rate > 70 BPM 
 Decreasing respiratory rate with bradycardia 
 Increased recession and effort of breathing at rest and or / 
following NG tube feeds 
 Severe sub / inter-costal recession / sub-sternal recession 
 Head bobbing / grunting / nasal flaring 
 Persistently raised or increasing carbon dioxide level with 
decreasing pH 
 Exhausted 
 Appears lifeless 
 Getting tired with poor laboured breathing 
 Reduced air entry 
 No response to previous treatment interventions 
 Complete inability to take oral feeds 
 Clinical signs of dehydration 
 Passing small volumes of concentrated urine / anuric 
 No muscle tone / ‘floppy’ 
 Decreased level of consciousness / unresponsive 
 Cardiovascular instability on handling 
 Clammy / sweaty 
 Poor perfusion with mottled appearance 
 High temperature 
 Cardio/respiratory arrest 
In your opinion does the infant have ‘severe’ bronchiolitis?        
 
























0.49 [0.28-0.64] 1.48 (1.93) 122/128 (6) 0.46 [0.23-0.62] 1.15 (1.81) 
Apnoea 127/128 (1) -0.12 [-0.59-0.20] 0.09 (0.42) 123/128 (5) -0.97 [-0.56-0.23] 0.08 (0.39) 




























































127/128 (1) 0.97 [0.96-0.98] 1.21 (1.28) 123/128 (5) 0.97 [0.96-0.98] 1.28 (1.23) 
Heart rate 124/128 (4) 0.71 [0.59-0.79] 0.56 (1.03) 123/128 (5) 0.70 [0.57-0.79] 0.42 (1.00) 
Appearance 126/128 (2) 0.54 [0.35-0.68] 0.44 (0.97) 123/128 (5) 0.41 [0.16-0.59] 0.28 (0.73) 
Feeding 126/128 (2) 0.80 [0.72-0.86] 2.11 (1.68) 123/128 (5) 0.80 [0.71-0.86] 1.97 (1.63) 
Urine Output 126/128 (2) 0.73 [0.62-0.81] 0.52 (0.95) 123/128 (5) 0.72 [0.60-0.80] 0.44 (0.83) 
CRT 125/128 (3) -0.14 [-0.63-0.19] 0.13 (0.49) 123/128 (5) 0.22 [-0.11-0.45] 0.05 (0.31) 
LIBSS-PRO score 
Total 
127/128 (1) 0.83 [0.75-0.88] 9.65 (7.25) 123/128 (5) 0.84 [0.77-0.89] 8.33 (7.03) 
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0.86 [0.80-0.90] 1.20 (1.84) 124/128 (4) 0.86 [0.80-0.90] 1.16 (1.82) 
Apnoea 124/128 (4) 0.35 [0.07-0.54] 0.10 (0.43) 124/128 (4) 0.83 [0.76-0.88] 0.08 (0.39) 




























































124/128 (4) 0.95 [0.93-0.96] 1.27 (1.28) 124/128 (4) 0.95 [0.93-0.96] 1.27 (1.23) 
Heart rate 123/128 (5) 0.50 [0.28-0.65] 0.55 (1.12) 122/128 (6) 0.50 [0.28-0.65] 0.41 (0.99) 
Appearance 123/128 (5) 0.72 [0.60-0.80] 0.28 (0.73) 124/128 (4) 0.69 [0.56-0.78] 0.27 (0.73) 
Feeding 124/128 (4) 0.96 [0.94-0.97] 1.85 (1.61) 123/128 (5) 0.94 [0.92-0.96] 1.98 (1.65) 
Urine Output 123/128 (5) 0.93 [0.90-0.95] 0.46 (0.84) 123/128 (5) 0.93 [0.90-0.95] 0.46 (0.84) 
CRT 124/128 (4) 0.78 [0.68-0.84] 0.16 (0.54) 122/128 (6) 0.26 [-0.04-0.48] 0.05 (0.31) 
LIBSS-PRO score 
Total 
124/128 (4) 0.92 [0.89-0.94] 8.27 (6.73) 124/128 (4) 0.93 [0.91-0.95] 8.35 (7.01) 
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